Ensembl_ID	Gene_symbol	logFC	FDR	Comparison	LncBook ID	Type	Conservation	miRNA	GWAS	nearest PC	Top correlated gene
ENSG00000117242	PINK1-AS	-1.28121811328699	4.03950310707398e-6	M1_vs_M0	HSALNG0001460	intronic_antisense	Not conserved	NA	-	DDOST	TIPIN
ENSG00000122043	LINC00544	-6.30362698215606	3.52860554638428e-6	M1_vs_M0	HSALNG0096079	integenic	Not conserved	hsa-miR-4478	-	MTUS2	ENSG00000259081
ENSG00000125462	MIR9-1HG	3.77928047198868	8.88619943841961e-13	M1_vs_M0	HSALNG0007588	sense	Not conserved	NA	NA	MEF2D	KRT8P46
ENSG00000132832	NA	5.15932656519308	0.00947900307683406	M1_vs_M0	HSALNG0146964	integenic	Not conserved	NA	NA	ADA	NIPAL4
ENSG00000136315	RNASE2CP	-3.21940603642788	1.2579705367309099e-12	M1_vs_M0	HSALNG0099840	integenic	Not conserved	NA	NA	RNASE3	ZNF252P
ENSG00000163597	SNHG16	2.23589488563808	3.0786255626009896e-89	M1_vs_M0	HSALNG0118862	integenic	Not conserved	NA	Adolescent idiopathic scoliosis,Macular telangiectasia type 2,-	PRCD	GRB2
ENSG00000167912	TOX-DT	-3.95413352560675	3.39954091984759e-8	M1_vs_M0	HSALNG0065583	anti_sense	Q75	hsa-miR-1237-5p,hsa-miR-4467,hsa-miR-3960,hsa-miR-1199-5p,hsa-miR-6763-5p	-	SDCBP	ENSG00000267546
ENSG00000174370	KCNJ5-AS1	-2.50133488207565	8.637261419742529e-75	M1_vs_M0	NA	NA	NA	NA	NA	TP53AIP1	WDR76
ENSG00000174403	CRMA	2.50239508943525	7.04688161407219e-5	M1_vs_M0	HSALNG0131539	integenic	Q50	hsa-miR-612,hsa-miR-762,hsa-miR-4472,hsa-miR-1343-3p,hsa-miR-6775-3p,hsa-miR-6810-3p,hsa-miR-6877-3p	Brain stem volume measurement; Brain volume measurement,Brain volume measurement,-	GATA5	SPATA33
ENSG00000175728	LINC02873	-6.14510168540303	1.7833318163391e-5	M1_vs_M0	HSALNG0088239	integenic	Q75	NA	-	ADAMTS15	CRYAB
ENSG00000176349	NA	2.78181086945514	6.624234904537e-14	M1_vs_M0	NA	NA	NA	NA	NA	ELFN1	ZNF462
ENSG00000176659	LINC02910	-5.21520825700724	2.167899281848e-52	M1_vs_M0	HSALNG0131382	integenic	Not conserved	NA	NA	CDH26	CCL21
ENSG00000177335	LINC02904	3.8738979888809	4.01175187536398e-42	M1_vs_M0	HSALNG0069224	integenic	Not conserved	hsa-miR-210-5p,hsa-miR-326,hsa-miR-331-3p,hsa-miR-939-3p,hsa-miR-4292,hsa-miR-1343-3p,hsa-miR-6735-5p	-	LY6E	UBTD2
ENSG00000177410	ZFAS1	1.41122218856334	5.011533217815899e-63	M1_vs_M0	HSALNG0130661	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4271,hsa-miR-7112-5p	Body height,Intelligence,Cognitive function measurement,-	DDX27	RAB3IL1
ENSG00000177699	NA	1.87733550773085	6.505884065886381e-14	M1_vs_M0	HSALNG0107519	anti_sense	Q90	NA	Rr interval,-	MORF4L1	ENSG00000230647
ENSG00000177822	TENM3-AS1	7.6134125514247	7.54036050078236e-15	M1_vs_M0	HSALNG0038869	integenic	Q90	NA	NA	DCTD	RLN1
ENSG00000178722	C5orf64	-1.78678596532655	0.0370096924194351	M1_vs_M0	HSALNG0148619	integenic	Q50	hsa-miR-665	-	ZSWIM6	ASB8
ENSG00000178803	ADORA2A-AS1	1.87760860714903	0.0187609718126641	M1_vs_M0	HSALNG0134495	anti_sense	Q50	hsa-miR-370-3p,hsa-miR-6807-3p	Alcohol consumption measurement,Acne,Sodium measurement,Glucagon measurement,Coffee consumption measurement,Supramarginal gyrus volume measurement,Tea consumption measurement,Cups of coffee per day measurement,Serum gamma-glutamyl transferase measurement,Coffee consumption measurement; Tea consumption measurement,Alcohol use disorder measurement; Alcohol consumption measurement,-	GUCD1	MIR186
ENSG00000178977	LINC00324	-2.72668741494923	9.32744432556169e-10	M1_vs_M0	HSALNG0114404	overlap_sense,sense	Q75	hsa-miR-23a-5p,hsa-miR-1260b,hsa-miR-4526	Apolipoprotein a 1 measurement,Mitochondrial dna measurement,Panic disorder; Anxiety disorder,Diastolic blood pressure,-,Neuroticism measurement,Monocyte count	CTC1	KIF20A
ENSG00000179428	IL6-AS1	5.01306153742108	0.0088766852148685	M1_vs_M0	HSALNG0056610	anti_sense,sense	Q50	NA	Platelet count; Aspartate aminotransferase measurement,Cerebrospinal fluid clusterin measurement,C-reactive protein measurement,Leukocyte count,C-reactive protein measurement; Mean corpuscular hemoglobin,Serum albumin measurement,Unipolar depression,Lymphocyte percentage of leukocytes,Serum alanine aminotransferase measurement,Parental genotype effect measurement; Birth weight,Leukocyte count; C-reactive protein measurement; Lymphocyte count,Lymphocyte count,Lung carcinoma,Mean corpuscular hemoglobin,Albumin:globulin ratio measurement; Serum non-albumin protein measurement,Platelet count,Bilirubin measurement,Leukocyte count; Neutrophil count; Myeloid white cell count; 3-hydroxyphenylacetic acid measurement,Serum albumin measurement; C-reactive protein measurement; Body height,Tonsillectomy risk measurement,Longevity; Takayasu arteritis,Eosinophil count,Pulse pressure measurement,Systemic lupus erythematosus,Serum non-albumin protein measurement,Aortic stenosis; Aortic valve calcification,Pulse pressure measurement; Cerebrospinal fluid clusterin measurement,-	STEAP1B	ENSG00000267801
ENSG00000180066	LINC02870	-4.09932321062089	1.96299415334552e-26	M1_vs_M0	HSALNG0081790	integenic	Q50	hsa-miR-1227-5p,hsa-miR-4485-5p,hsa-miR-4514,hsa-miR-4763-3p,hsa-miR-5001-3p,hsa-miR-6813-5p	-	PWWP2B	SEPSECS-AS1
ENSG00000180539	LINC02908	-2.41462969494947	1.1866855538373999e-83	M1_vs_M0	HSALNG0075339	anti_sense	Q50	hsa-miR-210-5p,hsa-miR-619-5p,hsa-miR-4308,hsa-miR-4270,hsa-miR-6752-3p	Leukocyte count,Lymphocyte count,-	PAXX	EDNRA
ENSG00000182257	PRR34	-1.10335778490266	0.0383860320640589	M1_vs_M0	HSALNG0147427	integenic	Not conserved	NA	-	WNT7B	ENSG00000259347
ENSG00000183154	NA	-2.37244854747632	2.6985289768849e-9	M1_vs_M0	HSALNG0150383	anti_sense	Q75	NA	-	BRF2	BRICD5
ENSG00000184566	NA	-2.39129952475546	0.00893891823625279	M1_vs_M0	HSALNG0083549	anti_sense	Not conserved	NA	NA	CAPRIN1	APOE
ENSG00000185168	LINC00482	-1.71813021907099	8.02730317951186e-22	M1_vs_M0	HSALNG0145393	integenic	Not conserved	hsa-miR-6852-5p	-	SLC38A10	CREB3L4
ENSG00000185332	TMEM105	-1.78122539153809	0.0020010906340826	M1_vs_M0	HSALNG0145394	integenic	Q50	hsa-miR-619-5p,hsa-miR-761,hsa-miR-1249-5p,hsa-miR-4447,hsa-miR-4472,hsa-miR-6803-5p	Sugar consumption measurement,-	SLC38A10	ENSG00000259238
ENSG00000185433	LINC00158	10.3003751056074	1.52659660007251e-90	M1_vs_M0	HSALNG0132374	integenic	Not conserved	NA	NA	MRPL39	GSAP
ENSG00000186019	ZNF225-AS1	1.67933648331504	6.45869243164977e-4	M1_vs_M0	HSALNG0126426	anti_sense	Not conserved	NA	Cytokine measurement,-	ZNF235	CDC27
ENSG00000186235	LINC02610	-1.01625385789346	0.00115339521219792	M1_vs_M0	HSALNG0023418	integenic	Not conserved	hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-4685-3p,hsa-miR-6753-5p,hsa-miR-6784-5p,hsa-miR-1273h-5p,hsa-miR-7846-3p,hsa-miR-8072	Chronotype measurement	HES6	DNAH6
ENSG00000186594	MIR22HG	1.13273395078101	1.4613203294144998e-24	M1_vs_M0	HSALNG0113835	anti_sense	Q90	hsa-miR-30d-3p,hsa-miR-30e-3p,hsa-miR-4268,hsa-miR-4433a-3p,hsa-miR-4468,hsa-miR-6735-5p	C-reactive protein measurement; Sex hormone-binding globulin measurement; Alkaline phosphatase measurement; Testosterone measurement; Calcium measurement; Urinary albumin to creatinine ratio; Serum albumin measurement; Triglyceride measurement,Calcium measurement; Blood protein measurement; Sex hormone-binding globulin measurement; Serum albumin measurement,-	TLCD2	ENSG00000269399
ENSG00000187013	LINC02875	-3.67373916830592	7.09537480955314e-4	M1_vs_M0	HSALNG0145122	integenic	Not conserved	hsa-miR-331-3p,hsa-miR-920,hsa-miR-4749-3p	Hypertension; Systolic blood pressure,-	TBX2	SHISA2
ENSG00000187185	NA	-8.74083619413875	1.0904595903773e-32	M1_vs_M0	HSALNG0111803	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-6069	-	KATNB1	ACP2
ENSG00000188185	LINC00265	2.34999780552179	9.787256364812041e-17	M1_vs_M0	HSALNG0057380	sense	Not conserved	hsa-miR-3925-3p,hsa-miR-6089	-	RALA	ITPRIPL2
ENSG00000196696	PDXDC2P-NPIPB14P	1.27066627152613	2.3312171141073e-4	M1_vs_M0	HSALNG0112405	integenic	Not conserved	hsa-miR-3201	Information processing speed,Vital capacity,Age at menarche,-	EXOSC6	CHIC1
ENSG00000196741	LINC01560	-1.28346040601163	0.00554791614106332	M1_vs_M0	HSALNG0137712	anti_sense	Not conserved	NA	NA	ZNF157	ETV1
ENSG00000196756	SNHG17	1.27005232590356	2.0909088630937898e-40	M1_vs_M0	HSALNG0129980	integenic	Q50	hsa-miR-25-5p,hsa-miR-619-5p,hsa-miR-3191-5p,hsa-miR-4323,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-3960,hsa-miR-4690-3p,hsa-miR-6792-3p,hsa-miR-8485	Excessive daytime sleepiness measurement,Response to fenofibrate; Triglyceride change measurement; Response to simvastatin,-	KIAA1755	LAMC1
ENSG00000196951	SCOC-AS1	-1.48087045713954	5.20605318542133e-7	M1_vs_M0	HSALNG0037486	anti_sense	Not conserved	hsa-miR-370-3p	NA	CLGN	ZCCHC10
ENSG00000197180	ATP6AP1-DT	1.24317548899412	6.02377258336897e-22	M1_vs_M0	HSALNG0140852	integenic	Q75	hsa-miR-619-5p,hsa-miR-4297,hsa-miR-4279	NA	DNASE1L1	SLC50A1
ENSG00000197301	HMGA2-AS1	-1.13581336861114	4.78118848015094e-24	M1_vs_M0	HSALNG0092012	anti_sense	Not conserved	NA	NA	LLPH	LPIN2
ENSG00000197503	LINC00477	2.77209019329435	5.48195894167376e-21	M1_vs_M0	HSALNG0089868	integenic	Q50	NA	Cognitive decline measurement,Smoking status measurement,Neutrophil count,-	SOX5	MFAP3L
ENSG00000197536	IRF1-AS1	4.12528266234151	3.369196275899279e-171	M1_vs_M0	HSALNG0044848	anti_sense,sense	Q50	hsa-miR-33b-5p,hsa-miR-4257,hsa-miR-4463,hsa-miR-6748-3p,hsa-miR-6803-5p	Fibrinogen measurement,Chronic obstructive pulmonary disease,Metabolite measurement,Apolipoprotein b measurement,Glycine measurement,Red blood cell distribution width,Neutrophil percentage of leukocytes,Ulcerative colitis; Diastolic blood pressure; Inflammatory bowel disease; Crohn's disease,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Adult onset asthma; Sclerosing cholangitis,Fibrinogen measurement; Sex hormone-binding globulin measurement,Urinary albumin to creatinine ratio,Diastolic blood pressure; Crohn's disease,Atopic asthma,Eosinophil count; Eosinophil percentage of leukocytes,Mean corpuscular hemoglobin,Nasal cavity polyp; Perceived unattractiveness to mosquitos measurement; Adult onset asthma,Serum metabolite measurement; Low density lipoprotein cholesterol measurement; Crohn's disease; Eczema; Systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis; Rheumatoid arthritis; Aspartate aminotransferase measurement,Respiratory system disease; Adult onset asthma,Carotid plaque build,Low density lipoprotein cholesterol measurement,Chronic obstructive pulmonary disease; Smoking status measurement,Neutrophil count,Fibrinogen measurement; Lymphocyte count,Polycystic ovary syndrome,Fibrinogen measurement; Sex hormone-binding globulin measurement; Balding measurement,Neutrophil percentage of granulocytes; Eosinophil percentage of granulocytes; Mosquito bite reaction itch intensity measurement; Basophil count; Mosquito bite reaction size measurement; Eosinophil percentage of leukocytes; Eosinophil count,Mitochondrial dna measurement,Estrogen-receptor positive breast cancer; Breast carcinoma,Inhalant adrenergic use measurement,Cardiovascular disease,Eosinophil count,Diastolic blood pressure,Lymphocyte percentage of leukocytes,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Platelet count,Platelet crit,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Eczema; Allergic rhinitis,Fev/fec ratio,Autoimmune thyroid disease; Psoriasis; Common variable immunodeficiency; Mosquito bite reaction itch intensity measurement; Ulcerative colitis; Ankylosing spondylitis; Basophil count; Systemic lupus erythematosus; Crohn's disease; Mosquito bite reaction size measurement; Celiac disease; Autoimmune disease; Juvenile idiopathic arthritis,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Leukocyte count; Crohn's disease; Eosinophil percentage of leukocytes; Eosinophil count; Sclerosing cholangitis; Aspartate aminotransferase measurement,Hemoglobin a1 measurement,Reticulocyte count; Reticulocyte measurement,-	NA	ENSG00000254287
ENSG00000197815	NA	-2.38990920002383	0.0103824481009101	M1_vs_M0	HSALNG0114992	anti_sense	Not conserved	hsa-miR-4492,hsa-miR-6089	Susceptibility to strep throat measurement	RAI1	ENSG00000279561
ENSG00000197989	SNHG12	1.14316718567599	1.69777492919074e-25	M1_vs_M0	HSALNG0002075	anti_sense	Q50	hsa-miR-363-5p,hsa-miR-324-5p,hsa-miR-3178,hsa-miR-4466,hsa-miR-6089,hsa-miR-6890-3p	-	TAF12	TYMS
ENSG00000198221	AFDN-DT	-4.89400593880922	0.0163885014654601	M1_vs_M0	HSALNG0055209	integenic	Q50	NA	-	FRMD1	AFDN-DT
ENSG00000198496	NBR2	1.0966425813256	2.02949601852176e-8	M1_vs_M0	HSALNG0116616	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-6089	Age at menopause,Neutrophil count,-	NBR1	SPATA25
ENSG00000203364	NA	5.56537019457162	0.00186157057350377	M1_vs_M0	HSALNG0072823	anti_sense	Not conserved	hsa-miR-4488,hsa-miR-6089,hsa-miR-6763-5p	Serum alanine aminotransferase measurement; Aspartate aminotransferase measurement,Aspartate aminotransferase measurement,Dna methylation,Response to tenofovir	CARD19	ENSG00000236885
ENSG00000203392	NA	-1.96664594174241	0.00453856351161119	M1_vs_M0	HSALNG0107312	anti_sense	Not conserved	NA	NA	SNX33	FBXO43
ENSG00000203446	SUGCT-AS1	5.30184324340795	5.00405622504437e-119	M1_vs_M0	HSALNG0057426	anti_sense	Q90	hsa-miR-6089,hsa-miR-6824-3p	-	MPLKIP	SCOC-AS1
ENSG00000203527	SCUBE1-AS1	-4.68126341024918	0.044449197315090803	M1_vs_M0	HSALNG0135784	anti_sense	Not conserved	NA	NA	TSPO	RGS9BP
ENSG00000203688	LINC02487	-6.22617359539289	5.20428619802981e-6	M1_vs_M0	HSALNG0055190	integenic	Not conserved	NA	-	FRMD1	USP51
ENSG00000203709	MIR29B2CHG	2.98627979261162	3.31267717784564e-69	M1_vs_M0	HSALNG0010132	integenic	Q50	NA	Febrile seizure (within the age range of 3 months to 6 years); Mmr-related febrile seizures,Reaction time measurement,Pulse pressure measurement,Red blood cell distribution width	CD34	TMEM62
ENSG00000203876	ADD3-AS1	-4.42770563958169	0.0448816798774854	M1_vs_M0	HSALNG0080557	anti_sense	Q50	NA	Mathematical ability,Mean corpuscular hemoglobin concentration,Biliary atresia,Cortical surface area measurement,Eosinophil count,Eosinophil count; Eosinophil percentage of leukocytes,Monocyte count,-	XPNPEP1	ADD3-AS1
ENSG00000203999	LINC01270	3.72710628188001	5.6344161273355e-7	M1_vs_M0	HSALNG0130755	integenic	Not conserved	NA	NA	CEBPB	ZNF350
ENSG00000204044	SLC12A5-AS1	1.72604817196982	0.045403579882145	M1_vs_M0	HSALNG0130456	anti_sense	Q75	hsa-miR-4258	Blood protein measurement,Triglyceride measurement; High density lipoprotein cholesterol measurement; Apolipoprotein b measurement,-	NCOA5	ZBED3-AS1
ENSG00000204387	SNHG32	1.18230781974805	8.79795531013624e-62	M1_vs_M0	HSALNG0049337	integenic	Not conserved	hsa-miR-4463,hsa-miR-4722-5p,hsa-miR-5680,hsa-miR-6800-3p	Hiv-1 infection,Serum igg glycosylation measurement,Platelet count,Coronary artery disease,Bmi-adjusted hip circumference,Response to thioamide; Drug-induced agranulocytosis,-	HSPA1B	HSD17B6
ENSG00000204581	ACOXL-AS1	-3.35805374303092	0.00463299253797162	M1_vs_M0	HSALNG0017866	anti_sense	Q50	hsa-miR-6741-5p	Bmi-adjusted waist circumference,Chronic lymphocytic leukemia,Churg-strauss syndrome,Prostate carcinoma,Igf-1 measurement,Triglyceride measurement; Serum gamma-glutamyl transferase measurement,Mean corpuscular volume; Lymphocyte count,Hodgkins lymphoma; Chronic lymphocytic leukemia; Multiple myeloma,Drugs used in diabetes use measurement; Erythrocyte count,-	BUB1	CD63-AS1
ENSG00000204682	MIR1915HG	-1.38075611301533	0.00380095313294712	M1_vs_M0	HSALNG0076590	integenic	Q50	hsa-miR-619-5p	Smoking initiation; Parental longevity; Body mass index,-	SKIDA1	DLGAP4
ENSG00000204860	FAM201A	-2.45495697360258	2.1984106032431e-7	M1_vs_M0	HSALNG0071146	anti_sense	Not conserved	hsa-miR-1205,hsa-miR-4281	Obsessive-compulsive disorder; Tourette syndrome,-	ALDH1B1	CPNE4
ENSG00000204876	NA	2.45548029860727	1.19293157163514e-4	M1_vs_M0	NA	NA	NA	NA	NA	RBM33	SPOPL
ENSG00000204929	LINC02934	2.16058880917402	0.0273603908509038	M1_vs_M0	HSALNG0015567	integenic	Not conserved	NA	-	ACTR2	CSPP1
ENSG00000205086	LINC02898	-5.17926567166538	5.71633754451674e-122	M1_vs_M0	NA	NA	NA	NA	NA	COX7A2L	GPC4
ENSG00000205488	CALML3-AS1	-5.0799881132835	0.00679961552739832	M1_vs_M0	HSALNG0075870	anti_sense	Q75	hsa-miR-216a-3p,hsa-miR-500b-3p,hsa-miR-3667-3p,hsa-miR-4691-5p,hsa-miR-4734,hsa-miR-6792-5p	Cortical surface area measurement,-	CALML5	ENSG00000226409
ENSG00000205628	LINC01446	-2.77892794985865	5.03528410167399e-4	M1_vs_M0	HSALNG0058095	integenic	Not conserved	NA	NA	SEC61G	ENSG00000259531
ENSG00000205837	LINC00487	4.90713732716047	3.02440196611267e-10	M1_vs_M0	HSALNG0012718	integenic	Q50	hsa-miR-4430	NA	CMPK2	NEUROD4
ENSG00000205853	RFPL3S	2.02341646938075	2.71709638650324e-4	M1_vs_M0	HSALNG0135027	anti_sense	Not conserved	hsa-miR-30b-3p,hsa-miR-593-3p,hsa-miR-6089	-	RTCB	ATP13A1
ENSG00000205885	C1RL-AS1	1.77940272372262	6.04228141175922e-6	M1_vs_M0	HSALNG0088972	anti_sense	Q50	hsa-miR-4418,hsa-miR-4733-3p,hsa-miR-6090,hsa-miR-6165,hsa-miR-8485	Neuritic plaque measurement,Platelet count,Platelet crit,-	CLSTN3	SARAF
ENSG00000205930	C21orf62-AS1	-1.82815227411181	0.00125307402674271	M1_vs_M0	HSALNG0132731	integenic	Q90	NA	Tea consumption measurement,-	OLIG2	SLCO4C1
ENSG00000206337	HCP5	2.714230243201	7.518143301455239e-89	M1_vs_M0	HSALNG0049264	sense	Not conserved	hsa-miR-4257,hsa-miR-4492,hsa-miR-6769b-5p	Trichloroethylene-induced hypersensitivity,Hiv-1 infection,Female reproductive system disease,Blood protein measurement,Heel bone mineral density,Systemic lupus erythematosus,Mhc class i polypeptide-related sequence a measurement,Uveitis,Reticulocyte measurement,Hiv-1 infection; Mhc class i polypeptide-related sequence a measurement; Susceptibility to common cold measurement; Mean platelet volume,Cervical carcinoma,Body height; Bmi-adjusted hip circumference; Basophil percentage of leukocytes,Platelet component distribution width; Eosinophil percentage of leukocytes,Temporal arteritis; Blood protein measurement,Platelet count; Atopic asthma,Platelet-to-lymphocyte ratio; Bmi-adjusted hip circumference,Bmi-adjusted waist-hip ratio,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Chronic hepatitis c virus infection,Psoriatic arthritis,Cervical intraepithelial neoplasia grade 2/3; Mhc class i polypeptide-related sequence a measurement; Bmi-adjusted hip circumference; Cervical carcinoma,Mosquito bite reaction size measurement; Aspirin use measurement; Calcium channel blocker use measurement,Neutrophil percentage of granulocytes; Eosinophil percentage of leukocytes; Eosinophil percentage of granulocytes,Bmi-adjusted hip circumference,Body weight,Neutrophil percentage of leukocytes,Response to antineoplastic agent,Beta-2 microglobulin measurement,Non-melanoma skin carcinoma,Bmi-adjusted hip circumference; Neutrophil count; Lymphocyte count,Neutrophil count,Bmi-adjusted waist-hip ratio; Red blood cell distribution width,Iritis,17-hydroxyprogesterone measurement,Blood protein measurement; Trefoil factor 3 measurement,Mhc class i polypeptide-related sequence a measurement; Hemoglobin measurement,Platelet-derived growth factor bb measurement,Autism spectrum disorder,Mean platelet volume,Platelet count,Age at diagnosis,Eosinophil count,Platelet aggregation; Prostate carcinoma,Uterine fibroid; Bmi-adjusted waist-hip ratio,Red blood cell distribution width,Keratinocyte carcinoma; Squamous cell carcinoma,Apolipoprotein b measurement,Intelligence,Lung carcinoma,Mhc class i polypeptide-related sequence a measurement; Blood protein measurement,Body height; Stromal cell-derived factor 1 alpha measurement,Granulocyte percentage of myeloid white cells,Susceptibility to mononucleosis measurement,Platelet component distribution width,Hiv-1 infection; Aids; Psoriasis; Drug-induced liver injury,Renal system measurement,Myositis,Polymyositis; Physical activity measurement; Bmi-adjusted waist-hip ratio; Myositis,Eosinophil count; Platelet count,Cytokine measurement; Herpes zoster,Thyroid peroxidase antibody measurement,Squamous cell lung carcinoma; Mmr-related febrile seizures; Bmi-adjusted waist circumference; Lung carcinoma; Eosinophil count,Appendicular lean mass,Glucose measurement,Platelet-to-lymphocyte ratio,Aging,Bmi-adjusted hip circumference; Mhc class i polypeptide-related sequence b measurement; Bmi-adjusted waist-hip ratio,Upper aerodigestive tract neoplasm; Bmi-adjusted hip circumference; Anilide use measurement; Lung carcinoma; Body weight,Parental longevity,Visual perception measurement,Carpal tunnel syndrome,Herpes zoster,Thyrotoxic periodic paralysis,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Susceptibility to cold sores measurement; Eosinophil percentage of leukocytes,Tonsillectomy risk measurement,Eosinophil percentage of leukocytes,Susceptibility to childhood ear infection measurement,Body height,Lymphocyte count; Basophil count; Myositis; Leukocyte count; Monocyte count,Serum alanine aminotransferase measurement,Bmi-adjusted waist-hip ratio; Mhc class i polypeptide-related sequence b measurement,Angina pectoris,Clinical treatment,Bmi-adjusted waist circumference; Autism spectrum disorder; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Susceptibility to chickenpox measurement,Susceptibility to shingles measurement,Parental genotype effect measurement; Birth weight,Body mass index; Visceral adipose tissue measurement,Response to drug; Drug-induced agranulocytosis,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Toxic epidermal necrolysis; Stevens-johnson syndrome,Eczema; Allergic rhinitis,Response to thioamide; Drug-induced agranulocytosis,Prion disease; Psychotic symptoms,Susceptibility to pneumonia measurement,Human papilloma virus infection; Oropharynx cancer,Bmi-adjusted waist circumference; Hypertension; Bmi-adjusted waist-hip ratio	MICB	XRN1
ENSG00000206344	HCG27	2.0637683525689	1.70444541859069e-4	M1_vs_M0	HSALNG0049246	integenic	Not conserved	hsa-miR-4640-3p,hsa-miR-6769b-5p	Sneeze,Multiple myeloma,Platelet-to-lymphocyte ratio,Bmi-adjusted waist-hip ratio,Squamous cell lung carcinoma; Peptic ulcer and gastro-oesophageal reflux disease (gord) drug use measurement; Upper aerodigestive tract neoplasm; Susceptibility to pneumonia measurement,Blood protein measurement,Intelligence; Diastolic blood pressure; Susceptibility to mycobacterium tuberculosis infection measurement,Cytokine measurement,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Susceptibility to shingles measurement,Lymphocyte count,Bmi-adjusted waist circumference,Bmi-adjusted hip circumference,Serum igg glycosylation measurement,Coronary artery disease,Platelet count,Autism spectrum disorder; Parental longevity,Von willebrand factor measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Autism spectrum disorder,High density lipoprotein cholesterol measurement,Lung carcinoma,Response to thioamide; Drug-induced agranulocytosis,Handedness,Lupus nephritis; Blood protein measurement,-	TCF19	CGN
ENSG00000212719	LINC02693	1.70427299274724	1.57693487235186e-10	M1_vs_M0	HSALNG0115274	integenic	Not conserved	hsa-miR-612,hsa-miR-4268,hsa-miR-3670,hsa-miR-4486,hsa-miR-4492,hsa-miR-4514,hsa-miR-6870-5p,hsa-miR-6879-5p	Protein measurement,-	NATD1	MARCKSL1
ENSG00000213373	LINC00671	-6.57586013636153	4.24951551812289e-7	M1_vs_M0	HSALNG0116587	integenic	Q50	hsa-miR-30b-3p,hsa-miR-363-5p,hsa-miR-331-3p,hsa-miR-619-5p,hsa-miR-1587,hsa-miR-6089,hsa-miR-1273h-5p	Triglyceride measurement,-	BECN1	ACTN4
ENSG00000213468	FIRRE	5.2345919109492	5.25901084956345e-13	M1_vs_M0	HSALNG0140173	integenic	Not conserved	hsa-miR-6089	NA	IGSF1	CHRNB1
ENSG00000213888	LINC01521	-1.87482183599168	1.59217014870071e-4	M1_vs_M0	HSALNG0147275	integenic	Q50	hsa-miR-619-5p	Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,-	DRG1	DERL3
ENSG00000214106	PAXIP1-AS2	-1.29768831201202	1.25699003211402e-9	M1_vs_M0	HSALNG0062534	anti_sense	Q75	NA	Corneal endothelial cell measurement,Cognitive function measurement,-	DPP6	ENSG00000230499
ENSG00000214293	APTR	1.07361556138934	5.24769236765643e-7	M1_vs_M0	HSALNG0059132	anti_sense	Q90	hsa-miR-4279,hsa-miR-4283,hsa-miR-1268b,hsa-miR-6791-3p	Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist-hip ratio,Lymphocyte count,Electrocardiography,Brain volume measurement,Facial morphology measurement,Body height,Serum gamma-glutamyl transferase measurement,Creatinine measurement; Glomerular filtration rate,-,Creatinine measurement,Eosinophil count	TMEM60	ALPL
ENSG00000214353	VAC14-AS1	1.12435621961701	0.0343863928642041	M1_vs_M0	HSALNG0112453	anti_sense	Not conserved	hsa-miR-4456,hsa-miR-6891-3p	NA	IL34	ZNF35
ENSG00000214401	KANSL1-AS1	-1.54593966977864	0.00573619066975876	M1_vs_M0	HSALNG0116913	anti_sense	Q75	hsa-miR-4665-3p,hsa-miR-9899	-	LRRC37A	ENSG00000286064
ENSG00000214894	LINC00243	3.7271464675479	5.6344161273355e-7	M1_vs_M0	HSALNG0049199	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6744-3p	Breast carcinoma,Mean platelet volume,Sleep duration,Cutaneous lupus erythematosus,Intelligence,Angina pectoris,Bmi-adjusted waist-hip ratio,Response to vaccine,Bmi-adjusted hip circumference,Reticulocyte count,Autoimmune thyroid disease; Bipolar disorder,Age-related macular degeneration,Reaction time measurement,Decreased fine motor function,17-hydroxyprogesterone measurement,Cytokine measurement,Protein measurement; Bmi-adjusted hip circumference,Bmi-adjusted hip circumference; Arterial stiffness measurement,Susceptibility to cold sores measurement,Susceptibility to plantar warts measurement,Susceptibility to chickenpox measurement,Susceptibility to shingles measurement,Autism spectrum disorder,Serum igg glycosylation measurement,Response to candesartan,Rosacea severity measurement,Cervical carcinoma,Eosinophil count,Glomerular filtration rate,Susceptibility to urinary tract infection measurement,Tonsillectomy risk measurement,Qrs amplitude; Qrs complex,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,-	IER3	SNAP25
ENSG00000215039	CD27-AS1	-1.73986910726437	7.36488183386822e-24	M1_vs_M0	HSALNG0088857	anti_sense	Q50	hsa-miR-642a-5p,hsa-miR-4292,hsa-miR-3620-5p,hsa-miR-4447,hsa-miR-1587,hsa-miR-6514-3p,hsa-miR-6752-3p,hsa-miR-6784-5p,hsa-miR-6890-3p	-	VAMP1	SPPL2B
ENSG00000215067	ALOX12-AS1	1.17674055068127	1.50312348818578e-10	M1_vs_M0	HSALNG0114242	integenic	Not conserved	hsa-miR-3944-5p	NA	SLC16A11	CCDC30
ENSG00000215458	AATBC	-2.99498669248415	3.90668995251673e-20	M1_vs_M0	HSALNG0133454	anti_sense	Not conserved	hsa-miR-6089	-	CSTB	RTCA
ENSG00000215765	NA	4.61531536136445	0.0351208870566581	M1_vs_M0	HSALNG0127569	sense	Not conserved	NA	Blood protein measurement,Monocyte percentage of leukocytes,-	KIR2DL1	TM4SF19-AS1
ENSG00000215866	LINC01356	-2.3909862110905	0.0420135136389946	M1_vs_M0	HSALNG0006139	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4433a-3p,hsa-miR-4433b-3p	Response to sulfasalazine; Drug-induced agranulocytosis	SLC16A1	DNAAF11
ENSG00000216863	LY86-AS1	1.95063049322086	0.0286305321629409	M1_vs_M0	HSALNG0047825	integenic	Not conserved	NA	NA	F13A1	RAD9A
ENSG00000217825	NA	5.16795434507914	0.00702155994623521	M1_vs_M0	HSALNG0062556	integenic	Not conserved	hsa-miR-3065-3p	NA	PAXIP1	DDX43
ENSG00000221883	ARIH2OS	1.25702827322249	7.46858067620886e-4	M1_vs_M0	HSALNG0025886	anti_sense,sense	Q50	hsa-miR-619-5p,hsa-miR-6089	Platelet crit,-	SLC25A20	ENSG00000253217
ENSG00000222012	NA	-1.79545409010122	0.00358888002450767	M1_vs_M0	NA	NA	NA	NA	NA	DNAJB6	PGRMC1
ENSG00000222031	NA	5.01686983564366	0.0129136924658262	M1_vs_M0	HSALNG0019597	integenic	Q75	hsa-miR-4717-5p	-	RBM43	VWCE
ENSG00000222042	NA	3.34461690662689	0.00633262643700758	M1_vs_M0	HSALNG0132366	integenic	Not conserved	NA	NA	MRPL39	IL6-AS1
ENSG00000222047	C10orf55	-2.33685492491124	5.6665191754625e-4	M1_vs_M0	HSALNG0078890	anti_sense,sense	Q75	NA	-	CAMK2G	CA11
ENSG00000223478	ZDHHC12-DT	-1.85643381190975	8.97471341981444e-7	M1_vs_M0	HSALNG0074656	anti_sense	Not conserved	hsa-miR-4492,hsa-miR-6799-5p	-	PKN3	FICD
ENSG00000223485	LINC01615	-1.71869532189222	5.91247563632214e-8	M1_vs_M0	HSALNG0055330	integenic	Q75	hsa-miR-4492,hsa-miR-4534,hsa-miR-4722-5p,hsa-miR-6514-3p,hsa-miR-6762-5p,hsa-miR-6848-3p	Response to diisocyanate,Central corneal thickness,-	THBS2	DMPK
ENSG00000223511	LINC02968	1.96146774865404	4.44001255985158e-6	M1_vs_M0	HSALNG0151032	integenic	Not conserved	hsa-miR-512-5p	NA	ASMT	ENSG00000289196
ENSG00000223552	CCR5AS	4.20575336439266	1.0475759655941301e-47	M1_vs_M0	HSALNG0025681	anti_sense	Not conserved	hsa-miR-455-3p,hsa-miR-619-5p	Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count,Ccl4 measurement,Leukocyte count,Granulocyte percentage of myeloid white cells,Ccl2 measurement,Aids,Blood urea nitrogen measurement,Monocyte count,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	LTF	CTSL
ENSG00000223725	NA	3.10911360603455	9.29672707525348e-4	M1_vs_M0	HSALNG0021871	integenic	Not conserved	NA	NA	METTL21A	ENSG00000285725
ENSG00000223764	LINC02593	-3.55658135140078	1.28561870783912e-16	M1_vs_M0	HSALNG0000054	integenic	Not conserved	hsa-miR-550a-5p,hsa-miR-550a-3-5p,hsa-miR-3188,hsa-miR-3620-5p,hsa-miR-1587	-	NOC2L	IL22RA1
ENSG00000223768	LINC00205	-1.50141665332226	6.70806219439557e-50	M1_vs_M0	HSALNG0133618	integenic	Q50	hsa-miR-92b-5p,hsa-miR-619-5p,hsa-miR-1205,hsa-miR-3692-5p,hsa-miR-3934-5p,hsa-miR-4472,hsa-miR-4505,hsa-miR-6751-3p,hsa-miR-6803-5p	Systemic lupus erythematosus,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,-	ADARB1	RTL3
ENSG00000223826	LINC01870	-4.6794129401984	0.023709837923617	M1_vs_M0	HSALNG0017377	integenic	Q50	hsa-miR-211-3p	-	CNOT11	SLC30A6-DT
ENSG00000223949	ROR1-AS1	7.29506401199475	3.0172763591998197e-12	M1_vs_M0	HSALNG0004144	anti_sense	Q90	NA	Intelligence,Blood protein measurement,-	ITGB3BP	TBC1D2
ENSG00000223960	CHROMR	2.13214339008415	9.75478870528347e-86	M1_vs_M0	HSALNG0020702	anti_sense	Q50	hsa-miR-6089	Blood protein measurement,Psoriasis; Atopic eczema,-,Oligoclonal band measurement	OSBPL6	INSR
ENSG00000224137	LINC01857	5.17485487461726	1.87785741022274e-12	M1_vs_M0	HSALNG0021881	integenic	Q50	hsa-miR-619-5p,hsa-miR-1285-3p,hsa-miR-6089	-	CCNYL1	CLCA2
ENSG00000224259	LINC01133	-1.4685841934883	0.0074010631435324	M1_vs_M0	HSALNG0007801	integenic	Q50	NA	Visual perception measurement; Granulocyte count,-	KCNJ9	ENSG00000261799
ENSG00000224281	SLC25A5-AS1	-1.13648829569393	0.0185526011869821	M1_vs_M0	HSALNG0139763	anti_sense	Q75	hsa-miR-6085,hsa-miR-6781-5p,hsa-miR-6803-5p,hsa-miR-7155-5p	Body height,Blood urea nitrogen measurement	STEEP1	SLC20A2
ENSG00000224307	LINC02975	-5.3951888742637	9.532354492348569e-22	M1_vs_M0	HSALNG0074715	integenic	Not conserved	hsa-miR-520a-5p,hsa-miR-4492,hsa-miR-4684-3p,hsa-miR-4748,hsa-miR-5693	NA	NA	LRRC77P
ENSG00000224397	PELATON	3.45934766262799	5.0155488939685704e-14	M1_vs_M0	HSALNG0130749	integenic	Q50	hsa-miR-619-5p,hsa-miR-665,hsa-miR-4258,hsa-miR-4284,hsa-miR-4491,hsa-miR-4701-3p,hsa-miR-4733-3p,hsa-miR-6090,hsa-miR-6132,hsa-miR-6748-3p,hsa-miR-6769b-5p,hsa-miR-6887-3p	Hair colour measurement,Monocyte percentage of leukocytes; Mammographic density measurement; Monocyte count,Granulocyte percentage of myeloid white cells; Monocyte count,Gut microbiome measurement,Monocyte percentage of leukocytes,Monocyte count,-	CEBPB	ARFGAP3
ENSG00000224478	NA	3.7271474935879	5.6344161273355e-7	M1_vs_M0	HSALNG0054727	integenic	Not conserved	hsa-miR-6089	Psoriasis vulgaris,Nicotine dependence symptom count; Depressive symptom measurement	FNDC1	ENSG00000241886
ENSG00000224563	LPP-AS1	5.17515211719845	0.00377919818134453	M1_vs_M0	HSALNG0031469	anti_sense	Q50	hsa-miR-6823-5p,hsa-miR-8485	Ccl11 measurement,Neoplasm of mature b-cells,-	BCL6	ENSG00000287126
ENSG00000224596	ZMIZ1-AS1	2.67422735545574	5.29228500164477e-82	M1_vs_M0	HSALNG0079114	anti_sense	Q50	hsa-miR-762,hsa-miR-939-3p,hsa-miR-3195,hsa-miR-4430,hsa-miR-4447,hsa-miR-4472,hsa-miR-4516,hsa-miR-4534,hsa-miR-3960,hsa-miR-6735-3p,hsa-miR-6780a-3p,hsa-miR-6788-5p,hsa-miR-6795-3p,hsa-miR-6803-5p,hsa-miR-6813-5p	Blood osmolality measurement,Hypermetropia,Interleukin 13 measurement,Susceptibility to rubella infection measurement,Body fat distribution,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Testosterone measurement,Mean corpuscular volume; Mean corpuscular hemoglobin; Red blood cell density measurement; Erythrocyte count,Mean corpuscular hemoglobin concentration,Body weight,Mean corpuscular volume,Mean reticulocyte volume; Reticulocyte count; Mean corpuscular volume; Reticulocyte measurement; Erythrocyte count,Mean corpuscular hemoglobin,Red blood cell distribution width,Erythrocyte count,Colorectal cancer; C-reactive protein measurement; Colorectal adenoma,Prostate carcinoma,-	ZCCHC24	GPX4
ENSG00000224614	TNK2-AS1	4.03029771223412	4.34156386845938e-22	M1_vs_M0	HSALNG0031857	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-5787,hsa-miR-6089	Blood urea nitrogen measurement; Creatinine measurement	MUC20	PXT1
ENSG00000224616	RTCA-AS1	-1.70328209233277	4.68944757794285e-10	M1_vs_M0	HSALNG0005524	integenic	Not conserved	hsa-miR-4514	Lung carcinoma,-	DBT	PITPNM2
ENSG00000224666	ETV7-AS1	6.62387739740547	1.22346343709289e-7	M1_vs_M0	HSALNG0049748	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3652,hsa-miR-4674,hsa-miR-6089	Rheumatoid arthritis,Leukocyte count,Mean platelet volume,Eczema; Allergic rhinitis,-	KCTD20	CIBAR1-DT
ENSG00000224738	NA	-2.92090506356057	0.00220964265683806	M1_vs_M0	HSALNG0117749	intronic_antisense	Q75	NA	NA	PRR11	SHKBP1
ENSG00000224939	LINC00184	2.59426764962593	0.0133125441425755	M1_vs_M0	HSALNG0011620	integenic	Q50	hsa-miR-885-3p,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6726-5p	Balding measurement,Red blood cell distribution width,Body height,Heel bone mineral density,Health study participation,Alkaline phosphatase measurement,Lymphocyte count,Reticulocyte count; Reticulocyte measurement; Red blood cell distribution width,Total cholesterol measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement,Eye colour measurement,Cardiac arrhythmia,Reticulocyte measurement; Red blood cell distribution width,Leukocyte count,Apolipoprotein b measurement,-	COA6	ORAI1
ENSG00000224969	NA	4.82259946777791	0.0150138226918283	M1_vs_M0	HSALNG0000070	anti_sense	Not conserved	NA	Blood protein measurement,-	HES4	KRTAP5-1
ENSG00000225032	NA	-1.76374251811709	2.31468360262168e-7	M1_vs_M0	HSALNG0074542	anti_sense	Q50	hsa-miR-6089	-	FPGS	ENSG00000280353
ENSG00000225127	LINC00237	1.06643820658403	0.00123925334107328	M1_vs_M0	HSALNG0129088	integenic	Q50	hsa-miR-920,hsa-miR-4660,hsa-miR-4701-3p,hsa-miR-6763-3p,hsa-miR-6873-3p	Body mass index,-	NKX2-4	ENSG00000248964
ENSG00000225234	TRAPPC12-AS1	1.72881087311762	0.0102632511172436	M1_vs_M0	HSALNG0012576	anti_sense	Not conserved	hsa-miR-3620-5p,hsa-miR-1587	Neurofibrillary tangles measurement,Neuritic plaque measurement; Cerebral amyloid angiopathy; Neurofibrillary tangles measurement,-	ADI1	TMEM123-DT
ENSG00000225280	NA	-2.32515422282467	0.00399332925191964	M1_vs_M0	HSALNG0129109	anti_sense	Q90	NA	Body mass index,Body height; Body mass index,Bmi-adjusted hip circumference,Red blood cell distribution width,-	XRN2	ENSG00000284630
ENSG00000225342	LRRK2-DT	1.61300761809209	1.60182789600475e-4	M1_vs_M0	HSALNG0090483	anti_sense	Q50	NA	Serum gamma-glutamyl transferase measurement,Crohn's disease,Mean platelet volume,Cathepsin l1 measurement,Low density lipoprotein cholesterol measurement,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,-	SLC2A13	ENSG00000273355
ENSG00000225365	NA	-4.67882129797149	0.0311647890635349	M1_vs_M0	HSALNG0062781	anti_sense	Not conserved	hsa-miR-4505,hsa-miR-1587	Hypermetropia,-	DYNC2I1	KIAA1549L
ENSG00000225439	BOLA3-DT	1.68450881920797	0.0039061294419847	M1_vs_M0	HSALNG0016018	anti_sense	Q90	hsa-miR-1237-5p,hsa-miR-4257,hsa-miR-4433a-3p,hsa-miR-4508,hsa-miR-6784-5p	-	MTHFD2	GALNT15
ENSG00000225764	P3H2-AS1	5.00969249209842	0.0074346047703468	M1_vs_M0	HSALNG0031535	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4257,hsa-miR-4433b-3p	-	CLDN16	P3H2-AS1
ENSG00000225791	TRAM2-AS1	-1.44873513574157	5.16289958366763e-12	M1_vs_M0	HSALNG0050617	anti_sense	Q75	hsa-miR-520a-5p,hsa-miR-525-5p,hsa-miR-500b-3p,hsa-miR-6807-3p,hsa-miR-6829-3p,hsa-miR-4433b-3p	Resistin measurement; Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Resistin measurement,Low density lipoprotein cholesterol measurement,Fasting blood glucose measurement,Oxalate measurement,Apolipoprotein b measurement,-	TMEM14A	FNDC3B
ENSG00000225792	SNX10-AS1	3.19536707698442	3.70814302366114e-6	M1_vs_M0	HSALNG0056814	anti_sense	Q90	hsa-miR-4505,hsa-miR-1587,hsa-miR-3960	Bmi-adjusted waist-hip ratio,Blood urea nitrogen measurement; Bmi-adjusted waist circumference,Body weight; Body mass index,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Vaginal microbiome measurement,-	HNRNPA2B1	CCDC125
ENSG00000225886	NA	4.41209851812639	2.1865534666936697e-55	M1_vs_M0	HSALNG0002013	integenic	Not conserved	NA	NA	FAM76A	RIGI
ENSG00000225953	SATB2-AS1	-2.17782438633595	1.77009660045699e-24	M1_vs_M0	HSALNG0021423	anti_sense	Q90	hsa-miR-3620-5p	Body height; Cortical thickness,Body height; Mathematical ability,-	C2orf69	TRIP13
ENSG00000225963	NA	1.16781483322803	5.31910380997295e-5	M1_vs_M0	HSALNG0022854	anti_sense	Q50	hsa-miR-6089,hsa-miR-6763-5p	Subcutaneous adipose tissue measurement,Metabolic rate measurement,Serum non-albumin protein measurement,Obsessive-compulsive disorder; Obsessive-compulsive symptom measurement,-	SP140	TSHZ2
ENSG00000225964	NRIR	4.71526115443717	6.22986027679229e-277	M1_vs_M0	HSALNG0012717	integenic	Q75	NA	Depressive symptom measurement,-	CMPK2	SECTM1
ENSG00000225975	ZNF567-DT	-1.00034949832509	0.00597443608498786	M1_vs_M0	HSALNG0125780	anti_sense	Not conserved	hsa-miR-4463,hsa-miR-6869-3p,hsa-miR-1273h-5p	NA	ZNF461	FTH1P11
ENSG00000226004	LINC02528	11.2473480141576	7.706335598897359e-156	M1_vs_M0	HSALNG0053802	integenic	Q50	NA	Eosinophil count; Ejection fraction measurement; Eosinophil percentage of leukocytes,Cardiac troponin t measurement,Rheumatoid arthritis,-	PERP	ENSG00000253838
ENSG00000226067	LINC00623	1.6471799791019	1.0667271337718999e-51	M1_vs_M0	HSALNG0006641	integenic	Not conserved	NA	NA	PPIAL4A	PDGFD
ENSG00000226091	LINC00937	5.43806408214811	3.4315384189026096e-25	M1_vs_M0	HSALNG0089057	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6089,hsa-miR-6735-5p	Viral load,-	FAM90A1	LY6E-DT
ENSG00000226125	LINC01907	-3.2793493477948	7.908348768531731e-14	M1_vs_M0	HSALNG0022889	integenic	Not conserved	hsa-miR-6089	-	GPR55	SYDE1
ENSG00000226137	BAIAP2-DT	-1.60551720517023	8.6659907418268e-87	M1_vs_M0	HSALNG0119226	integenic	Not conserved	hsa-miR-3943	-	AATK	C5AR2
ENSG00000226149	NA	-2.75130125356512	5.17090632295257e-5	M1_vs_M0	HSALNG0053423	anti_sense	Q50	hsa-miR-6763-5p,hsa-miR-8485	Sporadic amyotrophic lateral sclerosis,Hypermetropia; Self reported educational attainment; Refractive error; Retinal break; Retinal detachment; Age at onset; Myopia; Axial length measurement,Abnormality of refraction,Refractive error,Cortical surface area measurement,Body height,Cortical thickness,Sleep duration,Body mass index,Periodontitis,Cytokine measurement,Response to alcohol,-	ARHGAP18	PRADC1P1
ENSG00000226251	LINC02608	-1.74507197406426	2.07486293201492e-4	M1_vs_M0	HSALNG0010344	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-4707-3p,hsa-miR-6773-5p,hsa-miR-7843-5p	Intelligence,Monocyte count,Hemoglobin measurement; Red blood cell density measurement; Erythrocyte count,Neutrophil percentage of leukocytes; Erythrocyte count,Body height,Granulocyte percentage of myeloid white cells; High density lipoprotein cholesterol measurement; Monocyte percentage of leukocytes,Hypermetropia,Astigmatism,Bmi-adjusted waist-hip ratio,Aspartate aminotransferase measurement,Basophil count; Basophil percentage of leukocytes,Basophil count,Self reported educational attainment,Reticulocyte count,Hair colour measurement,-	PACC1	SRF
ENSG00000226281	NA	-3.37439997602593	5.52709324570844e-5	M1_vs_M0	HSALNG0047836	integenic	Not conserved	hsa-miR-762,hsa-miR-5787	NA	F13A1	FYN
ENSG00000226312	CFLAR-AS1	2.39586149420232	1.56776756678386e-8	M1_vs_M0	HSALNG0021529	anti_sense	Q50	hsa-miR-30b-3p	Total blood protein measurement,-	HYCC2	C9orf72
ENSG00000226409	NA	-5.08015045958168	0.00532140175372561	M1_vs_M0	HSALNG0053288	integenic	Not conserved	NA	NA	HDDC2	ENSG00000226409
ENSG00000226445	THBS2-AS1	-1.19015180409913	1.21138858457662e-4	M1_vs_M0	HSALNG0055336	anti_sense	Not conserved	NA	NA	C6orf120	TRGV8
ENSG00000226527	NA	-4.8949683980845	0.0251801511676782	M1_vs_M0	HSALNG0132741	integenic	Not conserved	NA	NA	C21orf62	RHOA-IT1
ENSG00000226571	NA	-5.86926553740114	6.59621672009211e-5	M1_vs_M0	HSALNG0053886	integenic	Q90	NA	-	HECA	LPAR3
ENSG00000226674	TEX41	2.0632344084879	1.76605853048048e-18	M1_vs_M0	HSALNG0019370	integenic	Q90	hsa-miR-619-5p,hsa-miR-4313,hsa-miR-4257,hsa-miR-4463,hsa-miR-6089,hsa-miR-6131,hsa-miR-6512-3p,hsa-miR-7150	Retinal nerve fibre layer thickness measurement; Retinal layer thickness measurement,Pr interval,Optic disc size measurement,Central corneal thickness; Neutrophil count; Intraocular pressure measurement; Leukocyte count; Monocyte count,Smoking initiation; Intraocular pressure measurement,Neutrophil count,Crohn's disease; Inflammatory bowel disease,Platelet count,Monocyte count,Urate measurement,Intelligence,Body weight; Body mass index,Mathematical ability,Breast carcinoma,Self reported educational attainment; Body mass index,Grip strength measurement,Smoking initiation,Hematocrit; Erythrocyte count,Hemoglobin measurement,Hematocrit,Triglyceride measurement,Hematocrit; Hemoglobin measurement; Chin morphology measurement; Balding measurement,Diastolic blood pressure,Facial morphology measurement,Body height,Hemoglobin measurement; Diastolic blood pressure,Reaction time measurement,Alopecia; Smoking behavior,Risk-taking behaviour; Arterial stiffness measurement,Hematocrit; Hemoglobin measurement,Electrocardiography,Skin aging measurement,Red blood cell density measurement; Erythrocyte count,Heel bone mineral density,Mean arterial pressure,Leukocyte count,Risk-taking behaviour,Atrial fibrillation,Blood phosphate measurement,Systolic blood pressure,Cortical surface area measurement,Lobe attachment; Myeloid white cell count,Arterial stiffness measurement,Neuroimaging measurement; Myeloid white cell count; Cortical thickness,Peak expiratory flow; Fev/fec ratio,Cortical thickness,Self reported educational attainment,Fev/fec ratio,Coronary artery disease,Smoking behavior,Hemorrhoid,Aortic stenosis,Antithrombotic agent use measurement,Creatinine measurement,Lobe attachment,Diet measurement,Protein measurement,Body mass index,Hypermetropia; Myopia,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Cortical surface area measurement; Neuroimaging measurement; Brain measurement,Aortic stenosis; Aortic valve calcification,Response to antihypertensive drug; Left ventricular mass,-	ARHGAP15	TMEM126B
ENSG00000226688	ENTPD1-AS1	-1.06237498105336	0.043701105699363	M1_vs_M0	HSALNG0079858	overlap_antisense,anti_sense	Not conserved	NA	Diverticular disease,White matter hyperintensity measurement,Bmi-adjusted waist circumference,Total blood protein measurement,Age at menopause,Mean corpuscular volume,-	TCTN3	LONP2
ENSG00000226711	FAM66C	-2.30108656506943	0.0196712054253331	M1_vs_M0	HSALNG0089052	integenic	Q50	NA	-	ZNF705A	ENSG00000276256
ENSG00000226756	NA	-2.51258227394106	0.0311298364559585	M1_vs_M0	HSALNG0015489	intronic_antisense	Q90	hsa-miR-4292	Mean corpuscular hemoglobin concentration,Mean corpuscular volume; Mean corpuscular hemoglobin concentration,Mean corpuscular volume; Mean corpuscular hemoglobin,Mean reticulocyte volume; Mean corpuscular volume,-	AFTPH	RPS3AP24
ENSG00000226791	LINC02611	-2.80731649151963	1.0371875572076799e-11	M1_vs_M0	HSALNG0017221	integenic	Q50	hsa-miR-6090,hsa-miR-7113-3p	Eosinophil count; Bipolar disorder,Bipolar disorder,Myositis,-	CRACDL	VRK1
ENSG00000226800	CACTIN-AS1	-1.23957656939228	0.0199491050070944	M1_vs_M0	HSALNG0123289	anti_sense	Q90	hsa-miR-4279,hsa-miR-4286,hsa-miR-6089,hsa-miR-6803-5p,hsa-miR-6813-5p,hsa-miR-6840-5p,hsa-miR-6886-5p	Igfbp-3 measurement,-	GIPC3	ENSG00000284630
ENSG00000226950	DANCR	-2.16728689840903	1.02478978036242e-26	M1_vs_M0	HSALNG0148096	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-7108-3p	Response to citalopram; Mood disorder; Response to escitalopram; Unipolar depression,-	RASL11B	EMC10
ENSG00000227066	NA	-1.05916673389649	2.6902872911297e-5	M1_vs_M0	HSALNG0001417	integenic	Not conserved	NA	NA	PLA2G2F	RPS9
ENSG00000227076	NA	-1.15815930716983	0.0492037941620647	M1_vs_M0	HSALNG0081497	sense	Not conserved	hsa-miR-548b-3p,hsa-miR-937-5p,hsa-miR-4472,hsa-miR-6780b-5p	Response to drug,-	PTPRE	ENSG00000272316
ENSG00000227398	KIF9-AS1	-1.52050898261437	0.0185497704598539	M1_vs_M0	HSALNG0025756	integenic	Not conserved	hsa-miR-4259,hsa-miR-6089,hsa-miR-8485	NA	KLHL18	RBM33-DT
ENSG00000227467	LINC01537	-4.88317771875189	7.02247467833482e-10	M1_vs_M0	HSALNG0141635	anti_sense	Not conserved	NA	-	ATG16L2	SKA1
ENSG00000227486	NA	1.47016155238357	6.56789557773336e-4	M1_vs_M0	HSALNG0138143	integenic	Q90	hsa-miR-4279,hsa-miR-4488,hsa-miR-6132,hsa-miR-6816-5p,hsa-miR-7111-3p	Prostate specific antigen measurement,Androgenetic alopecia,3-hydroxy-1-methylpropylmercapturic acid measurement,Neuroticism measurement; Balding measurement,Creatinine measurement	KLF8	UTP15
ENSG00000227502	MROCKI	3.17054558567835	7.77120088574533e-83	M1_vs_M0	HSALNG0052921	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505	NA	HDAC2	ANKRD1
ENSG00000227508	LINC01624	-3.57533782379804	0.00197006032737654	M1_vs_M0	HSALNG0055432	integenic	Not conserved	hsa-miR-342-5p	Anti-thyroglobulin antibody measurement,Lymphocyte count; Platelet crit; Leukocyte count; Platelet count; Monocyte count,Leukocyte count; Lymphocyte count; Monocyte count,Blood protein measurement,Testosterone measurement	FAM120B	ENSG00000229407
ENSG00000227527	NA	-1.35541957332672	0.0137244515748119	M1_vs_M0	HSALNG0002990	sense	Q50	hsa-miR-3960	NA	FOXJ3	FOXD2-AS1
ENSG00000227531	NA	9.96971416674175	5.6826004905790894e-54	M1_vs_M0	HSALNG0073676	integenic	Q50	hsa-miR-23a-5p,hsa-miR-619-5p,hsa-miR-6089,hsa-miR-7107-5p	Bmi-adjusted waist-hip ratio,Monocyte count,Bmi-adjusted hip circumference,Electrocardiography,Leukocyte count,Body height at birth; Birth weight,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Monocyte count,Granulocyte percentage of myeloid white cells; Waist-hip ratio; Bmi-adjusted hip circumference; Myeloid white cell count; Bmi-adjusted waist-hip ratio; Monocyte count; Monocyte percentage of leukocytes,Late-onset alzheimers disease,Myeloid white cell count,Leukocyte count; Lymphocyte percentage of leukocytes,Monocyte percentage of leukocytes,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,Body height,Neutrophil percentage of leukocytes; Bmi-adjusted waist-hip ratio; Monocyte count,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count,Neutrophil percentage of leukocytes; Birth weight; Basophil count,Eosinophil count,Parental genotype effect measurement; Birth weight,Response to antineoplastic agent; Venous thromboembolism,-	OR2K2	CD80
ENSG00000227544	LINC03013	-4.42741383768666	0.0485903317531195	M1_vs_M0	HSALNG0057229	integenic	Q90	hsa-miR-619-5p,hsa-miR-5006-3p	-	SEPTIN7	ENSG00000285672
ENSG00000227630	LINC01132	-6.37619970403137	5.73744196229421e-6	M1_vs_M0	HSALNG0011630	integenic	Q50	hsa-miR-4456,hsa-miR-4717-3p,hsa-miR-6752-3p	Urate measurement,Hmg coa reductase inhibitor use measurement,-	COA6	RPA3
ENSG00000227704	NA	-2.39301228395494	3.23394915933118e-4	M1_vs_M0	HSALNG0055383	anti_sense	Not conserved	hsa-miR-1227-5p	-	ERMARD	PRSS30P
ENSG00000227719	NA	-1.84745999956167	0.00223265204699579	M1_vs_M0	HSALNG0056082	anti_sense	Q75	hsa-miR-6809-3p	NA	GLCCI1	GFOD2
ENSG00000227741	NA	2.50878265907338	1.27130449148961e-13	M1_vs_M0	HSALNG0007819	anti_sense	Q90	hsa-miR-1227-5p,hsa-miR-4483,hsa-miR-3960,hsa-miR-6846-5p,hsa-miR-7109-5p	-	DCAF8	HLA-DMB
ENSG00000227896	WAPL-DT	-3.30857150714224	1.20413733507399e-4	M1_vs_M0	HSALNG0079399	anti_sense	Q90	hsa-miR-4660,hsa-miR-4687-3p,hsa-miR-6089,hsa-miR-6779-5p	Parental longevity,-	OPN4	PCTP
ENSG00000227917	NA	1.11606199203719	1.53168919395328e-6	M1_vs_M0	HSALNG0069521	integenic	Not conserved	hsa-miR-4722-5p	-	FOXD4	ZNF850
ENSG00000227920	NA	-5.65019997212083	9.15025854057892e-4	M1_vs_M0	HSALNG0049822	integenic	Not conserved	NA	-	CMTR1	KIAA1549L
ENSG00000227953	LINC01341	-1.17193579883401	0.0132595600543968	M1_vs_M0	HSALNG0012202	integenic	Q50	hsa-miR-939-5p,hsa-miR-4436a,hsa-miR-6089,hsa-miR-6753-5p,hsa-miR-6775-3p,hsa-miR-6812-3p,hsa-miR-7160-5p	-	SCCPDH	MCMBP
ENSG00000228022	HCG20	4.15112392941915	1.08386100030971e-5	M1_vs_M0	HSALNG0049198	integenic	Not conserved	NA	NA	TUBB	ATAD1
ENSG00000228058	LINC01736	-7.40311540565032	1.92200351611509e-13	M1_vs_M0	HSALNG0011359	integenic	Not conserved	NA	NA	GALNT2	ZNF548
ENSG00000228060	PABPC4-AS1	1.21636237955491	0.0204415968012424	M1_vs_M0	HSALNG0002780	anti_sense	Q50	hsa-miR-619-5p	C-reactive protein measurement; Mean corpuscular hemoglobin concentration; Red blood cell distribution width; Testosterone measurement; Apolipoprotein a 1 measurement; Mean corpuscular hemoglobin; High density lipoprotein cholesterol measurement; Hdl cholesterol change measurement; Mean corpuscular volume; Physical activity,Bmi-adjusted waist circumference,High density lipoprotein cholesterol measurement; Fev/fec ratio; Mean corpuscular hemoglobin concentration; Bilirubin measurement,Mean corpuscular hemoglobin,C-reactive protein measurement; Drugs used in diabetes use measurement; Fev/fec ratio,Body mass index,-	BMP8A	NSUN6
ENSG00000228109	MELTF-AS1	-1.52050900935105	0.0185497704598539	M1_vs_M0	HSALNG0031988	anti_sense	Q50	hsa-miR-331-3p,hsa-miR-1228-5p,hsa-miR-4472,hsa-miR-4492,hsa-miR-4701-3p,hsa-miR-4734,hsa-miR-7108-3p	-	NCBP2AS2	NCAPH2
ENSG00000228162	NA	-4.67941047917277	0.0206518594844287	M1_vs_M0	HSALNG0023160	integenic	Q50	hsa-miR-4472,hsa-miR-6838-3p	Family history of lung cancer; Lung adenocarcinoma,-	SPP2	ENSG00000285863
ENSG00000228172	NA	-1.40146313619925	0.0429639275164352	M1_vs_M0	HSALNG0001828	anti_sense	Q50	hsa-miR-6873-3p	-	AUNIP	DIABLO
ENSG00000228203	GRASLND	4.60938239391012	0.0272189295579002	M1_vs_M0	HSALNG0012734	anti_sense	Q50	hsa-miR-4710	NA	CMPK2	NME8
ENSG00000228221	LINC00578	-6.85693388516961	5.6757354744614304e-9	M1_vs_M0	HSALNG0030898	integenic	Not conserved	hsa-miR-4505	NA	KCNMB2	LINC01943
ENSG00000228274	NA	-1.96041228187027	2.95480426618384e-4	M1_vs_M0	HSALNG0135429	anti_sense	Q50	hsa-miR-4695-5p,hsa-miR-6089,hsa-miR-6754-5p	Mean corpuscular volume,C-reactive protein measurement,Hemoglobin measurement,Hematocrit,-	JOSD1	ENSG00000250979
ENSG00000228302	NA	-1.24796983816425	0.00261416014864102	M1_vs_M0	HSALNG0142716	anti_sense	Not conserved	hsa-miR-1268b	Forced expiratory volume	NUDT5	ENSG00000277782
ENSG00000228318	NA	6.67730946913145	5.06481768464387e-8	M1_vs_M0	HSALNG0133209	anti_sense,sense	Not conserved	hsa-miR-1268b,hsa-miR-6089	Serum alanine aminotransferase measurement,3-hydroxypropylmercapturic acid measurement,Atrial fibrillation; Diastolic blood pressure; Ventricular rate measurement; Diabetes mellitus; Heart failure; Cancer; Body mass index; Stroke; Total cholesterol measurement; Systolic blood pressure; Mortality; High density lipoprotein cholesterol measurement; Triglyceride measurement; Hematocrit; Glucose measurement; Coronary artery disease,-	TMPRSS2	RFX6
ENSG00000228340	MIR646HG	-4.61648645317073	1.4470569812507098e-23	M1_vs_M0	HSALNG0131404	integenic	Not conserved	NA	-	CDH26	EBPL
ENSG00000228436	RRAGC-DT	1.77399013514446	0.00166312903162471	M1_vs_M0	HSALNG0002723	overlap_antisense,anti_sense	Q90	hsa-miR-363-5p,hsa-miR-619-5p	Protein measurement,Blood protein measurement,Kunitz-type protease inhibitor 1 measurement,Triglyceride measurement,Age at menopause,Unipolar depression,Sweet beverage consumption measurement,-	AKIRIN1	LINC02454
ENSG00000228526	MIR34AHG	1.48403688836885	0.032767332441578	M1_vs_M0	HSALNG0000682	integenic	Q50	hsa-miR-4279,hsa-miR-500b-3p,hsa-miR-4723-3p,hsa-miR-6724-5p,hsa-miR-6744-3p,hsa-miR-7150,hsa-miR-7152-5p	Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count; Aspartate aminotransferase measurement,Body height,Lean body mass,Linguistic error measurement; Specific language impairment,-	GPR157	THAP12P7
ENSG00000228649	SNHG26	1.22410781222142	1.45118943624427e-8	M1_vs_M0	HSALNG0056623	integenic	Q75	hsa-miR-483-3p,hsa-miR-4320	Alkaline phosphatase measurement,-	IL6	KDM7A-DT
ENSG00000228742	LINC02577	3.9416565911346	3.29467501737452e-28	M1_vs_M0	HSALNG0060386	integenic	Not conserved	hsa-miR-4281,hsa-miR-4710	Eosinophil count,Agents acting on the renin-angiotensin system use measurement,Systolic blood pressure; Common carotid intimal medial thickness; Alcohol drinking,Diuretic use measurement,Systolic blood pressure; Mean arterial pressure,Eosinophil percentage of leukocytes,Cognitive inhibition measurement,-	PIK3CG	SLC7A5
ENSG00000228824	MIR4500HG	-2.00196147395811	1.81349497364053e-4	M1_vs_M0	HSALNG0144006	overlap_antisense	Not conserved	NA	Varicose veins,-	SLITRK6	ENSG00000270504
ENSG00000228952	LINC02041	2.7050333237228	7.14556912642592e-4	M1_vs_M0	HSALNG0031422	integenic	Not conserved	hsa-miR-4534	-	RTP4	ENSG00000259810
ENSG00000228956	SATB1-AS1	-1.35349717325343	3.48518355246815e-8	M1_vs_M0	HSALNG0147471	integenic	Q50	NA	NA	KCNH8	SLMAP
ENSG00000229140	CCDC26	-2.00310767855063	0.0287552734156659	M1_vs_M0	HSALNG0068551	integenic	Q50	hsa-miR-575,hsa-miR-619-5p,hsa-miR-885-3p,hsa-miR-4287,hsa-miR-4328,hsa-miR-3677-3p,hsa-miR-6809-3p,hsa-miR-6873-3p,hsa-miR-6892-3p,hsa-miR-8485	Dna methylation,Eczema,Balding measurement,Heel bone mineral density,Lip morphology measurement,Facial morphology measurement,Unipolar depression,Creatinine measurement,Cleft lip; Oral cleft; Cleft palate,Myeloid white cell count,Cleft lip; Progranulin measurement,Cortical surface area measurement; Cortical thickness,Alkaline phosphatase measurement,Cleft lip; Neuroimaging measurement; Heel bone mineral density; Blood phosphate measurement; Cleft palate; Brain measurement,Cleft lip; Oral cleft,Lung adenocarcinoma,Leukocyte count,Neutrophil count,Cleft lip,Eosinophil count,Vital capacity,Self reported educational attainment,Forced expiratory volume,Mathematical ability,Fev/fec ratio,Acute lymphoblastic leukemia,Body height,Monocyte count,Monocyte percentage of leukocytes,B-cell acute lymphoblastic leukemia,Gut microbiome measurement,Creatinine measurement; Glomerular filtration rate,Nicotine dependence,Glioma,Central nervous system cancer,Hypospadias,Urate measurement,Lateral occipital cortex volume measurement,Uterine fibroid,Platelet count; Platelet crit,Indole-3-propionate measurement,Bullous pemphigoid,Cortical surface area measurement,Mitochondrial dna measurement,Inflammatory bowel disease; Mean corpuscular hemoglobin concentration; Mean corpuscular hemoglobin; Monocyte count; Mean corpuscular volume,Leukocyte count; Monocyte count,Mean corpuscular volume; Mean corpuscular hemoglobin; Erythrocyte count,Eosinophil count; Monocyte count; Basophil count; Eosinophil percentage of leukocytes,Eosinophil count; Eosinophil percentage of granulocytes; Eosinophil percentage of leukocytes,Neutrophil-to-lymphocyte ratio,Cortical thickness,Leukocyte count; Neutrophil count; Myeloid white cell count,Neutrophil percentage of leukocytes; Mean corpuscular hemoglobin,Mosaic loss of chromosome y measurement,Resistin measurement; Myeloperoxidase measurement,Lymphocyte percentage of leukocytes; Neutrophil count,Eosinophil percentage of leukocytes; Eosinophil percentage of granulocytes,Leukocyte count; Neutrophil count; Monocyte count,Neutrophil percentage of granulocytes; Neutrophil percentage of leukocytes,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,Inflammatory bowel disease; Ulcerative colitis; Monocyte count; Monocyte:lymphocyte ratio; Mean corpuscular volume; Red blood cell density measurement; Erythrocyte count,Adolescent idiopathic scoliosis,Monocyte count; Mean corpuscular hemoglobin concentration; Erythrocyte count,Neutrophil count; Basophil count; Leukocyte count; Eosinophil count; Granulocyte count,Mean corpuscular volume; Mean corpuscular hemoglobin; Monocyte count,Erythrocyte count,Leukocyte count; Lymphocyte percentage of leukocytes; Neutrophil count; Myeloid white cell count,Red blood cell density measurement,Mean reticulocyte volume,Neutrophil percentage of leukocytes,Basophil percentage of granulocytes; Educational attainment; Basophil count; Basophil percentage of leukocytes,Granulocyte percentage of myeloid white cells,Eye color,Monocyte percentage of leukocytes; Monocyte count,Neuroimaging measurement; Glioblastoma multiforme; Glioma; White matter microstructure measurement; Brain volume measurement; Age at onset; Central nervous system cancer,Platelet count,Basophil count,Retinopathy,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count,Leukocyte count; Lymphocyte percentage of leukocytes; Myeloid white cell count,Basophil count; Eosinophil percentage of leukocytes,Platelet crit,Eosinophil count; Eosinophil percentage of leukocytes,Response to methotrexate; Juvenile idiopathic arthritis,Cleft lip; Cleft palate,Unipolar depression; Endometriosis,Brain volume measurement; Neuroimaging measurement; Brain measurement,-	GSDMC	ENSG00000274265
ENSG00000229271	NA	1.82398373997774	0.01084421426699	M1_vs_M0	HSALNG0024495	sense	Not conserved	NA	Response to opioid,-	DAZL	CD5L
ENSG00000229334	TMEM44-AS2	-2.75016599658749	7.032353865930779e-11	M1_vs_M0	HSALNG0031749	anti_sense	Not conserved	NA	Progranulin measurement	FAM43A	ENSG00000260086
ENSG00000229431	MED8-AS1	1.27182004441808	6.19176138263105e-6	M1_vs_M0	HSALNG0003091	anti_sense	Q75	NA	White matter microstructure measurement,Platelet count; Platelet crit,Igf-1 measurement,-	SZT2	QPCT
ENSG00000229484	LINC02766	-2.7768125812288	3.25488775819795e-6	M1_vs_M0	HSALNG0000944	integenic	Not conserved	NA	-	VPS13D	MT2P1
ENSG00000229618	NA	3.801560013908	2.5765912367377e-4	M1_vs_M0	HSALNG0056278	integenic	Q90	NA	NA	ARL4A	ENSG00000238015
ENSG00000229619	MBNL1-AS1	-3.07422603907731	1.07813711657168e-52	M1_vs_M0	HSALNG0029874	anti_sense	Q50	hsa-miR-4492,hsa-miR-5587-3p	Body height,Balding measurement,Colorectal cancer,Pulse pressure measurement,Hematocrit; Hemoglobin measurement,Lymphocyte percentage of leukocytes; Neutrophil count,Neutrophil count,Myeloid white cell count,-	IGSF10	SNRPD3
ENSG00000229873	OGFR-AS1	2.02863051151186	1.26805465313529e-5	M1_vs_M0	HSALNG0131564	anti_sense	Q90	hsa-miR-1271-5p,hsa-miR-6800-3p	-	TCFL5	NOP14-AS1
ENSG00000229922	LINC02865	3.09490842249429	8.72287258793521e-4	M1_vs_M0	HSALNG0053801	integenic	Q50	hsa-miR-6873-3p	Eosinophil count; Ejection fraction measurement; Eosinophil percentage of leukocytes,Cardiac troponin t measurement,Rheumatoid arthritis,Phosphatidylcholine ether measurement,-	TNFAIP3	LINC00487
ENSG00000229950	TFAP2A-AS1	1.58910800560145	0.0089781754903146	M1_vs_M0	HSALNG0048011	anti_sense	Q90	NA	Human papilloma virus infection; Oral cavity cancer; Oropharynx cancer,Squamous cell lung carcinoma,-	GCNT2	ENSG00000237669
ENSG00000229953	BCAN-AS2	-3.97895763804221	1.61730953679037e-35	M1_vs_M0	HSALNG0007612	anti_sense	Q75	hsa-miR-4722-5p,hsa-miR-6511a-3p	Blood protein measurement,-	NES	C2orf92
ENSG00000230107	NA	-1.83758336821942	2.56311619306211e-4	M1_vs_M0	HSALNG0135708	integenic	Q90	hsa-miR-3158-5p,hsa-miR-4650-5p,hsa-miR-4691-5p,hsa-miR-6089,hsa-miR-6132	NA	SERHL2	LINC02860
ENSG00000230149	NA	1.94312743270045	0.00427833384630222	M1_vs_M0	HSALNG0135439	anti_sense,sense	Q90	hsa-miR-1227-5p,hsa-miR-500b-3p	White matter microstructure measurement,-	GTPBP1	NDRG4
ENSG00000230185	HSDL2-AS1	2.33996776129684	0.0111173583711475	M1_vs_M0	HSALNG0073771	anti_sense	Q75	hsa-miR-4279,hsa-miR-4741,hsa-miR-6089	Epstein-barr virus infection,Chronotype measurement,Fev/fec ratio; Response to bronchodilator,Hip bone mineral density; Hip bone size,-	PTBP3	ENSG00000251661
ENSG00000230322	NA	4.82397314712997	0.0142265718180501	M1_vs_M0	HSALNG0142712	intronic_antisense	Not conserved	NA	NA	USP6NL	H1-3
ENSG00000230387	NA	-7.79834809721775	3.54497055634869e-17	M1_vs_M0	HSALNG0129227	integenic	Q50	hsa-miR-151b,hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-5006-5p,hsa-miR-8485	Serum alanine aminotransferase measurement,Susceptibility to mycobacterium tuberculosis infection measurement,Venous thromboembolism	SSTR4	SLC46A1
ENSG00000230426	LINC01036	-3.50914777208178	7.00489535100955e-8	M1_vs_M0	HSALNG0009116	integenic	Q50	hsa-miR-619-5p,hsa-miR-3940-5p,hsa-miR-6802-5p	Asthma exacerbation measurement,Diet measurement,Unipolar depression,Fatty acid measurement; Fasting blood insulin measurement,Mouth morphology measurement,Non-alcoholic steatohepatitis,Protein measurement,5-hiaa measurement,Adolescent idiopathic scoliosis,Response to tenofovir,Corneal endothelial cell measurement,Interleukin 13 measurement,-	PLA2G4A	ACTR10
ENSG00000230537	LINC02937	-2.96394638035927	4.4279075563881e-11	M1_vs_M0	HSALNG0072707	integenic	Not conserved	NA	Eosinophil count	AUH	ENSG00000291064
ENSG00000230606	APPAT	-5.08030215516568	0.00456612118842733	M1_vs_M0	HSALNG0017139	integenic	Not conserved	hsa-miR-612,hsa-miR-4742-5p,hsa-miR-4787-5p,hsa-miR-6803-5p,hsa-miR-6860	NA	ANKRD36B	SYNGR4
ENSG00000230615	NA	4.27253255824662	3.20197015927392e-6	M1_vs_M0	HSALNG0003151	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-1224-3p	-	KLF17	UPF3A
ENSG00000230647	NA	8.44064940602382	2.47726094372563e-23	M1_vs_M0	HSALNG0145008	integenic	Q75	hsa-miR-619-5p	Heel bone mineral density,-	HS3ST3B1	ENSG00000213172
ENSG00000230730	NA	-4.8938344054216	0.0110300838767849	M1_vs_M0	HSALNG0013891	anti_sense	Not conserved	NA	Heel bone mineral density	TRMT61B	AFDN-DT
ENSG00000230731	LINC02938	2.49047307706622	0.0249543573759576	M1_vs_M0	HSALNG0096739	integenic	Q50	hsa-miR-874-3p,hsa-miR-6764-3p	Hair colour measurement,Forced expiratory volume; Fev/fec ratio,Balding measurement,Fev/fec ratio,Dupuytren contracture; Chronic obstructive pulmonary disease,Heel bone mineral density,Body height,Peripheral arterial disease; Traffic air pollution measurement,-	SMIM2	DYNLRB1
ENSG00000230736	NA	3.88342949529418	1.92629078119743e-4	M1_vs_M0	HSALNG0135029	integenic	Not conserved	NA	NA	RFPL3	ENSG00000261884
ENSG00000230773	NA	1.678930645755	6.72583501060555e-4	M1_vs_M0	HSALNG0014797	integenic	Not conserved	NA	NA	FBXO11	ENSG00000289939
ENSG00000230852	LINC02857	4.82283305167508	0.0141337481574363	M1_vs_M0	HSALNG0051633	integenic	Q50	NA	NA	MRAP2	HMGB1P31
ENSG00000230928	NA	-5.52804885142413	4.99738756055383e-4	M1_vs_M0	HSALNG0080002	anti_sense	Not conserved	hsa-miR-6763-5p	Body height	R3HCC1L	ST8SIA1
ENSG00000230943	LINC02541	1.6018660652796	5.74249999168554e-5	M1_vs_M0	HSALNG0052910	integenic	Not conserved	NA	NA	HDAC2	NAF1
ENSG00000231064	THBS3-AS1	-1.73271588915549	0.00317583249152289	M1_vs_M0	HSALNG0007477	anti_sense	Q90	hsa-miR-4667-3p,hsa-miR-6089,hsa-miR-6803-5p,hsa-miR-6769b-5p	Gastric carcinoma,Treatment-resistant hypertension,Carpal tunnel syndrome,Occipital lobe volume measurement; Calcium measurement; Heel bone mineral density,Hemoglobin a1 measurement; Mean corpuscular hemoglobin concentration,Cancer antigen 15.3 measurement; Fev/fec ratio,Glomerular filtration rate; Bmi-adjusted waist circumference; Cancer antigen 15.3 measurement; Creatinine measurement; Cortical thickness,-	MTX1	SCARA3
ENSG00000231079	KIF5C-AS1	-1.91557025687319	0.0450191845339256	M1_vs_M0	HSALNG0019510	anti_sense	Q50	hsa-miR-4448,hsa-miR-4455	-	MMADHC	RSPH9
ENSG00000231106	LINC01436	1.29197282826608	2.41276984655008e-17	M1_vs_M0	HSALNG0132900	anti_sense	Q90	hsa-miR-1224-3p,hsa-miR-4478	-	CBR1	ELAC2
ENSG00000231113	LINC02976	-1.79619810225986	3.72986837704026e-12	M1_vs_M0	HSALNG0050136	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6089	Diabetic nephropathy; Mean corpuscular hemoglobin,Apolipoprotein a 1 measurement,-	CNPY3	BTG3
ENSG00000231160	KLF3-AS1	-1.44228880230026	0.00625345937285553	M1_vs_M0	HSALNG0148326	integenic	Q50	NA	Eosinophil percentage of leukocytes,Mean platelet volume; Eosinophil count,Comparative body size at age 10, self-reported; Neuroimaging measurement; Brain volume measurement; Brain measurement; Cortical thickness,Erythrocyte count,Eosinophil count; Eosinophil percentage of leukocytes,Neutrophil percentage of granulocytes	TLR10	ASMTL-AS1
ENSG00000231233	CFAP58-DT	2.31787098634749	0.00246459370190502	M1_vs_M0	HSALNG0080427	integenic	Q50	NA	NA	ITPRIP	HNRNPA0
ENSG00000231312	MAP4K3-DT	2.31038345384176	1.44584700384516e-26	M1_vs_M0	HSALNG0014372	anti_sense,sense	Q50	hsa-miR-619-5p,hsa-miR-4447,hsa-miR-6089,hsa-miR-8485	Hematocrit; Hemoglobin measurement,Hematocrit; Erythrocyte count,Hematocrit,Hemoglobin measurement,Red blood cell density measurement,Response to candesartan,-	TMEM178A	DNAJC1
ENSG00000231407	GORAB-AS1	7.6152105289966	6.731015508946941e-15	M1_vs_M0	HSALNG0008377	anti_sense	Q50	hsa-miR-5011-3p,hsa-miR-8485	Bmi-adjusted waist-hip ratio,Adolescent idiopathic scoliosis,Bmi-adjusted waist circumference,Soluble triggering receptor expressed on myeloid cells 2 measurement,-,Androgenetic alopecia	KIFAP3	ACOD1
ENSG00000231426	FILNC1	-2.73512898742879	8.25171182038097e-12	M1_vs_M0	HSALNG0053896	integenic	Q50	hsa-miR-619-5p	Serum igg glycosylation measurement,Age at onset,Response to simvastatin; Pcsk9 protein measurement,-	HECA	GPX1P1
ENSG00000231528	FAM225A	2.87152128768013	2.42839100285758e-126	M1_vs_M0	HSALNG0073810	integenic	Not conserved	NA	NA	SLC31A2	KLHL29
ENSG00000231535	LINC00278	1.42050735480708	3.38002017673294e-16	M1_vs_M0	HSALNG0140973	integenic	Not conserved	NA	NA	ZFY	UEVLD
ENSG00000231609	EHBP1-AS1	-1.10087128638677	2.43284684526893e-4	M1_vs_M0	HSALNG0015409	anti_sense	Q90	hsa-miR-4292,hsa-miR-5698,hsa-miR-6728-3p,hsa-miR-6780a-3p	Balding measurement,Vital capacity,Low density lipoprotein cholesterol measurement,Alcohol use disorder measurement; Alcohol consumption measurement,-	WDPCP	FBXL19-AS1
ENSG00000231612	NA	-5.24566674070684	0.0039918319540466	M1_vs_M0	HSALNG0012153	anti_sense	Q50	hsa-miR-670-5p	Diverticular disease,-	SMYD3	LNCARSR
ENSG00000231613	NA	-3.93287666200082	1.05823297534965e-4	M1_vs_M0	HSALNG0005090	sense	Q50	hsa-miR-4505,hsa-miR-4741,hsa-miR-5787	Protein measurement,Mean platelet volume	NA	ARFGEF1
ENSG00000231628	NA	-2.09140974520634	0.0152676057451035	M1_vs_M0	HSALNG0052370	anti_sense	Not conserved	NA	-	LIN28B	DDX12P
ENSG00000231638	LUARIS	5.79310492239509	2.75443507022085e-4	M1_vs_M0	HSALNG0057557	anti_sense	Q90	NA	Beta-amyloid 1-42 measurement; Cerebrospinal fluid biomarker measurement,-	COA1	LINC01841
ENSG00000231652	CD109-AS1	-1.13733495885091	0.00456907581100338	M1_vs_M0	HSALNG0051248	anti_sense	Q75	hsa-miR-4677-5p,hsa-miR-4783-5p	Angina pectoris; Myocardial infarction; Heel bone mineral density,-	SLC17A5	KCTD13-DT
ENSG00000231711	LINC00899	-2.49902345241599	6.58806015207091e-27	M1_vs_M0	HSALNG0135993	integenic	Q50	hsa-miR-320a-5p,hsa-miR-762,hsa-miR-3178,hsa-miR-6763-3p	Birth weight,Smoking status measurement	WNT7B	CHODL
ENSG00000231721	LINC-PINT	3.03322355187857	1.21887536279558e-125	M1_vs_M0	HSALNG0150064	integenic	Q50	NA	NA	KLF14	SERINC5
ENSG00000231728	TMSB15B-AS1	-2.95247215094353	0.0302521045151037	M1_vs_M0	HSALNG0139338	integenic	Not conserved	NA	NA	RAB9B	LY9
ENSG00000231808	LINC01388	1.53968188282741	2.83145057603475e-32	M1_vs_M0	HSALNG0069521	integenic	Not conserved	hsa-miR-4722-5p	-	FOXD4	POLK
ENSG00000231877	NA	-7.50103564353385	2.24676822413576e-51	M1_vs_M0	HSALNG0011827	integenic	Q75	hsa-miR-4308,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-2467-3p,hsa-miR-6089,hsa-miR-6510-5p,hsa-miR-6877-3p	Adolescent idiopathic scoliosis,White matter microstructure measurement,Neurofibrillary tangles measurement,Intelligence,Protein measurement,Frontal pole volume measurement,Serum selenium measurement,Economic and social preference,Dysphagia,Cognitive decline measurement,C-peptide measurement,Hippocampal volume,Serum alanine aminotransferase measurement; Response to combination chemotherapy,Caudate nucleus measurement; Functional brain measurement; Response to reward,-	RYR2	SV2B
ENSG00000231889	TRAF3IP2-AS1	1.2816316417340201	2.71531524744512e-4	M1_vs_M0	HSALNG0052788	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4463,hsa-miR-6812-3p,hsa-miR-6886-3p,hsa-miR-10392-3p	Psoriatic arthritis,Abnormality of refraction,Triglyceride measurement; High density lipoprotein cholesterol measurement; Smoking behavior,Ulcerative colitis; Crohn's disease; Inflammatory bowel disease,Manic episode measurement; Depressive episode measurement,Non-melanoma skin carcinoma,Esophageal varices,Inflammatory bowel disease,C-reactive protein measurement,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,Psoriasis; Psoriatic arthritis; Psoriasis vulgaris,-,Balding measurement	MFSD4B	CCDC121
ENSG00000231971	CT69	3.41929941867286	2.38779596169574e-5	M1_vs_M0	HSALNG0053626	integenic	Q90	hsa-miR-619-5p,hsa-miR-3652,hsa-miR-4447,hsa-miR-4486,hsa-miR-6089	Mean corpuscular hemoglobin,Urate measurement,Erythrocyte count,Glomerular filtration rate,Abnormality of refraction,Mean corpuscular volume,Melanoma,Varicose veins,Hair colour measurement,Eosinophil count,Electrocardiography,Monocyte count,Platelet component distribution width; Platelet crit; Platelet count,Reticulocyte count,Leukocyte count,Platelet count,Triacylglycerol 52:5 measurement; Triacylglycerol 54:8 measurement,Calcium measurement,Platelet crit,Lymphocyte count,Coronary artery calcification,Red blood cell distribution width,Platelet-to-lymphocyte ratio,Cirrhosis of liver; Non-alcoholic fatty liver disease,Mean corpuscular hemoglobin; Erythrocyte count,Pulse pressure measurement,-	SGK1	SYVN1
ENSG00000231999	LRRC8C-DT	-1.02119413630749	2.25449291571081e-4	M1_vs_M0	HSALNG0005078	integenic	Q75	NA	NA	GBP5	SLC25A6P2
ENSG00000232006	NA	4.15154538470082	1.0462426144935e-5	M1_vs_M0	HSALNG0149924	integenic	Not conserved	hsa-miR-4691-5p	NA	NA	PRELID3B
ENSG00000232043	NA	2.37688840517142	0.0406154319879953	M1_vs_M0	HSALNG0130783	anti_sense	Not conserved	NA	Heel bone mineral density,Duchenne muscular dystrophy; Disease progression measurement	RIPOR3	LINC02454
ENSG00000232082	RPS6KA2-IT1	2.45312171909768	1.33792077254327e-7	M1_vs_M0	HSALNG0055101	sense	Not conserved	hsa-miR-4505,hsa-miR-6895-5p	NA	RPS6KA2	ENSG00000279491
ENSG00000232098	ZNF584-DT	-2.08613119312059	3.45902762170539e-13	M1_vs_M0	HSALNG0127962	anti_sense	Not conserved	NA	Mean platelet volume,-	ZNF837	C2CD2
ENSG00000232104	RFX3-DT	1.44381614123301	9.350132669168631e-9	M1_vs_M0	HSALNG0069687	integenic	Q75	NA	NA	KCNV2	CRISPLD1
ENSG00000232197	NA	-2.59043872110937	8.07153133061758e-17	M1_vs_M0	HSALNG0055420	integenic	Not conserved	hsa-miR-6883-5p,hsa-miR-6890-3p	Prostate carcinoma,-	FAM120B	EBF1
ENSG00000232354	VIPR1-AS1	-8.27051245687911	6.59589948185392e-24	M1_vs_M0	HSALNG0025430	anti_sense	Q50	hsa-miR-3194-5p,hsa-miR-3198	Cerebrospinal fluid clusterin measurement,Bmi-adjusted hip circumference,-	SEC22C	SESN1
ENSG00000232453	LINC02777	-1.89432796172875	2.75576943759686e-4	M1_vs_M0	HSALNG0003962	integenic	Not conserved	NA	Bmi-adjusted hip circumference,-	JUN	GHDC
ENSG00000232485	RPL37A-DT	-2.45878987578034	9.92444696753896e-4	M1_vs_M0	HSALNG0022128	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-4286	-	MARCHF4	KCNG1
ENSG00000232520	GCSIR	-6.22698234798848	3.76142459515969e-5	M1_vs_M0	HSALNG0022903	integenic	Q50	hsa-miR-4508,hsa-miR-5011-3p,hsa-miR-7160-3p	-	ITM2C	KATNAL2
ENSG00000232533	FAM131B-AS2	-2.92535833670697	7.83056464511706e-127	M1_vs_M0	HSALNG0061960	integenic	Not conserved	hsa-miR-10392-3p	-	EPHA1	CD180
ENSG00000232618	HIVEP2-DT	5.0097351578111	0.00757653049982452	M1_vs_M0	HSALNG0054003	anti_sense	Q50	hsa-miR-4279	Mean platelet volume,-	AIG1	ARHGAP18
ENSG00000232628	NA	-2.20233776171806	0.0258454679739266	M1_vs_M0	HSALNG0010945	integenic	Not conserved	NA	Ceramide measurement	NVL	AKNAD1
ENSG00000232679	LINC01705	2.88800646468433	1.26074821136846e-4	M1_vs_M0	HSALNG0010821	integenic	Q50	hsa-miR-619-5p,hsa-miR-6728-3p,hsa-miR-6729-3p,hsa-miR-8485	Eosinophil percentage of leukocytes,Homa-ir,Self reported educational attainment,Colorectal cancer,Adolescent idiopathic scoliosis,C-reactive protein measurement,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,Colon carcinoma,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Progressive supranuclear palsy,Tonsillectomy risk measurement,Thyroid stimulating hormone measurement,Self reported educational attainment; Intelligence,Fev/fec ratio; Response to bronchodilator,Colorectal cancer; Colorectal adenoma,Colorectal cancer; Progressive supranuclear palsy,Cluster headache,-	DUSP10	ENSG00000243176
ENSG00000232855	NA	4.82774776011248	0.0228324232302951	M1_vs_M0	HSALNG0132498	integenic	Q90	NA	NA	N6AMT1	BBOX1-AS1
ENSG00000232931	LINC00342	-3.17216374809168	1.6476208310239501e-74	M1_vs_M0	HSALNG0146543	integenic	Not conserved	NA	NA	ANKRD36C	LINC00623
ENSG00000232956	SNHG15	2.08243739320916	6.31610670863432e-142	M1_vs_M0	HSALNG0057702	anti_sense,sense	Q50	hsa-miR-4726-3p,hsa-miR-7107-5p	Body height,Diastolic blood pressure,-	MYO1G	P2RY8
ENSG00000233030	NA	3.12498476355811	1.9105950890026e-41	M1_vs_M0	HSALNG0142341	anti_sense,intronic_sense	Not conserved	NA	Monocyte count,-	H2BC18	SCG3
ENSG00000233038	PTPRN2-AS1	-3.79255205386997	2.19717952499935e-15	M1_vs_M0	HSALNG0062762	anti_sense	Not conserved	hsa-miR-762,hsa-miR-3195,hsa-miR-4297,hsa-miR-5787,hsa-miR-6813-5p,hsa-miR-7113-3p	-	DNAJB6	SSBP2
ENSG00000233086	LNCARSR	-6.05913750572414	8.24137600701503e-5	M1_vs_M0	HSALNG0072133	integenic	Q50	hsa-miR-30b-3p,hsa-miR-6089	Pr interval,Balding measurement,Eczema,Neuroimaging measurement; Brain measurement,-	GNAQ	THSD7A
ENSG00000233093	LINC00892	-4.88317766604879	7.02247467833482e-10	M1_vs_M0	HSALNG0140334	integenic	Q50	hsa-miR-671-5p	NA	CD40LG	ZEB1-AS1
ENSG00000233098	CCDC144NL-AS1	1.24275771429573	1.33107878596616e-62	M1_vs_M0	HSALNG0115238	integenic	Not conserved	hsa-miR-4286	NA	DHRS7B	TSPAN1
ENSG00000233117	LINC00702	-1.37217013981165	2.51710427700903e-28	M1_vs_M0	HSALNG0075773	integenic	Q50	hsa-miR-4279,hsa-miR-4710	Anti-thyroglobulin antibody measurement,Biological sex,Body height,-	KLF6	NRSN2
ENSG00000233153	UBE2E2-DT	5.00530009666002	0.0119976085284568	M1_vs_M0	HSALNG0024658	integenic	Q75	hsa-miR-486-3p,hsa-miR-1224-3p,hsa-miR-6089,hsa-miR-6891-5p	Reaction time measurement,-	NKIRAS1	IFNL1
ENSG00000233223	NA	2.30718705660396	2.83815443956395e-26	M1_vs_M0	HSALNG0114322	anti_sense	Q50	hsa-miR-363-5p,hsa-miR-1224-3p,hsa-miR-6089,hsa-miR-7160-3p	Testosterone measurement; Sex hormone-binding globulin measurement; Serum igm measurement,Testosterone measurement,Serum metabolite measurement,Cortical thickness,Metabolic syndrome,Heel bone mineral density,Fev/fec ratio; Response to bronchodilator,-,Testosterone measurement; Sex hormone-binding globulin measurement,Protein measurement; Sex hormone-binding globulin measurement; Serum iga measurement,Red blood cell distribution width,Platelet component distribution width	SOX15	GATA5
ENSG00000233237	LINC00472	-3.04788291482384	1.2977147244376e-28	M1_vs_M0	HSALNG0051173	integenic	Q50	NA	NA	B3GAT2	XRCC2
ENSG00000233251	NA	5.201122444205	0.016777296501847	M1_vs_M0	HSALNG0015066	anti_sense	Q50	hsa-miR-4279,hsa-miR-4472	Lysophosphatidylcholine 18:2 measurement; Lysophosphatidylcholine 18:1 measurement,Cleft lip,-	EFEMP1	ADAMTSL4-AS1
ENSG00000233321	LINC02669	-3.10008380031714	0.0171973480202495	M1_vs_M0	HSALNG0142700	integenic	Q50	NA	NA	PITRM1	ENSG00000279267
ENSG00000233338	TLR8-AS1	-2.95247109996814	0.0302464808081789	M1_vs_M0	HSALNG0136678	anti_sense	Q50	NA	Bmi-adjusted hip circumference,Systemic lupus erythematosus,Monocyte count,Celiac disease,C-reactive protein measurement,-	FAM9C	CALU
ENSG00000233355	CHRM3-AS2	-3.43801221484791	3.3979949293488e-5	M1_vs_M0	HSALNG0011884	anti_sense	Q50	NA	Chronic obstructive pulmonary disease,Fev/fec ratio,Breast milk measurement,-	GREM2	MAP3K8
ENSG00000233384	CNIH3-AS2	-2.50378767415311	6.88890125263494e-24	M1_vs_M0	HSALNG0010968	anti_sense	Q75	hsa-miR-4467,hsa-miR-3960,hsa-miR-7156-3p	-	WDR26	CMTM7
ENSG00000233532	LINC00460	5.69722435223024	4.32806052149275e-4	M1_vs_M0	HSALNG0099182	integenic	Q75	NA	-	DAOA	NRG4
ENSG00000233539	NA	3.90873239395801	2.7904711265665e-11	M1_vs_M0	HSALNG0057793	integenic	Not conserved	NA	Response to diisocyanate,Glomerular filtration rate,Uric acid measurement,Lobe attachment,Igf-1 measurement,Igfbp-3 measurement; Igf-1 measurement,Glomerular filtration rate; Thyroid stimulating hormone measurement; Blood urea nitrogen measurement; Creatinine measurement; Igfbp-3 measurement; Urate measurement,Blood urea nitrogen measurement; Glomerular filtration rate,Cytokine measurement,Comparative body size at age 10, self-reported	TNS3	ENSG00000238015
ENSG00000233542	NA	-5.08157779806772	0.0117767213129776	M1_vs_M0	HSALNG0000215	integenic	Not conserved	hsa-miR-30c-2-3p,hsa-miR-30c-1-3p,hsa-miR-619-5p	-	CFAP74	ASB11
ENSG00000233559	LINC00513	-1.69425167414157	0.0370737553310279	M1_vs_M0	HSALNG0061393	integenic	Not conserved	NA	Parental genotype effect measurement; Vitamin d measurement	MKLN1	SMC2-DT
ENSG00000233621	ZC3H12A-DT	2.31478170592014	9.151889190088049e-109	M1_vs_M0	HSALNG0002623	integenic	Not conserved	NA	NA	MEAF6	MLST8
ENSG00000233828	MIR4280HG	-6.60668249058725	3.2224054015045902e-24	M1_vs_M0	HSALNG0043286	integenic	Q50	hsa-miR-6503-3p	NA	CCNH	PTPN3
ENSG00000233871	DLG5-AS1	-2.49892763763758	1.03762896905833e-4	M1_vs_M0	HSALNG0079068	anti_sense	Q50	NA	Serum gamma-glutamyl transferase measurement,-	RPS24	RTF1
ENSG00000233884	NA	-3.57572554198776	0.00137915466882952	M1_vs_M0	HSALNG0072499	integenic	Not conserved	hsa-miR-6085,hsa-miR-7855-5p	-	CDK20	ZNF517
ENSG00000233922	LINC01694	-1.13355236196311	0.0153223973224882	M1_vs_M0	HSALNG0133661	integenic	Q75	hsa-miR-6763-5p	Covid-19,Myopia,Self reported educational attainment,-	PCBP3	ELOA
ENSG00000233975	LINC02574	2.04957889748746	7.12025539608744e-5	M1_vs_M0	HSALNG0002009	integenic	Q50	hsa-miR-619-5p	Body weight,Systolic blood pressure; Pulse pressure measurement; Mean arterial pressure,Body mass index,-	IFI6	HVCN1
ENSG00000234028	EIF2AK3-DT	-1.46223405899538	0.0283235668820353	M1_vs_M0	HSALNG0016705	anti_sense	Q50	NA	-	RPIA	ENSG00000277879
ENSG00000234076	TPRG1-AS1	-2.68127188012993	1.60475996664154e-7	M1_vs_M0	HSALNG0031482	anti_sense	Q50	hsa-miR-619-5p	-	P3H2	GLRB
ENSG00000234147	NA	-1.35898431003225	3.6980629580061394e-40	M1_vs_M0	HSALNG0053918	integenic	Q75	hsa-miR-4281,hsa-miR-6776-5p,hsa-miR-8485	3-hydroxypropylmercapturic acid measurement,Susceptibility to bacterial meningitis measurement,Sleep quality,Facial emotion recognition measurement,Response to diisocyanate,Acute lymphoblastic leukemia,Systolic blood pressure change measurement; Response to hydrochlorothiazide,Fev/fec ratio,Reaction time measurement,-	NMBR	RPS5
ENSG00000234191	LINC01283	2.57766509784219	1.1812766204500398e-56	M1_vs_M0	HSALNG0137357	integenic	Q75	NA	NA	BCOR	GFPT2
ENSG00000234199	LINC01191	1.59700336719861	4.17687506569596e-5	M1_vs_M0	HSALNG0018115	integenic	Not conserved	NA	NA	ACTR3	BLOC1S6
ENSG00000234263	MAP3K5-AS1	3.09998083343558	1.19944131790585e-5	M1_vs_M0	HSALNG0053716	anti_sense	Q75	NA	Unipolar depression	PEX7	RPL22P24
ENSG00000234286	NA	-2.3116279938732	3.93221118130493e-5	M1_vs_M0	HSALNG0149890	anti_sense	Q50	NA	NA	TRA2A	PMFBP1
ENSG00000234311	NA	-3.62954929589597	5.72063718998399e-29	M1_vs_M0	HSALNG0081788	integenic	Q90	hsa-miR-574-5p,hsa-miR-6852-5p	Heel bone mineral density,Myopathy; Response to simvastatin,-	STK32C	CTSF
ENSG00000234390	USP27X-DT	1.48695307526233	0.0198882879043907	M1_vs_M0	HSALNG0151200	integenic	Q90	NA	NA	PAGE1	ENSG00000255026
ENSG00000234432	LINC02983	-2.1793558891779	1.93243364004679e-4	M1_vs_M0	HSALNG0149872	integenic	Q50	hsa-miR-4733-3p	-	TNRC18	MTND4P26
ENSG00000234456	MAGI2-AS3	2.09422769203577	8.76004158049082e-15	M1_vs_M0	HSALNG0059170	anti_sense	Q75	hsa-miR-339-5p,hsa-miR-4447,hsa-miR-3960,hsa-miR-5001-3p,hsa-miR-6749-3p,hsa-miR-6786-5p,hsa-miR-8485	-	GNAI1	SYNPO2
ENSG00000234464	NA	-7.71630971668653	3.88551418463887e-16	M1_vs_M0	HSALNG0142045	integenic	Not conserved	hsa-miR-363-5p,hsa-miR-1268b,hsa-miR-6089	NA	RYR2	ERVK3-1
ENSG00000234506	LINC01506	4.3266627337684	1.44204980528315e-6	M1_vs_M0	HSALNG0071693	integenic	Not conserved	hsa-miR-5787	NA	TMEM252	ENSG00000290041
ENSG00000234717	TMEM212-AS1	6.1499732024854	1.8744792924128e-5	M1_vs_M0	HSALNG0030700	anti_sense	Q50	hsa-miR-5004-3p,hsa-miR-6089	Sex hormone-binding globulin measurement,Body mass index,Colorectal cancer,Corneal resistance factor,White matter hyperintensity measurement; Hypertension,-	PLD1	DDX43
ENSG00000234753	FOXP4-AS1	2.95261052556019	0.00169998452620237	M1_vs_M0	HSALNG0050034	integenic	Q90	hsa-miR-1227-5p,hsa-miR-6089,hsa-miR-8485	-	TFEB	GMCL1
ENSG00000234883	MIR155HG	3.38704900067163	1.7317370268759397e-140	M1_vs_M0	HSALNG0132382	anti_sense,sense	Q75	hsa-miR-6089,hsa-miR-8485	Neuropsychological test,Intelligence,Response to carboplatin,Nicotine dependence symptom count,Gout,Open-angle glaucoma,Triglyceride measurement,Erythrocyte count,Chronic lymphocytic leukemia,Cerebrospinal fluid biomarker measurement; Alpha synuclein measurement,Duchenne muscular dystrophy; Disease progression measurement,-,Amyloid plaque accumulation rate	JAM2	MT1M
ENSG00000235027	PRADX	1.45800565914115	4.13681714684848e-6	M1_vs_M0	NA	NA	NA	NA	NA	KRTAP5-6	TLR5
ENSG00000235092	ID2-AS1	-1.30660121079288	1.86693540558009e-8	M1_vs_M0	HSALNG0012846	anti_sense	Q90	hsa-miR-4787-5p,hsa-miR-6784-5p,hsa-miR-6793-3p,hsa-miR-6858-5p,hsa-miR-6877-3p,hsa-miR-7108-3p	-	KIDINS220	ACE
ENSG00000235172	LINC01366	2.37881880016768	0.0451033015637253	M1_vs_M0	HSALNG0046513	integenic	Not conserved	NA	NA	KCNIP1	ZNF714
ENSG00000235204	NA	-1.22057595047885	0.0022188415886943	M1_vs_M0	HSALNG0074324	anti_sense	Q50	NA	-	PSMB7	PTBP2
ENSG00000235257	ITGA9-AS1	-1.50314060986423	0.0343590635228973	M1_vs_M0	HSALNG0025195	anti_sense	Not conserved	NA	NA	PLCD1	GDPD3
ENSG00000235385	LINC02154	6.88369912241328	3.7154780180640305e-9	M1_vs_M0	HSALNG0136703	overlap_sense	Not conserved	NA	NA	ATXN3L	KLHDC7B-DT
ENSG00000235478	LINC01664	-1.52051483481924	0.0185497704598539	M1_vs_M0	HSALNG0133870	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4279,hsa-miR-6132	Aging,Emotional symptom measurement,-	IL17RA	ENSG00000256448
ENSG00000235513	L3MBTL2-AS1	3.33090406585422	8.57926143660316e-103	M1_vs_M0	HSALNG0135617	anti_sense	Q75	hsa-miR-6731-5p	Anorexia nervosa; Autism spectrum disorder; Depressive symptom measurement; Obsessive-compulsive disorder; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder; Tourette syndrome; Neuroticism measurement,Neuroticism measurement,Breast carcinoma,Red blood cell distribution width,Mood instability measurement,Anxiety measurement; Neuroticism measurement,Depressive symptom measurement; Unipolar depression; Wellbeing measurement; Bipolar disorder; Neuroticism measurement,-	CHADL	SRC
ENSG00000235531	MSC-AS1	3.37876272106017	6.467278803862759e-262	M1_vs_M0	HSALNG0066120	anti_sense	Not conserved	NA	Lung carcinoma,Gout,Clinical treatment,Attention deficit hyperactivity disorder,Smoking behaviour measurement,Mental development measurement,Diastolic blood pressure,Forced expiratory volume; Response to bronchodilator,-	KCNB2	SET
ENSG00000235560	ZNF747-DT	-1.91425728093001	0.0420431472321367	M1_vs_M0	HSALNG0110746	anti_sense	Not conserved	hsa-miR-30b-3p,hsa-miR-378g	Serum gamma-glutamyl transferase measurement,Ccl5 measurement,-	ITGAL	TMEM276
ENSG00000235706	DICER1-AS1	-1.25645769427382	0.00355504488597655	M1_vs_M0	HSALNG0103422	anti_sense	Q90	hsa-miR-4472,hsa-miR-4787-5p,hsa-miR-6089,hsa-miR-6803-5p	-	GLRX5	STX1B
ENSG00000235724	PSMD14-DT	2.37667820193731	0.0382572239221574	M1_vs_M0	HSALNG0019993	integenic	Q90	NA	Intelligence; Unipolar depression	DPP4	FRY
ENSG00000235770	LINC00607	6.39701576263286	4.67579377704844e-30	M1_vs_M0	HSALNG0022091	integenic	Not conserved	NA	-	MREG	VCAM1
ENSG00000235813	NA	3.09990353101952	1.19960783008547e-5	M1_vs_M0	HSALNG0140236	anti_sense	Not conserved	hsa-miR-619-5p	Leukocyte count,Blood urea nitrogen measurement,Hematocrit; Creatinine measurement; Glomerular filtration rate,Creatinine measurement,Birth weight	HPRT1	ENSG00000258101
ENSG00000235823	OLMALINC	-1.39552770760385	6.845998233263851e-9	M1_vs_M0	HSALNG0080102	sense	Q50	hsa-miR-378a-5p,hsa-miR-619-5p,hsa-miR-6089	Alkaline phosphatase measurement,-	SCD	ZNF274
ENSG00000235831	BHLHE40-AS1	1.67044967641936	0.0157761485332855	M1_vs_M0	HSALNG0023884	anti_sense	Q50	NA	Psoriasis vulgaris,Keratoconus,Autoimmune thyroid disease,-	SUMF1	ACAT2
ENSG00000235908	RHOA-IT1	-4.89520061971385	0.0330602334367063	M1_vs_M0	HSALNG0025938	sense	Not conserved	hsa-miR-5787	Intelligence,-	NA	RHOA-IT1
ENSG00000235978	NA	2.18302013166697	0.00713682248987219	M1_vs_M0	HSALNG0023883	anti_sense	Q75	hsa-miR-3155b	Systolic blood pressure,Serum gamma-glutamyl transferase measurement,Thrombin activatable fibrinolysis inhibitor activation peptide measurement,-	SUMF1	ENSG00000275765
ENSG00000236008	LINC01814	-2.57904937349837	4.6000284679453804e-9	M1_vs_M0	HSALNG0012834	integenic	Not conserved	hsa-miR-7160-3p	NA	KIDINS220	C4orf46
ENSG00000236013	LINC02941	-5.36576558054438	4.5904328756626505e-14	M1_vs_M0	HSALNG0053902	integenic	Not conserved	hsa-miR-574-5p	NA	HECA	ZNF385B
ENSG00000236021	COP1-DT	1.03630252209004	0.0188808259492354	M1_vs_M0	HSALNG0008629	integenic	Q75	hsa-miR-619-5p,hsa-miR-6763-5p	Wellbeing measurement; Neuroticism measurement; Depressive symptom measurement,Body height,Cognitive function measurement,Bmi-adjusted hip circumference,Wellbeing measurement,Bmi-adjusted waist-hip ratio; Physical activity measurement,Unipolar depression; Endometriosis,-	PAPPA2	ADGRF4
ENSG00000236120	NA	-2.45959618243972	0.00105385904998387	M1_vs_M0	HSALNG0136490	integenic	Not conserved	NA	Facial morphology measurement	NLGN4X	LINC00910
ENSG00000236345	SCAT8	-1.57619815814694	1.11535274921471e-17	M1_vs_M0	HSALNG0050986	anti_sense	Q75	hsa-miR-6763-5p	-	PHF3	NECAB2
ENSG00000236364	NA	-3.23802063755475	2.06137189815119e-4	M1_vs_M0	HSALNG0008158	anti_sense	Q50	NA	-	TMCO1	DSC3
ENSG00000236393	NA	-6.95563391768732	8.491057798943731e-10	M1_vs_M0	HSALNG0137402	integenic	Q75	NA	Mean platelet volume	ATP6AP2	ATAD5
ENSG00000236404	VLDLR-AS1	3.59400338367708	2.90025436646657e-26	M1_vs_M0	HSALNG0150761	integenic	Q50	hsa-miR-4463	NA	PUM3	ENSG00000272156
ENSG00000236449	NA	-1.31450573591863	0.00159441035769797	M1_vs_M0	HSALNG0020501	anti_sense	Q75	hsa-miR-642b-5p,hsa-miR-4488,hsa-miR-6873-3p	Mean platelet volume; Platelet component distribution width,Mean platelet volume,Pulse pressure measurement; Systolic blood pressure,Atrial fibrillation,Pulse pressure measurement; Platelet component distribution width; Systolic blood pressure,Protein measurement,Resting heart rate,Agents acting on the renin-angiotensin system use measurement,Response to radiation,Qrs amplitude; Qrs complex,Forced expiratory volume; Response to bronchodilator,-	SCRN3	NME6
ENSG00000236453	NA	2.53165980002071	1.35933113235417e-10	M1_vs_M0	HSALNG0059602	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3622b-5p	Eye colour measurement,Brcax breast cancer,Asparaginase hypersensitivity,Aging,Athletic endurance measurement,Circadian rhythm,-	GNG11	ATP5MKP1
ENSG00000236548	RNF217-AS1	-1.97004633361	1.27851226177148e-7	M1_vs_M0	HSALNG0053257	anti_sense	Q50	NA	Calcium measurement,-	HDDC2	ENSG00000227632
ENSG00000236682	MAP3K2-DT	1.83108303236986	1.73657435820031e-6	M1_vs_M0	HSALNG0018617	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-1237-5p,hsa-miR-4292,hsa-miR-3180,hsa-miR-4488,hsa-miR-3960	Protein c measurement,Self reported educational attainment,-	PROC	C18orf21
ENSG00000236700	LINC01010	4.06940080590776	4.73901856162464e-165	M1_vs_M0	HSALNG0053623	integenic	Q50	hsa-miR-619-5p,hsa-miR-4267,hsa-miR-4430,hsa-miR-6089	Dental caries,-	TBPL1	RPLP0P2
ENSG00000236708	SDK1-AS1	2.59406854657594	0.0140047135156844	M1_vs_M0	HSALNG0055787	anti_sense	Q90	hsa-miR-3960,hsa-miR-4787-5p	NA	CARD11	IGHMBP2
ENSG00000236753	MKLN1-AS	1.35470926514102	1.7012777685491302e-14	M1_vs_M0	HSALNG0061408	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4525	Skin aging measurement,Balding measurement,Puberty onset measurement,Alopecia; Androgenetic alopecia,-	PODXL	ZNF124
ENSG00000236790	LINC00299	-3.09880439960788	0.0268344276436911	M1_vs_M0	HSALNG0012827	integenic	Not conserved	hsa-miR-761	NA	KIDINS220	SIX2
ENSG00000236841	NA	5.01032108781569	0.0100781228554174	M1_vs_M0	HSALNG0020020	overlap_antisense,anti_sense	Q90	NA	Cognitive function measurement; Mathematical ability,-	GCA	ENSG00000253125
ENSG00000236871	LINC00106	-1.45098575166617	1.50929537988172e-5	M1_vs_M0	HSALNG0136360	integenic	Not conserved	hsa-miR-1227-5p,hsa-miR-3178,hsa-miR-6089,hsa-miR-6816-5p,hsa-miR-8485	NA	IL3RA	ENSG00000256973
ENSG00000236885	NA	5.67136845659861	0.00254772152448679	M1_vs_M0	HSALNG0146626	integenic	Not conserved	hsa-miR-653-3p	NA	RBM43	ENSG00000203364
ENSG00000236901	MIR600HG	-1.88403618419045	4.5914234526941796e-33	M1_vs_M0	HSALNG0074272	sense	Not conserved	NA	-	STRBP	TP73-AS1
ENSG00000236939	BAALC-AS2	4.14040684189956	4.56123608618972e-21	M1_vs_M0	HSALNG0067505	anti_sense	Q50	hsa-miR-4447	Pelvic organ prolapse,Cognitive function measurement,Myopia,Late-onset alzheimers disease,Mathematical ability,Colorectal cancer; Breast carcinoma,Triglyceride measurement; Response to diuretic,Hemoglobin a1 measurement,-	AZIN1	SMTNL1
ENSG00000236985	NA	3.88355010731497	1.92311195030898e-4	M1_vs_M0	HSALNG0128858	integenic	Not conserved	hsa-miR-619-5p	NA	KIF16B	ABCC11
ENSG00000237036	ZEB1-AS1	-2.51919948343886	1.27779156452434e-10	M1_vs_M0	HSALNG0077083	anti_sense	Q90	hsa-miR-30b-3p,hsa-miR-3178,hsa-miR-3960,hsa-miR-4685-3p,hsa-miR-4707-5p,hsa-miR-5587-3p,hsa-miR-6089,hsa-miR-6769b-3p,hsa-miR-7113-3p,hsa-miR-9901	Lumbar disc degeneration,Mathematical ability,Sex hormone-binding globulin measurement,Glucose homeostasis measurement; Disposition index measurement,Tinnitus; Response to cisplatin,Peripheral arterial disease; Traffic air pollution measurement,-	ZNF438	ENSG00000290357
ENSG00000237125	HAND2-AS1	-5.24746107261225	0.0120418178056443	M1_vs_M0	HSALNG0038609	anti_sense	Q90	hsa-miR-513a-5p,hsa-miR-619-5p,hsa-miR-4297,hsa-miR-4316,hsa-miR-4281,hsa-miR-4285,hsa-miR-1268b,hsa-miR-4505,hsa-miR-6089,hsa-miR-6726-5p,hsa-miR-6732-5p,hsa-miR-6732-3p,hsa-miR-6735-5p,hsa-miR-6747-3p,hsa-miR-6805-5p,hsa-miR-6813-5p,hsa-miR-6845-3p,hsa-miR-8485	Pr interval,Lower face morphology measurement,Cardiac arrhythmia,Electrocardiography,Moderate albuminuria,Response to drug,Cocaine dependence,Diabetic nephropathy,Pulse pressure measurement,Vital capacity,Hormone measurement,Cardiac arrhythmia; Atrial fibrillation,Atrial fibrillation,Inguinal hernia,Multiple myeloma,Heel bone mineral density,Erosive tooth wear measurement,Bone mineral content measurement,Response to bisphosphonate; Atypical femoral fracture,Ovarian serous carcinoma; Response to carboplatin; Response to paclitaxel; Progression free survival,Parental genotype effect measurement; Birth weight,-	SAP30	HAND2-AS1
ENSG00000237187	NR2F1-AS1	-1.31638745855186	1.03446461607779e-7	M1_vs_M0	HSALNG0043533	anti_sense	Q90	NA	-	FAM172A	FBXO28
ENSG00000237220	NA	5.80914455800798	6.58901361343415e-4	M1_vs_M0	HSALNG0019571	anti_sense	Q50	hsa-miR-6089	Platelet count,Arterial stiffness measurement,-	TNFAIP6	NGF
ENSG00000237250	NA	-4.67941118495169	0.0214642500756932	M1_vs_M0	HSALNG0011815	integenic	Not conserved	NA	NA	RYR2	ENSG00000237250
ENSG00000237352	LINC01358	2.15763153204595	4.94394173348135e-9	M1_vs_M0	HSALNG0003970	integenic	Q50	NA	Serum albumin measurement,Response to lithium ion; Bipolar disorder,Hematocrit; Pulse pressure measurement,-	FGGY	CPXM1
ENSG00000237361	TUSC8	-1.37620965960518	0.016406553676694	M1_vs_M0	HSALNG0096756	integenic	Not conserved	hsa-miR-3940-5p,hsa-miR-6132	Sex hormone-binding globulin measurement,-	TSC22D1	ARMC2-AS1
ENSG00000237422	NA	-3.13766565563711	1.15003204167598e-5	M1_vs_M0	HSALNG0072689	integenic	Q50	hsa-miR-331-3p,hsa-miR-619-5p,hsa-miR-4292,hsa-miR-5001-3p,hsa-miR-6763-3p	Antisaccade response measurement,Adenosine diphosphate measurement,Balding measurement,Platelet crit,Platelet count,Ulcerative colitis; Inflammatory bowel disease,Eczema,Bmi-adjusted waist-hip ratio,Waist-hip ratio,Neutrophil percentage of granulocytes,Eosinophil percentage of leukocytes,Eosinophil count,Bilirubin measurement; Aspartate aminotransferase measurement,Parental genotype effect measurement; Gestational blood glucose measurement; Glycosuria,Hematocrit; Hemoglobin measurement; Erythrocyte count,Leukocyte count,-	AUH	TMEM143
ENSG00000237484	LINC01684	2.36106152346012	1.02225698190736e-44	M1_vs_M0	HSALNG0147058	integenic	Not conserved	NA	-	JAM2	ZNF804A
ENSG00000237505	PKN2-AS1	2.86836022458883	0.00302350066345705	M1_vs_M0	HSALNG0004980	anti_sense	Q75	hsa-miR-338-3p,hsa-miR-619-5p,hsa-miR-5680,hsa-miR-6779-5p	Platelet count; Platelet crit,Platelet count,Sleep apnea measurement,Memory performance,Platelet crit,Response to tnf antagonist,Protein measurement,Educational attainment,Breast carcinoma,Autosomal dominant compelling helio-ophthalmic outburst syndrome,Diastolic blood pressure,Intraocular pressure measurement,Prostate specific antigen measurement,Prostate carcinoma,Brain volume measurement,Glaucoma; Open-angle glaucoma; Intraocular pressure measurement,Cortical surface area measurement,Cognition,Open-angle glaucoma,Response to paclitaxel,Gut microbiome measurement,Clostridium difficile infection,Adolescent idiopathic scoliosis,Cytokine measurement,Cortical surface area measurement; Brain volume measurement; Neuroimaging measurement,Brain volume measurement; Cortical thickness,Cortical surface area measurement; Neuroimaging measurement; Brain measurement,Diet measurement,Microglial activation measurement,Body mass index,Body height,Periodontitis; Systolic blood pressure,Hematocrit; Hemoglobin measurement,Serum st2 measurement; Systolic blood pressure,Irritable bowel syndrome,Cannabis dependence measurement,Risk-taking behaviour,Susceptibility to childhood ear infection measurement,Neuropsychological test,Age at first sexual intercourse measurement,Age at first birth measurement,Coronary artery disease,Nicotine dependence symptom count,Self reported educational attainment,Pulse pressure measurement,Bmi-adjusted waist circumference,Abnormality of refraction,Serum gamma-glutamyl transferase measurement,Body height; Serum gamma-glutamyl transferase measurement,Serum alanine aminotransferase measurement; Bmi-adjusted waist circumference; Serum gamma-glutamyl transferase measurement; Body height; Aspartate aminotransferase measurement,Serum alanine aminotransferase measurement; Serum gamma-glutamyl transferase measurement; Red blood cell density measurement; Aspartate aminotransferase measurement,Systolic blood pressure; Mean arterial pressure,Platelet component distribution width,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,Parental genotype effect measurement; Vitamin d measurement,Peripheral arterial disease; Traffic air pollution measurement,Obsessive-compulsive disorder; Autism spectrum disorder,-	GTF2B	ZDHHC11
ENSG00000237596	NA	5.31972911038142	7.87697251687265e-14	M1_vs_M0	HSALNG0053689	anti_sense	Q50	hsa-miR-185-3p,hsa-miR-5572,hsa-miR-6763-5p	Hemoglobin measurement,Red blood cell distribution width,Erythrocyte count,Body height; Heel bone mineral density,Heel bone mineral density; Blood phosphate measurement,Heel bone mineral density,Age at menarche,Blood phosphate measurement,Alcoholic liver cirrhosis,Calcium measurement,Facial morphology measurement,Brcax breast cancer,Sphingomyelin 22:0 measurement,Aspartate aminotransferase measurement,Adolescent idiopathic scoliosis,Open-angle glaucoma,Glaucoma; Open-angle glaucoma; Intraocular pressure measurement,Intraocular pressure measurement,Diverticulitis,Response to corticosteroid; Response to synacthen; Cortisol measurement,Bipolar disorder; Body mass index,-	MTFR2	THAP6
ENSG00000237742	HEY2-AS1	-5.08152300879696	0.0111629685760232	M1_vs_M0	HSALNG0053298	integenic	Not conserved	NA	NA	HDDC2	TUBA3FP
ENSG00000237753	SLC20A1-DT	-1.43133093661164	7.12372552991665e-10	M1_vs_M0	HSALNG0017985	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-3652,hsa-miR-4443,hsa-miR-4508,hsa-miR-378j	-	CKAP2L	ZDHHC16
ENSG00000237787	LINC02877	4.82583169113678	0.0175996369010862	M1_vs_M0	HSALNG0029938	integenic	Not conserved	NA	NA	RAP2B	H1-3
ENSG00000237797	MACORIS	-4.89101087071343	0.0436184627635331	M1_vs_M0	HSALNG0077098	integenic	Q50	NA	Waist-hip ratio; Sex interaction measurement; Age at assessment; Bmi-adjusted waist-hip ratio	ARHGAP12	SPEN-AS1
ENSG00000237836	PHKA2-AS1	-4.89384260949409	0.0112130582299201	M1_vs_M0	HSALNG0136885	anti_sense	Q50	NA	-	PPEF1	NECTIN3
ENSG00000237877	LINC01473	1.64986993534625	3.56078402742624e-5	M1_vs_M0	HSALNG0020959	integenic	Q50	NA	NA	ZSWIM2	LSM12
ENSG00000237927	NA	8.32789056629415	9.39806336677402e-23	M1_vs_M0	HSALNG0054755	integenic	Not conserved	hsa-miR-183-5p,hsa-miR-5585-3p,hsa-miR-6089	Lipoprotein a measurement,Atrophic macular degeneration,-	SOD2	FGF10-AS1
ENSG00000237938	NA	1.52550535019041	1.96516301407577e-4	M1_vs_M0	HSALNG0001105	anti_sense	Q75	hsa-miR-5047	Systolic blood pressure,-	UQCRHL	ADGRB1
ENSG00000237980	LINC02773	4.94344438769596	1.59266891626455e-10	M1_vs_M0	HSALNG0010379	integenic	Q50	hsa-miR-4313,hsa-miR-4466	-	BATF3	ZNG1E
ENSG00000238005	LNCATV	-1.4785105455146	4.47625271533561e-5	M1_vs_M0	HSALNG0011660	integenic	Q50	hsa-miR-6089,hsa-miR-6769b-3p	Serum gamma-glutamyl transferase measurement,Platelet count,Monocyte percentage of leukocytes; Monocyte count,Apolipoprotein a 1 measurement,Low density lipoprotein cholesterol measurement,Response to vaccine; Cytokine measurement,Cognitive function measurement,-	TOMM20	PTPN4
ENSG00000238045	MVP-DT	1.50100464959372	2.26391302366451e-5	M1_vs_M0	HSALNG0144898	anti_sense	Q90	hsa-miR-4745-3p	NA	CDIPT	PTCHD3P2
ENSG00000238062	SPATA3-AS1	-5.08022420824149	0.0048016614778225	M1_vs_M0	HSALNG0022908	anti_sense	Q50	hsa-miR-4688	-	GPR55	SPATA3-AS1
ENSG00000238078	LINC01352	1.6046321014964	3.2248260167470804e-9	M1_vs_M0	HSALNG0010764	sense	Not conserved	NA	NA	NA	LRRC61
ENSG00000238099	LINC01625	-2.51121722311612	0.0273902086376376	M1_vs_M0	HSALNG0053881	integenic	Q90	hsa-miR-33b-5p,hsa-miR-4281,hsa-miR-1268b	Fev/fec ratio; Response to bronchodilator,-	CITED2	OXCT1
ENSG00000238160	LINC02863	-1.31709828385349	0.0038532540414247	M1_vs_M0	HSALNG0044838	anti_sense	Q50	hsa-miR-4436a	Fibrinogen measurement,Chronic obstructive pulmonary disease,Metabolite measurement,Apolipoprotein b measurement,Glycine measurement,Red blood cell distribution width,Neutrophil percentage of leukocytes,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	IRF1	HYLS1
ENSG00000238164	TNFRSF14-AS1	1.67010402691452	7.72617434895238e-27	M1_vs_M0	HSALNG0000275	anti_sense	Q75	hsa-miR-505-5p,hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4481,hsa-miR-1343-3p,hsa-miR-5589-5p,hsa-miR-6751-3p,hsa-miR-6769a-3p,hsa-miR-6813-5p,hsa-miR-6852-5p	Eosinophil count,Rheumatoid arthritis,Eosinophil count; Eosinophil percentage of leukocytes,-	HES5	ECHDC3
ENSG00000239213	NCK1-DT	-1.4051782596215	3.3020897817458897e-12	M1_vs_M0	HSALNG0029189	anti_sense	Q90	hsa-miR-23a-5p,hsa-miR-135a-3p,hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-4447,hsa-miR-3960,hsa-miR-6089	Lymphocyte count,Body mass index,-	STAG1	EXO5
ENSG00000239415	NA	-2.09668535730638	0.0430822231904135	M1_vs_M0	HSALNG0133724	sense	Q50	hsa-miR-6089	-	MCM3AP	NKX3-2
ENSG00000239653	PSMD6-AS2	1.53413688689222	0.00512841209839064	M1_vs_M0	HSALNG0026555	anti_sense	Q50	hsa-miR-619-5p	Drugs used in diabetes use measurement,Glomerular filtration rate,Neuroimaging measurement; Cortical thickness,-	ATXN7	ATP6V1E2
ENSG00000239911	PRKAG2-AS1	1.48939648087374	0.0122531432658561	M1_vs_M0	HSALNG0062390	anti_sense	Q90	hsa-miR-1227-5p,hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-6791-5p	-	GALNTL5	TSBP1-AS1
ENSG00000240057	NEPRO-AS1	2.65295529703686	7.968620596565921e-14	M1_vs_M0	HSALNG0028082	integenic	Q90	hsa-miR-296-3p	Telomere length,Myopia,Body height	GTPBP8	PCBP4
ENSG00000240219	NA	3.02174018700771	1.09876897992709e-6	M1_vs_M0	HSALNG0009887	anti_sense	Q75	hsa-miR-650,hsa-miR-1301-3p,hsa-miR-4252,hsa-miR-5047,hsa-miR-6744-3p	Body height,Neuropsychological test,Household income,Upper aerodigestive tract neoplasm,Prostate carcinoma,Mathematical ability,Self reported educational attainment; Sodium measurement,Intelligence,Biological sex,Platelet crit,Diet measurement,Self reported educational attainment,Motor function measurement; Response to levodopa; Response to zonisamide,Self reported educational attainment; Intelligence; Cognitive function measurement; Mathematical ability,Self reported educational attainment; Intelligence; Household income; Mathematical ability,Social interaction measurement,-	MDM4	XACT
ENSG00000240405	SAMMSON	1.76045748016912	0.0171218146510555	M1_vs_M0	HSALNG0026723	integenic	Not conserved	NA	NA	MITF	UBE2K
ENSG00000240990	HOXA11-AS	-1.82140727058506	1.95850437059119e-13	M1_vs_M0	HSALNG0056865	anti_sense	Q90	hsa-miR-920,hsa-miR-4286,hsa-miR-3960,hsa-miR-4769-5p,hsa-miR-5197-3p,hsa-miR-6741-3p,hsa-miR-10394-3p	Ulcerative colitis,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Waist-hip ratio,Bmi-adjusted waist-hip ratio,Heel bone mineral density,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Bmi-adjusted waist circumference; Body fat percentage; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Aspartate aminotransferase measurement,Diuretic use measurement,-	EVX1	COG4
ENSG00000241743	XACT	2.51981786014237	7.61202169874363e-13	M1_vs_M0	HSALNG0139599	integenic	Not conserved	NA	NA	AMOT	RAD9B
ENSG00000241769	EOLA1-DT	-2.71002660860648	9.91724116097939e-4	M1_vs_M0	HSALNG0140599	anti_sense,sense	Not conserved	hsa-miR-4257	NA	NA	ENSG00000225806
ENSG00000241886	NA	3.52413407097434	3.36110232071948e-8	M1_vs_M0	HSALNG0137207	sense	Q90	NA	-	GK	ENSG00000224478
ENSG00000241990	PRR34-AS1	-1.43590253388042	0.00305635622723366	M1_vs_M0	HSALNG0135994	integenic	Q50	hsa-miR-920,hsa-miR-939-5p,hsa-miR-3620-5p,hsa-miR-4472,hsa-miR-4505,hsa-miR-1587,hsa-miR-3972,hsa-miR-4707-5p,hsa-miR-5587-3p,hsa-miR-5589-5p,hsa-miR-6775-3p	Birth weight,Wellbeing measurement; Dupuytren contracture,Alcohol use disorder measurement; Alcohol consumption measurement,Body weight,Body height; Body weight,Smoking status measurement,Attention deficit hyperactivity disorder; Bipolar disorder; Major depressive disorder; Autism spectrum disorder,-	PPARA	ARFIP1
ENSG00000242242	NECTIN3-AS1	-4.51182229676247	2.03395850814486e-7	M1_vs_M0	HSALNG0027990	integenic	Not conserved	NA	NA	ZBED2	ENSG00000286681
ENSG00000242258	LINC00996	4.71011827020783	1.1266085404690699e-131	M1_vs_M0	HSALNG0062275	sense	Not conserved	NA	Electroencephalogram measurement	GIMAP8	KCNA3
ENSG00000242516	LINC00960	-1.28002803592165	7.47071172552193e-8	M1_vs_M0	HSALNG0026938	anti_sense	Not conserved	hsa-miR-619-5p	NA	FRG2C	LINC02454
ENSG00000242741	LINC02005	4.6096380247684	0.029679690860328	M1_vs_M0	HSALNG0026866	integenic	Q50	NA	Forced expiratory volume; Fev/fec ratio; Hair colour measurement,Testosterone measurement,-	PPP4R2	ENSG00000251288
ENSG00000243055	GK-AS1	3.32432971224055	1.30726255175787e-10	M1_vs_M0	HSALNG0151186	anti_sense	Q50	hsa-miR-619-5p	-	TAB3	SLC9A8
ENSG00000243176	NA	1.51779571219174	1.7061840391438401e-09	M1_vs_M0	HSALNG0030112	anti_sense	Q75	NA	NA	PTX3	PMP22
ENSG00000243799	PEX5L-AS1	-5.24405099961305	0.00666367357663232	M1_vs_M0	HSALNG0030989	anti_sense	Not conserved	NA	-	USP13	TRIL
ENSG00000243926	TIPARP-AS1	-2.70976625087522	0.00107349278207445	M1_vs_M0	HSALNG0030062	anti_sense	Q75	hsa-miR-6727-5p	-	SSR3	PABPC4
ENSG00000244040	IL12A-AS1	-1.69406061290559	0.0320277249309761	M1_vs_M0	HSALNG0030211	integenic	Not conserved	NA	NA	NA	ASIC1
ENSG00000244124	ATP1B3-AS1	5.80265596026574	3.98976296986499e-4	M1_vs_M0	HSALNG0029431	anti_sense	Q50	NA	Pulse pressure measurement; Mean corpuscular hemoglobin,Red blood cell distribution width,Hair color,Hair colour measurement,Thyroid preparation use measurement,-	TFDP2	H1-3
ENSG00000244158	CALHM6-AS1	4.83354611116217	0.021481276766537	M1_vs_M0	HSALNG0053007	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-1285-5p	-	TRAPPC3L	PSD2
ENSG00000244586	WNT5A-AS1	6.37174248645106	5.27826361981779e-6	M1_vs_M0	HSALNG0147531	anti_sense	Q90	hsa-miR-7108-3p	-	CACNA2D3	MAPK10
ENSG00000244998	NA	-6.30276621359603	9.8119249024085e-6	M1_vs_M0	HSALNG0150503	anti_sense	Not conserved	NA	-	GPR20	METTL21A
ENSG00000245008	NA	-2.47804245013957	0.00521815081935605	M1_vs_M0	HSALNG0088107	anti_sense	Q50	hsa-miR-7150	Lymphocyte percentage of leukocytes; Lymphocyte count,Rheumatoid arthritis; Neoplasm of mature b-cells,Total blood protein measurement,Serum non-albumin protein measurement,Systemic lupus erythematosus; Chronic lymphocytic leukemia,Albumin:globulin ratio measurement; Lymphocyte count; Serum non-albumin protein measurement,Rheumatoid arthritis,Digit length ratio,Monocyte count,Monocyte percentage of leukocytes,Bmi-adjusted waist circumference,-	ETS1	LTB
ENSG00000245017	LINC02453	-4.89271917490787	0.0206318430850042	M1_vs_M0	HSALNG0093379	integenic	Q90	NA	Colorectal adenoma,-	IKBIP	RPL6P19
ENSG00000245105	A2M-AS1	-2.15414382197734	0.00305844377867434	M1_vs_M0	HSALNG0089113	anti_sense	Not conserved	hsa-miR-1228-5p,hsa-miR-4307,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-6090	-	KLRG1	ENSG00000233351
ENSG00000245248	USP2-AS1	-1.19876748152377	6.86673747428741e-8	M1_vs_M0	HSALNG0143088	integenic	Not conserved	NA	-	RNF26	LRRC73
ENSG00000245293	CYP2U1-AS1	-4.84165178931378	1.40970444881108e-9	M1_vs_M0	HSALNG0036264	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-874-5p,hsa-miR-548l,hsa-miR-4328,hsa-miR-10392-3p	Monoclonal gammopathy,Protein measurement,Glycine measurement,-	LEF1	CIP2A
ENSG00000245468	LINC02447	-1.81342376350722	0.00657609646842502	M1_vs_M0	HSALNG0032671	integenic	Q50	NA	-	GRPEL1	SVIP
ENSG00000245532	NEAT1	1.11437021005393	3.88661633668012e-40	M1_vs_M0	HSALNG0084892	integenic	Q50	hsa-miR-4308,hsa-miR-4710,hsa-miR-6724-5p,hsa-miR-6747-3p,hsa-miR-8485	Bmi-adjusted hip circumference,Hemoglobin a1 measurement,-	FRMD8	TCF12-DT
ENSG00000245556	SCAMP1-AS1	1.32381308164906	2.95683159887178e-13	M1_vs_M0	HSALNG0042878	integenic	Q50	hsa-miR-619-5p	NA	AP3B1	MAN1C1
ENSG00000245598	DACT3-AS1	3.10892963140953	0.0194030222267085	M1_vs_M0	HSALNG0145768	anti_sense	Q90	NA	-	CALM3	HIBADH
ENSG00000245648	KLRK1-AS1	-5.52844752410689	9.53275692119835e-4	M1_vs_M0	HSALNG0089224	anti_sense	Q50	NA	Maximal oxygen uptake measurement,Nkg2-d type ii integral membrane protein measurement,-	KLRD1	INTS1
ENSG00000245685	FRG1-DT	-1.372515164926	0.0352762420634646	M1_vs_M0	HSALNG0039382	integenic	Not conserved	NA	-	FRG2	ENSG00000262823
ENSG00000245750	DRAIC	-2.51296423051741	0.0242875163087497	M1_vs_M0	HSALNG0106878	integenic	Q75	NA	-	RPLP1	ARG1
ENSG00000245812	LINC02202	2.78433668570088	0.0047938838847302	M1_vs_M0	HSALNG0046188	integenic	Q75	hsa-miR-3178,hsa-miR-4290,hsa-miR-4534,hsa-miR-4737,hsa-miR-6068,hsa-miR-6089,hsa-miR-6769b-3p	-	UBLCP1	UGT8
ENSG00000245928	SDAD1-AS1	7.22153767224459	1.1323833022263599e-11	M1_vs_M0	HSALNG0035291	anti_sense	Not conserved	NA	Lung carcinoma,Blood protein measurement,-	ART3	CLEC4E
ENSG00000245954	LINC02273	-5.96763697375928	1.41749047680615e-4	M1_vs_M0	HSALNG0037887	integenic	Q75	hsa-miR-504-3p,hsa-miR-6089	Systemic lupus erythematosus,Reaction time measurement,Smoking status measurement,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,Body mass index,-	FHIP1A	FAM118A
ENSG00000245975	MINDY2-DT	-2.90873421103776	1.46173828983131e-4	M1_vs_M0	HSALNG0106254	anti_sense	Q90	NA	Parental longevity,-	ADAM10	LINC02296
ENSG00000246100	LINC00900	1.03948761295187	4.25236321940553e-12	M1_vs_M0	HSALNG0087365	integenic	Q75	hsa-miR-665,hsa-miR-4281,hsa-miR-1268b,hsa-miR-3960	NA	CADM1	GTF2E1
ENSG00000246174	KCTD21-AS1	-1.02709510671928	0.0406043983650874	M1_vs_M0	HSALNG0085965	anti_sense	Q50	hsa-miR-619-5p	-	USP35	ENSG00000205018
ENSG00000246331	NA	-4.89386289771173	0.0117098480350051	M1_vs_M0	HSALNG0090149	integenic	Q50	hsa-miR-619-5p,hsa-miR-4447,hsa-miR-6089,hsa-miR-6132,hsa-miR-6803-5p,hsa-miR-10392-3p	Macrophage inflammatory protein 1a measurement,Macrophage colony stimulating factor measurement,Optic disc size measurement,Parental genotype effect measurement; Birth weight,Colorectal cancer,-	TSPAN11	HPCAL4
ENSG00000246375	PPM1K-DT	7.5868813195573	1.4110987298814301e-14	M1_vs_M0	HSALNG0035747	anti_sense	Q50	hsa-miR-6089	Urate measurement,Serum metabolite measurement,Metabolite measurement; Blood metabolite measurement; Coronary artery calcification; Amino acid measurement,Bipolar disorder,Serum metabolite measurement; Amino acid measurement,Gout; Urate measurement,Blood metabolite measurement; Breast carcinoma,Gout,Protein measurement; Blood metabolite measurement; Amino acid measurement,-	HERC6	FAM107A
ENSG00000246430	LINC00968	1.06757641456369	0.0131142762163663	M1_vs_M0	HSALNG0065481	integenic	Q75	hsa-miR-6791-5p	NA	PENK	RAB18
ENSG00000246582	TNFRSF10A-DT	2.08850768201816	8.509456968643129e-16	M1_vs_M0	HSALNG0063968	anti_sense	Not conserved	hsa-miR-4687-5p	Wet macular degeneration; Atrophic macular degeneration; Central serous retinopathy; Tnf-related apoptosis-inducing ligand measurement; Age-related macular degeneration,Protein measurement	CHMP7	SLC7A6
ENSG00000246662	CIBAR1-DT	6.15780201008937	2.67330789421747e-5	M1_vs_M0	HSALNG0066967	integenic	Q50	NA	-	RBM12B	TAC3
ENSG00000246763	RGMB-AS1	-2.70692410533632	1.30526164213043e-8	M1_vs_M0	HSALNG0043698	anti_sense	Q90	hsa-miR-9899	-	CHD1	CENPN
ENSG00000246859	STARD4-AS1	-2.67644964989697	6.9615435716157e-54	M1_vs_M0	HSALNG0044138	integenic	Not conserved	NA	NA	CAMK4	FRMD8
ENSG00000246898	LINC00920	-3.24114283069982	1.3989761837654901e-9	M1_vs_M0	HSALNG0112089	integenic	Not conserved	hsa-miR-5003-3p	NA	CDH5	ABCB11
ENSG00000247092	SNHG10	-1.32275993132888	2.60875822652763e-7	M1_vs_M0	HSALNG0103440	anti_sense	Q50	hsa-miR-6089,hsa-miR-6779-5p,hsa-miR-6780a-3p	Corneal endothelial cell measurement,Erythrocyte count,-	SYNE3	IL17RA
ENSG00000247095	MIR210HG	-2.39368842639275	2.9008781904246697e-31	M1_vs_M0	HSALNG0081992	anti_sense	Q50	hsa-miR-766-3p,hsa-miR-4707-5p,hsa-miR-5587-3p,hsa-miR-6735-5p,hsa-miR-6735-3p,hsa-miR-6858-5p,hsa-miR-7843-5p	Systemic lupus erythematosus,High density lipoprotein cholesterol measurement,-	LMNTD2	TMEM160
ENSG00000247151	CSTF3-DT	-1.91456982340018	0.0442022124947697	M1_vs_M0	HSALNG0083517	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4755-3p,hsa-miR-6089	Alcohol use disorder measurement; Alcohol consumption measurement,-	TCP11L1	LINC03018
ENSG00000247240	UBL7-DT	-1.479395661201	1.6994801563816e-5	M1_vs_M0	HSALNG0107191	integenic	Q50	hsa-miR-619-5p,hsa-miR-885-3p,hsa-miR-1227-5p,hsa-miR-6763-5p,hsa-miR-8072	Mean corpuscular volume,Caffeine metabolite measurement,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,-	ARID3B	MUC4
ENSG00000247317	LY6E-DT	5.56500191460157	8.3185432957639e-36	M1_vs_M0	HSALNG0069213	anti_sense	Not conserved	hsa-miR-6132,hsa-miR-6779-5p,hsa-miR-6784-5p,hsa-miR-6869-3p,hsa-miR-8485	-	LY6S	LINC00937
ENSG00000247400	DNAJC3-DT	-1.04443575428764	0.00393109258814501	M1_vs_M0	HSALNG0098734	integenic	Q50	hsa-miR-4472,hsa-miR-6803-5p	Alkaline phosphatase measurement	DZIP1	MNX1
ENSG00000247774	PCED1B-AS1	-2.28457510058664	2.42798693321433e-75	M1_vs_M0	HSALNG0090741	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3940-5p,hsa-miR-6089	Antihypertensive use measurement,Body height,-	AMIGO2	RPL7A
ENSG00000247796	MOCS2-DT	-1.34828860798529	0.0291751955332069	M1_vs_M0	HSALNG0041764	anti_sense	Q50	hsa-miR-6807-5p	Systemic juvenile idiopathic arthritis,Intelligence,Anorexia nervosa; Autism spectrum disorder; Obsessive-compulsive disorder; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder; Tourette syndrome,-	ITGA2	DNAAF2
ENSG00000247934	NA	1.27423535722302	3.54584395658815e-4	M1_vs_M0	HSALNG0090059	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3529-5p,hsa-miR-6089	Serum igg glycosylation measurement,Seasonal allergic rhinitis,Bmi-adjusted waist circumference,Balding measurement,Open-angle glaucoma,Gut microbiome measurement,Attention deficit hyperactivity disorder; Behavior,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference,Blood protein measurement,Brain volume measurement,Cortical surface area measurement; Facial morphology measurement,Forced expiratory volume; Vital capacity,Reticulocyte measurement,Bmi-adjusted hip circumference,Volumetric bone mineral density,Chronic obstructive pulmonary disease,Body height,Neuroimaging measurement; Cortical thickness,Forced expiratory volume; Response to bronchodilator,Brain volume measurement; Neuroimaging measurement; Brain measurement,-	PTHLH	UBLCP1
ENSG00000247982	LINC00926	2.60636834344631	1.6259707875843199e-109	M1_vs_M0	HSALNG0106171	sense	Q50	hsa-miR-4492,hsa-miR-4508,hsa-miR-6803-5p	-	TCF12	NFKBIZ
ENSG00000248138	NA	-5.08057814926947	0.00630659267926701	M1_vs_M0	HSALNG0033105	integenic	Q75	NA	NA	CD38	NOVA2
ENSG00000248187	NA	-2.56313792258725	8.470032976994591e-15	M1_vs_M0	HSALNG0037074	integenic	Q50	hsa-miR-6855-5p,hsa-miR-6769b-5p	NA	PGRMC2	PLA2G5
ENSG00000248202	LINC02234	-4.40182890615376	8.67395151134982e-7	M1_vs_M0	HSALNG0043678	integenic	Q75	NA	Pr interval,Estradiol measurement,Loneliness measurement,Ovarian serous carcinoma; Ovarian carcinoma; Progression free survival,-	LNPEP	ZNF710-AS1
ENSG00000248309	MEF2C-AS1	-1.62000828554978	5.62620321557399e-8	M1_vs_M0	HSALNG0043388	integenic	Not conserved	NA	NA	POLR3G	EMC10
ENSG00000248318	NA	-3.6670222431326	2.03056029347642e-6	M1_vs_M0	HSALNG0068083	anti_sense	Q75	NA	-	MTBP	ENSG00000259081
ENSG00000248360	LINC00504	1.15904242150085	9.90634945655789e-25	M1_vs_M0	HSALNG0033029	integenic	Q75	hsa-miR-5047	Diacylglycerol 36:2 measurement,Protein measurement,Skin pigmentation,Nausea,Systolic blood pressure,-	FBXL5	CTSF
ENSG00000248371	LINC02056	1.63759839650853	0.00593881682745258	M1_vs_M0	HSALNG0042592	integenic	Not conserved	NA	NA	ZNF366	SNRPGP15
ENSG00000248464	FGF10-AS1	5.69519919413258	5.24015112339608e-4	M1_vs_M0	HSALNG0041545	anti_sense	Q90	hsa-miR-3622a-5p	Keratinocyte carcinoma; Basal cell carcinoma; Non-melanoma skin carcinoma,Balding measurement,Alopecia,Forced expiratory volume,Breast carcinoma,Lip morphology measurement,Dental caries; Dentures,-	MRPS30	LINC02100
ENSG00000248473	LINC01962	-4.40218504954344	1.10795839411812e-6	M1_vs_M0	HSALNG0047230	integenic	Q75	hsa-miR-1268b,hsa-miR-4497,hsa-miR-6089,hsa-miR-8072	-	TRIM7	RPL8P3
ENSG00000248538	PPP1R3B-DT	-4.6624936835389	2.39784568162522e-8	M1_vs_M0	HSALNG0063318	integenic	Q50	hsa-miR-6803-5p	NA	ERI1	RECQL5
ENSG00000248587	GDNF-AS1	3.70854642492586	0.00153393835977668	M1_vs_M0	HSALNG0041260	integenic	Q75	NA	NA	WDR70	ENSG00000288811
ENSG00000248673	LINC01331	-4.89363784530316	0.0111524525191794	M1_vs_M0	HSALNG0042682	integenic	Q50	NA	-	ENC1	CENPW
ENSG00000248677	LINC02102	6.31614462615406	2.22983626782119e-5	M1_vs_M0	HSALNG0039917	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-7160-3p	Body height,-	NSUN2	SLC22A1
ENSG00000248693	LINC02100	5.69340822595459	2.83677714601302e-4	M1_vs_M0	HSALNG0040483	integenic	Not conserved	NA	NA	CDH18	LINC02100
ENSG00000248714	ZNF652-AS1	-5.24442486952202	0.00972204401427572	M1_vs_M0	HSALNG0117177	anti_sense	Q90	hsa-miR-219a-2-3p,hsa-miR-619-5p,hsa-miR-4430,hsa-miR-4787-5p,hsa-miR-6803-5p	Diastolic blood pressure; Neuroimaging measurement; Brain measurement; Systolic blood pressure; Atopic asthma; Body height; Atopic eczema; Coronary artery disease,Testosterone measurement; Body fat distribution; Family history of alzheimer’s disease; Late-onset alzheimers disease,Eosinophil percentage of leukocytes; Eczema; Inhalant adrenergic use measurement; Allergic rhinitis; Eosinophil count,Uric acid measurement; Testosterone measurement; Sex hormone-binding globulin measurement,Age at first sexual intercourse measurement; Diastolic blood pressure; Eczema; Systolic blood pressure,Diastolic blood pressure; Alcohol drinking; Systolic blood pressure; Mean arterial pressure; Coronary artery disease; Alcohol consumption measurement,Testosterone measurement,Diuretic use measurement,Cardiovascular disease,Prostate carcinoma,Comparative body size at age 10, self-reported; Self rated health; Monocyte count; Angina pectoris; Agents acting on the renin-angiotensin system use measurement,Eosinophil count; Basophil count; Adult onset asthma,Adult onset asthma,Systemic lupus erythematosus,Inhalant adrenergic use measurement,Glucocorticoid use measurement,Sex hormone-binding globulin measurement,Fev/fec ratio; Appendicular lean mass,Mean corpuscular hemoglobin concentration; Mean corpuscular volume; Red blood cell density measurement,Coronary artery disease,Behavior or behavioral disorder measurement,Systolic blood pressure,Lower body strength measurement,Cortical surface area measurement; Neuroimaging measurement,-,Hemoglobin measurement; Systolic blood pressure; Leukocyte count; Hematocrit; Coronary artery disease	NGFR	PPP4R1
ENSG00000248927	NA	1.71144188798679	5.4482127677151196e-11	M1_vs_M0	HSALNG0044434	sense	Q90	NA	Self reported educational attainment,Mathematical ability,Fev/fec ratio,-	PRR16	TBX1
ENSG00000249001	NA	-4.7591015641542	1.29764077289652e-78	M1_vs_M0	HSALNG0035715	anti_sense	Q50	hsa-miR-4281,hsa-miR-4486	Urate measurement,Sparc-like protein 1 measurement,Idiopathic dilated cardiomyopathy,Body weight,Gout; Urate measurement,Bmi-adjusted hip circumference,Mental or behavioural disorder,Heel bone mineral density,Body height,-,Omega-6:omega-3 polyunsaturated fatty acid ratio; Omega-3 polyunsaturated fatty acid measurement; Docosahexaenoic acid measurement	SPARCL1	GFI1
ENSG00000249096	LINC02362	1.42917334609684	7.5244306834105e-6	M1_vs_M0	HSALNG0039015	integenic	Not conserved	hsa-miR-6089,hsa-miR-6127,hsa-miR-6129	NA	IRF2	ASAH2B
ENSG00000249171	NA	5.45651391963513	9.03302737283983e-4	M1_vs_M0	HSALNG0035597	integenic	Not conserved	NA	Autism spectrum disorder	ABRAXAS1	LGALS3
ENSG00000249173	LINC01093	4.99302973844944	0.022047186732805	M1_vs_M0	HSALNG0039055	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6808-5p,hsa-miR-6769b-5p	NA	ACSL1	LINC01093
ENSG00000249249	TICAM2-AS1	2.3178707346874	0.00246434583325682	M1_vs_M0	HSALNG0044270	anti_sense	Q90	NA	-	AP3S1	TCEAL1
ENSG00000249307	LINC01088	-4.43741260559312	3.2611995870380397e-26	M1_vs_M0	HSALNG0035427	integenic	Not conserved	hsa-miR-619-5p	NA	BMP2K	TBRG1
ENSG00000249502	MED28-DT	3.14806474280066	1.84479023041011e-50	M1_vs_M0	HSALNG0033145	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4771	-	FAM184B	MARCHF3
ENSG00000249592	PCGF3-AS1	-1.03453230263807	2.37690769279789e-6	M1_vs_M0	HSALNG0032188	anti_sense	Q75	NA	-	CPLX1	RNF10
ENSG00000249669	CARMN	-2.30060818281844	0.0271786059321075	M1_vs_M0	HSALNG0045753	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-5787,hsa-miR-6751-3p,hsa-miR-6769a-3p	Antipsychotic drug related weight gain,Heel bone mineral density,3-hydroxypropylmercapturic acid measurement,Diet measurement; Bilirubin measurement,-	PCYOX1L	A1BG-AS1
ENSG00000249685	NA	1.780713548154	1.82672755684965e-4	M1_vs_M0	HSALNG0033928	integenic	Q50	NA	Acute lymphoblastic leukemia	KLHL5	CCDC30
ENSG00000249771	NA	4.08734291844384	2.11823017809345e-5	M1_vs_M0	HSALNG0034072	integenic	Q90	hsa-miR-619-5p,hsa-miR-4258	-	PHOX2B	GLIS2
ENSG00000249816	LINC00964	-1.0363611036463	0.015331023146811701	M1_vs_M0	HSALNG0068291	integenic	Not conserved	NA	NA	ZNF572	ENSG00000280132
ENSG00000249917	LINC00536	8.44036132684151	5.7710174977862995e-24	M1_vs_M0	HSALNG0067917	integenic	Not conserved	NA	NA	TRPS1	ENSG00000253207
ENSG00000249937	LINC02223	5.50645529371573	6.54464632324546e-27	M1_vs_M0	HSALNG0040447	integenic	Q50	NA	NA	TAF11L14	GIPR
ENSG00000250033	SLC7A11-AS1	3.10492407148763	0.0140701470387213	M1_vs_M0	HSALNG0037355	anti_sense	Q75	hsa-miR-6089	Body height,Neuroticism measurement,Neurotic disorder,Wellbeing measurement; Neuroticism measurement,Eosinophil count; Serum metabolite measurement; Depressive symptom measurement; Eosinophil percentage of leukocytes,Eosinophil count,Ccl2 measurement,Wellbeing measurement; Smoking behaviour measurement,-	NOCT	MOV10L1
ENSG00000250073	ESAM-AS1	-2.08581709215636	0.00162410899995311	M1_vs_M0	HSALNG0087909	anti_sense	Q50	hsa-miR-4447	-	NRGN	ARPC1AP4
ENSG00000250116	RHOQ-AS1	3.85933995442808	8.90085391300579e-8	M1_vs_M0	HSALNG0014691	anti_sense	Q75	NA	-	PIGF	ENSG00000236985
ENSG00000250159	PKD2L2-DT	-1.41944621110779	0.00530225532729174	M1_vs_M0	HSALNG0045129	integenic	Not conserved	NA	NA	FAM13B	ENSG00000271978
ENSG00000250167	NA	-2.08781201163414	0.00507412724142724	M1_vs_M0	HSALNG0045048	sense	Not conserved	hsa-miR-4313	NA	SLC25A48	ENSG00000233755
ENSG00000250222	TRIM7-AS2	-2.62634982486629	0.0125901980086959	M1_vs_M0	HSALNG0047235	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-1249-3p,hsa-miR-1268b,hsa-miR-6085,hsa-miR-6089,hsa-miR-6838-3p,hsa-miR-7150	-	TRIM41	ECHDC2
ENSG00000250240	NA	1.3674457346273	9.52981205632982e-7	M1_vs_M0	HSALNG0043615	anti_sense	Q75	NA	-	SPATA9	ZNF432
ENSG00000250274	NA	4.32352476197911	3.0111251555893e-11	M1_vs_M0	NA	NA	NA	NA	NA	LCP2	FKRP
ENSG00000250497	NA	4.32578643137515	1.57053736352857e-6	M1_vs_M0	HSALNG0033009	integenic	Q50	hsa-miR-181d-3p,hsa-miR-3158-3p,hsa-miR-3960,hsa-miR-5047	Facial morphology measurement,Erythrocyte count,-	BOD1L1	HS2ST1
ENSG00000250509	NA	5.78738762157578	2.0342498080027399e-19	M1_vs_M0	HSALNG0047167	integenic	Q75	hsa-miR-619-5p,hsa-miR-6086	Joint damage measurement,-	CNOT6	PCNX1
ENSG00000250519	NA	1.51808132013296	4.5410548752125305e-9	M1_vs_M0	HSALNG0086510	integenic	Q50	NA	Serum alanine aminotransferase measurement,-	PANX1	TRPM8
ENSG00000250657	NA	-4.75483308620742	5.714747159649651e-9	M1_vs_M0	HSALNG0034131	integenic	Q50	hsa-miR-4516	Mhpg measurement; 5-hiaa measurement,-	GRXCR1	LDHB
ENSG00000250748	MSRB3-AS1	-3.16542892855147	3.80539701109807e-4	M1_vs_M0	HSALNG0091992	integenic	Not conserved	hsa-miR-6089	Creatinine measurement	WIF1	MDFI
ENSG00000250777	NA	-3.2389431576676	2.0170356191745e-4	M1_vs_M0	HSALNG0037343	integenic	Q75	hsa-miR-6825-5p	Parental longevity,Energy intake,Systemic lupus erythematosus,Sleep duration; Triglyceride measurement,Triglyceride measurement; High density lipoprotein cholesterol measurement,-	PCDH18	CHRM5
ENSG00000250929	LINC01181	5.39146383903682	2.7860089650830296e-25	M1_vs_M0	HSALNG0067501	integenic	Q50	NA	Small vessel stroke,Idiopathic osteonecrosis of the femoral head,Attention deficit hyperactivity disorder,Growth-regulated alpha protein measurement,Pelvic organ prolapse,-	BAALC	CFHR4
ENSG00000251002	TRD-AS1	-2.297835405377	1.91107917000421e-4	M1_vs_M0	HSALNG0099951	integenic	Not conserved	hsa-miR-4505	NA	DAD1	ENSG00000279088
ENSG00000251136	RIPK2-DT	4.254403409285	4.0920032152110494e-276	M1_vs_M0	HSALNG0066822	integenic	Q50	NA	Human papilloma virus infection; Oropharynx cancer,-	NBN	UGDH
ENSG00000251141	MRPS30-DT	4.05587419761275	4.09067087190747e-9	M1_vs_M0	HSALNG0041549	anti_sense	Q50	hsa-miR-6878-3p	Balding measurement,Lip morphology measurement,Dental caries; Dentures,Breast carcinoma,Gut microbiome measurement,Breast carcinoma; Cancer,Creatinine measurement,Protein measurement,Glomerular filtration rate,Response to cetuximab; Skin disease,Depressive symptom measurement; Response to antidepressant,Upper face morphology measurement,-	FGF10	ENSG00000254165
ENSG00000251165	F11-AS1	4.61832148373845	0.0422124841112868	M1_vs_M0	HSALNG0039179	intronic_sense	Not conserved	NA	NA	NA	ENSG00000289110
ENSG00000251209	LINC00923	-1.89460718304924	1.77789663632157e-8	M1_vs_M0	HSALNG0108451	integenic	Q50	hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6803-5p	Executive function measurement,Dna methylation,Small cell lung carcinoma,Thyroid carcinoma,Bone mineral content measurement,Body mass index,Smoking status measurement,Diastolic blood pressure,Systolic blood pressure,Bmi-adjusted waist-hip ratio,Childhood trauma measurement; Smoking behaviour measurement,Response to ketamine; Dissociation measurement,Ischemic stroke; Coronary artery disease,-	PGPEP1L	EIF1AY
ENSG00000251230	MIR3945HG	9.85611087766611	1.01721323528681e-57	M1_vs_M0	HSALNG0039050	integenic	Not conserved	hsa-miR-619-5p	Mean platelet volume,Mean reticulocyte volume,-	ACSL1	ETS2
ENSG00000251273	LINC02228	-2.84602457176709	3.04335150006037e-4	M1_vs_M0	HSALNG0040674	integenic	Q50	NA	-	CDH10	PCDHGB6
ENSG00000251293	NA	3.63083487919529	0.00126271675567613	M1_vs_M0	HSALNG0044415	integenic	Q75	hsa-miR-8485	Age at onset,Body mass index,Cognitive decline measurement,Response to carboplatin,Adolescent idiopathic scoliosis,Aging,Gut microbiome measurement,Body height; Fev/fec ratio; Body mass index,-	DTWD2	ENSG00000282988
ENSG00000251301	LINC02384	7.77831567640402	2.72972648646843e-16	M1_vs_M0	HSALNG0092162	integenic	Not conserved	hsa-miR-6089	NA	MDM1	FCGR3B
ENSG00000251363	LINC02315	-1.7520828706722	3.62976820064235e-4	M1_vs_M0	HSALNG0100823	integenic	Not conserved	hsa-miR-619-5p	NA	LRFN5	ZNF528-AS1
ENSG00000251393	NA	2.37977330047866	2.21022090851252e-26	M1_vs_M0	HSALNG0102349	anti_sense	Q75	hsa-miR-619-5p	Self reported educational attainment,Platelet component distribution width,Platelet crit,-	RIOX1	MIR3945HG
ENSG00000251613	NA	2.02830192537501	0.0224819075297376	M1_vs_M0	HSALNG0042584	anti_sense	Q50	hsa-miR-766-5p,hsa-miR-3195,hsa-miR-3940-5p	Heel bone mineral density,Total cholesterol measurement,Low density lipoprotein cholesterol measurement,Reaction time measurement,Lung cancer,Handedness,Gut microbiome measurement,Femoral neck bone mineral density,Hemoglobin a1 measurement; Mean corpuscular hemoglobin; Mean corpuscular hemoglobin concentration,Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Serum gamma-glutamyl transferase measurement,Hematocrit,Aspartate aminotransferase to alanine aminotransferase ratio,Total blood protein measurement,Platelet count,Hemoglobin measurement,Eosinophil count,Platelet-to-lymphocyte ratio,Eosinophil count; Bone density; Heel bone mineral density,Digestive system infectious disease,-	ZNF366	ZBTB7A
ENSG00000251615	NA	1.20477113108407	0.0105984104166189	M1_vs_M0	NA	NA	NA	NA	NA	ACOX3	EIF4A1P2
ENSG00000251632	LINC02172	-5.39312005188119	0.00424885984509098	M1_vs_M0	HSALNG0037341	integenic	Q50	NA	Abnormality of refraction,Ccl5 measurement,Obsessive-compulsive disorder; Autism spectrum disorder,-	NOCT	GJC1
ENSG00000253141	NA	-2.31266833761082	1.72143962492797e-33	M1_vs_M0	HSALNG0046692	integenic	Q50	hsa-miR-198,hsa-miR-665,hsa-miR-4435,hsa-miR-4446-3p,hsa-miR-4505,hsa-miR-5787,hsa-miR-6728-3p	Antipsychotic drug related weight gain,Stroke,Cognitive function measurement,Prostate carcinoma; Cytokine measurement,Peripheral arterial disease; Traffic air pollution measurement,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Oral cleft,Cleft lip; Cleft palate,Body height,Bmi-adjusted hip circumference,Adiponectin measurement,-	BNIP1	MEX3D
ENSG00000253147	LINC03023	5.79764364334668	1.28959125525853e-4	M1_vs_M0	HSALNG0063824	integenic	Q50	hsa-miR-6779-5p,hsa-miR-6889-3p	Sphingomyelin measurement,Cervical carcinoma,Response to tamsulosin,Body height; Body mass index,Body mass index,Attention function measurement,Cholesteryl ester 18:0 measurement; Sphingomyelin 16:1 measurement,Beta-amyloid 1-42 measurement,Sphingomyelin 18:1 measurement,Microglial activation measurement,Diabetes mellitus biomarker,Interleukin-6 measurement,Entorhinal cortical volume,Visceral adipose tissue measurement,Influenza a (h1n1),Protein measurement,Cognitive inhibition measurement,Self reported educational attainment; Intelligence; Cognitive function measurement; Mathematical ability,Irritable bowel syndrome,Mathematical ability,Diastolic blood pressure; Sodium measurement,Squamous cell lung carcinoma; Family history of lung cancer,Preterm premature rupture of the membranes; Spontaneous preterm birth,-	ATP6V1B2	NME8
ENSG00000253161	LINC01605	-6.79096428666758	1.75512180811732e-38	M1_vs_M0	HSALNG0150382	integenic	Q90	hsa-miR-149-3p,hsa-miR-4486	Body height,Endometriosis,-	BRF2	ZXDB
ENSG00000253177	NA	-4.98383196829295	2.5698723985588297e-34	M1_vs_M0	HSALNG0066950	integenic	Q50	NA	-	CIBAR1	PFAS
ENSG00000253182	LINC02948	5.57586741989867	0.00182315928822512	M1_vs_M0	HSALNG0064277	integenic	Q50	hsa-miR-6876-5p	Colorectal cancer,High density lipoprotein cholesterol measurement; Response to statin,Body height,Mean arterial pressure,-	HMBOX1	LINC02857
ENSG00000253199	LINC02153	6.50023950048437	1.23561882410444e-6	M1_vs_M0	HSALNG0063824	integenic	Q50	hsa-miR-6779-5p,hsa-miR-6889-3p	Sphingomyelin measurement,Cervical carcinoma,Response to tamsulosin,Body height; Body mass index,Body mass index,Attention function measurement,Cholesteryl ester 18:0 measurement; Sphingomyelin 16:1 measurement,Beta-amyloid 1-42 measurement,Sphingomyelin 18:1 measurement,Microglial activation measurement,Diabetes mellitus biomarker,Interleukin-6 measurement,Entorhinal cortical volume,Visceral adipose tissue measurement,Influenza a (h1n1),Protein measurement,Cognitive inhibition measurement,Self reported educational attainment; Intelligence; Cognitive function measurement; Mathematical ability,Irritable bowel syndrome,Mathematical ability,Diastolic blood pressure; Sodium measurement,Squamous cell lung carcinoma; Family history of lung cancer,Preterm premature rupture of the membranes; Spontaneous preterm birth,-	ATP6V1B2	KRT8P26
ENSG00000253207	NA	6.67619524060808	1.05657155428029e-7	M1_vs_M0	HSALNG0067821	integenic	Not conserved	NA	-	UTP23	IFITM3P4
ENSG00000253217	NA	1.43301693936461	0.02932899774455	M1_vs_M0	HSALNG0067281	anti_sense	Q75	NA	Unipolar depression,Lymphocyte count,-	SPAG1	ARIH2OS
ENSG00000253227	NA	-4.0829098079135004	2.91642142042134e-5	M1_vs_M0	HSALNG0068255	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-1285-5p	NA	FER1L6	DDX12P
ENSG00000253230	MIR124-1HG	-1.82104536775722	3.3955682938106897e-49	M1_vs_M0	HSALNG0063354	integenic	Q75	hsa-miR-486-3p,hsa-miR-650,hsa-miR-1224-3p,hsa-miR-762,hsa-miR-3178,hsa-miR-3677-3p,hsa-miR-4467,hsa-miR-4505,hsa-miR-3960,hsa-miR-6779-5p,hsa-miR-6858-3p,hsa-miR-7150	Obesity; Body mass index,Bipolar disorder,Bmi-adjusted waist circumference,-	PRSS51	ADPGK-AS1
ENSG00000253286	NA	5.66227743843317	1.00879624671588e-17	M1_vs_M0	HSALNG0068229	anti_sense	Q50	hsa-miR-6829-5p	Electrocardiography; Pr interval; Atrial fibrillation,Qrs duration,Systolic blood pressure,Electrocardiography,-	FAM91A1	PTX3
ENSG00000253317	NA	1.74766774173957	2.80595042141888e-4	M1_vs_M0	HSALNG0066124	integenic	Not conserved	NA	-	KCNB2	PSME3IP1
ENSG00000253414	LINC01605	-4.12147082580816	2.62161827886167e-41	M1_vs_M0	HSALNG0150382	integenic	Q90	hsa-miR-149-3p,hsa-miR-4486	Body height,Endometriosis,-	BRF2	UCP2
ENSG00000253420	NA	-4.4277837988236	0.0489075165786874	M1_vs_M0	HSALNG0067589	anti_sense	Q50	NA	-	LRP12	ADD3-AS1
ENSG00000253477	NA	3.51968439464105	1.39877077003779e-12	M1_vs_M0	HSALNG0067527	anti_sense,sense	Q90	hsa-miR-1233-5p,hsa-miR-6089,hsa-miR-6726-3p,hsa-miR-6748-3p,hsa-miR-7150,hsa-miR-8485	-	NA	FAM151B
ENSG00000253490	LINC02099	-5.39367610935754	0.00105251787302404	M1_vs_M0	HSALNG0064314	integenic	Q50	NA	Balding measurement,-	LEPROTL1	AMBP
ENSG00000253522	MIR3142HG	3.95660634019227	1.55349574988285e-114	M1_vs_M0	HSALNG0046249	integenic	Not conserved	NA	NA	PTTG1	ADAMDEC1
ENSG00000253535	ADAM7-AS1	6.43378736335484	2.027421333163e-28	M1_vs_M0	HSALNG0064058	integenic	Not conserved	NA	NA	NEFL	TAF5LP1
ENSG00000253549	CA3-AS1	-3.26112345883539	1.79297841703293e-14	M1_vs_M0	HSALNG0066709	anti_sense	Q50	hsa-miR-491-5p,hsa-miR-4482-5p,hsa-miR-4707-5p,hsa-miR-6810-5p	Glomerular filtration rate,-	CA1	CDCA3
ENSG00000253557	NA	-4.92321318909079	2.77139096769988e-50	M1_vs_M0	HSALNG0063737	integenic	Q50	hsa-miR-7155-5p	Bone quantitative ultrasound measurement,Platelet count,Mean platelet volume,Gout,Smooth surface dental caries,Urate measurement,Intelligence,Insulin measurement,Telomere length,-	PSD3	TSPAN9
ENSG00000253591	KCNIP1-AS1	-5.76491883880915	7.2795339005999e-4	M1_vs_M0	HSALNG0046523	anti_sense	Q75	hsa-miR-505-5p,hsa-miR-1301-3p,hsa-miR-4300,hsa-miR-4687-5p	Viral load,Abruptio placentae,Sclerosing cholangitis,Memory performance,-	KCNMB1	RPL17P24
ENSG00000253633	LINC03047	-4.89245005051893	0.0277132636158992	M1_vs_M0	HSALNG0067441	integenic	Q50	NA	Mean platelet volume,Iga glomerulonephritis,Platelet component distribution width,-	ODF1	SBNO1-AS1
ENSG00000253641	LINC03022	-1.67111367421733	5.37479139677592e-5	M1_vs_M0	HSALNG0063375	anti_sense	Not conserved	NA	Bmi-adjusted waist circumference; White matter microstructure measurement,Bmi-adjusted waist-hip ratio,Neuroticism measurement,Bmi-adjusted waist circumference,-	PRSS55	LTB4R2
ENSG00000253671	NA	-2.5043314676066	1.4197750443350901e-14	M1_vs_M0	HSALNG0063682	anti_sense	Q50	hsa-miR-1268b,hsa-miR-6089,hsa-miR-6769b-3p,hsa-miR-6867-5p	Body height,Blood protein measurement,Fev change measurement; Response to bronchodilator,-	PCM1	ENSG00000289050
ENSG00000253746	NA	-7.00253103985461	3.34621612331922e-10	M1_vs_M0	HSALNG0064563	integenic	Q50	hsa-miR-4447,hsa-miR-4508,hsa-miR-4539,hsa-miR-3960,hsa-miR-6501-3p,hsa-miR-6780a-3p,hsa-miR-8072	Mathematical ability,Adolescent idiopathic scoliosis,Interleukin-6 measurement,Body height,Endometriosis,Sex hormone-binding globulin measurement,Triglyceride measurement,Empathy measurement,Leukocyte count; Lymphocyte count,Body mass index,-	BRF2	BCL10
ENSG00000253768	NA	-2.29757472362093	0.0183166370436993	M1_vs_M0	HSALNG0046699	integenic	Q50	hsa-miR-762,hsa-miR-3195,hsa-miR-4281,hsa-miR-4685-5p,hsa-miR-4734,hsa-miR-5587-3p,hsa-miR-6085,hsa-miR-6721-5p,hsa-miR-6813-5p,hsa-miR-7112-5p,hsa-miR-7113-5p	Sitting height ratio,Waist-hip ratio; Body height; Bmi-adjusted hip circumference,Body height; Bmi-adjusted hip circumference,Bmi-adjusted hip circumference,Heel bone mineral density,Body height,Bmi-adjusted waist circumference; Sitting height ratio; Urate measurement,-	CPEB4	RASL10B
ENSG00000253821	NA	1.29982957112044	1.2270973356611e-40	M1_vs_M0	HSALNG0065531	integenic	Not conserved	NA	NA	FAM110B	PIDD1
ENSG00000253838	NA	9.19518049974893	7.202723756053319e-44	M1_vs_M0	HSALNG0150187	sense	Q50	NA	-	IDO1	SIMALR
ENSG00000253853	NA	-1.33726457995349	0.0114743561546742	M1_vs_M0	HSALNG0063032	integenic	Not conserved	NA	NA	MYOM2	ENSG00000226180
ENSG00000253858	NA	-6.57620249900087	5.73827082631181e-7	M1_vs_M0	HSALNG0046523	anti_sense	Q75	hsa-miR-505-5p,hsa-miR-1301-3p,hsa-miR-4300,hsa-miR-4687-5p	Viral load,Abruptio placentae,Sclerosing cholangitis,Memory performance,-	KCNMB1	EMC1
ENSG00000253891	NA	7.14407661595091	4.2970569384314194e-11	M1_vs_M0	HSALNG0064035	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-1249-5p,hsa-miR-4447,hsa-miR-4463,hsa-miR-4505,hsa-miR-7106-5p	Bmi-adjusted waist circumference; Body height; Bmi-adjusted hip circumference,Bmi-adjusted waist circumference,Body height,Ankylosing spondylitis,Cleft palate,Necrotizing enterocolitis,Hair colour measurement,Susceptibility to scarlet fever measurement,White matter integrity,Corneal endothelial cell measurement,Idiopathic dilated cardiomyopathy,Mathematical ability,Age at onset,Nicotine withdrawal symptom count,Pallidum volume,Myopia,Brain volume measurement,Seasonality measurement,Interleukin-6 measurement,Forced expiratory volume; Fev/fec ratio; Response to bronchodilator,Fev/fec ratio; Response to bronchodilator,Myocarditis; Response to clozapine,Cingulate cortex measurement; Amyloid-beta measurement,Brain volume measurement; Neuroimaging measurement,-	STC1	EFCAB3
ENSG00000253930	TNFRSF10A-AS1	1.62472103705188	0.0412083183222952	M1_vs_M0	HSALNG0150163	anti_sense	Not conserved	NA	NA	CHMP7	DLG4
ENSG00000253944	MTUS1-DT	-3.5567605973697	7.75549366771151e-6	M1_vs_M0	HSALNG0063682	anti_sense	Q50	hsa-miR-1268b,hsa-miR-6089,hsa-miR-6769b-3p,hsa-miR-6867-5p	Body height,Blood protein measurement,Fev change measurement; Response to bronchodilator,-	PCM1	FEZ1
ENSG00000253968	NA	-1.83198721485635	1.24450281714763e-13	M1_vs_M0	HSALNG0046692	integenic	Q50	hsa-miR-198,hsa-miR-665,hsa-miR-4435,hsa-miR-4446-3p,hsa-miR-4505,hsa-miR-5787,hsa-miR-6728-3p	Antipsychotic drug related weight gain,Stroke,Cognitive function measurement,Prostate carcinoma; Cytokine measurement,Peripheral arterial disease; Traffic air pollution measurement,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Oral cleft,Cleft lip; Cleft palate,Body height,Bmi-adjusted hip circumference,Adiponectin measurement,-	BNIP1	PDCD6IPP2
ENSG00000254006	NA	-3.88778296557398	6.59173010667069e-29	M1_vs_M0	HSALNG0065805	integenic	Q90	NA	NA	CYP7B1	GYG2
ENSG00000254027	LNMICC	-1.02136267758855	0.0060814120238787	M1_vs_M0	HSALNG0066560	anti_sense	Not conserved	hsa-miR-3195,hsa-miR-4508	-	PMP2	PCAT1
ENSG00000254041	NA	4.60613618038648	0.0324026605916939	M1_vs_M0	HSALNG0067574	anti_sense	Q90	hsa-miR-7151-5p	Lymphocyte count,Bipolar disorder; Attention deficit hyperactivity disorder; Autism spectrum disorder; Unipolar depression,-	LRP12	DDX43
ENSG00000254054	NA	-5.55532906782227	4.11265263899465e-50	M1_vs_M0	HSALNG0063689	anti_sense	Q50	hsa-miR-331-3p,hsa-miR-3194-3p,hsa-miR-4257,hsa-miR-2467-3p	NA	PCM1	NUDT18
ENSG00000254102	BHLHE22-AS1	-2.72188149472902	3.3100017223916396e-40	M1_vs_M0	HSALNG0065796	anti_sense	Q50	NA	Risk-taking behaviour,Systolic blood pressure,-	CYP7B1	MMRN2
ENSG00000254139	LINC03018	1.15018691138248	0.0219272688707931	M1_vs_M0	HSALNG0065529	integenic	Q50	NA	Disease progression measurement,Nose morphology measurement,Ischemic stroke,Gut microbiome measurement,-	FAM110B	ENSG00000267344
ENSG00000254154	CRYZL2P-SEC16B	1.57572134332283	0.00345490024291502	M1_vs_M0	HSALNG0008675	integenic	Q90	NA	Body mass index,Total blood protein measurement; Insomnia,-	SEC16B	HERC2P10
ENSG00000254242	NA	-3.10069334219914	0.0161931979694362	M1_vs_M0	HSALNG0063740	integenic	Not conserved	hsa-miR-619-5p	Platelet count,Mean platelet volume	SH2D4A	RNF103
ENSG00000254287	NA	9.15638156151977	3.3433440196394295e-42	M1_vs_M0	HSALNG0150387	anti_sense	Q50	NA	-	ADAM2	OTOF
ENSG00000254290	NA	-3.10050776674604	0.0156991806093219	M1_vs_M0	HSALNG0064563	integenic	Q50	hsa-miR-4447,hsa-miR-4508,hsa-miR-4539,hsa-miR-3960,hsa-miR-6501-3p,hsa-miR-6780a-3p,hsa-miR-8072	Mathematical ability,Adolescent idiopathic scoliosis,Interleukin-6 measurement,Body height,Endometriosis,Sex hormone-binding globulin measurement,Triglyceride measurement,Empathy measurement,Leukocyte count; Lymphocyte count,Body mass index,-	BRF2	NAGS
ENSG00000254416	LINC02732	5.00608364917881	0.0105541962948604	M1_vs_M0	HSALNG0087054	integenic	Q75	hsa-miR-4505	Cognition,Serum metabolite measurement; Coronary artery disease,Angina pectoris; Antithrombotic agent use measurement; Aspirin use measurement; Myocardial infarction,Angina pectoris; Vasodilators used in cardiac diseases use measurement; Aspirin use measurement,Body height,Coronary artery disease,-	FDX1	IFNL1
ENSG00000254510	NA	-4.40182930432002	8.68165707344361e-7	M1_vs_M0	HSALNG0085021	integenic	Q90	hsa-miR-637,hsa-miR-1237-5p,hsa-miR-4472	Bmi-adjusted waist circumference; Attention deficit hyperactivity disorder; Substance abuse; Risk-taking behaviour; Antisocial behaviour measurement,Vital capacity,Bmi-adjusted waist-hip ratio,-	NPAS4	CD101
ENSG00000254528	FXYD6-AS1	-4.29978106045702	8.483195574094739e-11	M1_vs_M0	HSALNG0087478	anti_sense	Q50	NA	-	IL10RA	PCDHGB4
ENSG00000254531	FLJ20021	-1.87399562624838	6.06670208187555e-18	M1_vs_M0	HSALNG0148159	anti_sense	Not conserved	hsa-miR-6780a-3p	-	BANK1	MORC3
ENSG00000254560	BBOX1-AS1	5.17821019470298	0.00679263336900924	M1_vs_M0	HSALNG0083285	anti_sense	Q75	NA	Breast carcinoma,Serum metabolite measurement,Attempted suicide; Body mass index,Balding measurement,Testosterone measurement,-	CCDC34	CD82-AS1
ENSG00000254602	MIR130AHG	6.44117428023526	2.14187820104458e-6	M1_vs_M0	HSALNG0084300	overlap_antisense,sense	Q90	hsa-miR-619-5p,hsa-miR-6880-5p	Alcohol use disorder measurement; Mean corpuscular hemoglobin; Mean corpuscular volume,Glomerular filtration rate,-	CLP1	NME8
ENSG00000254614	CAPN1-AS1	-1.96042882385977	2.95480426618384e-4	M1_vs_M0	HSALNG0084866	anti_sense	Not conserved	hsa-miR-4505,hsa-miR-5787	Bmi-adjusted hip circumference,-	SYVN1	GCOM1
ENSG00000254659	LINC02715	5.00527033661176	0.0120555594712598	M1_vs_M0	HSALNG0087023	overlap_antisense,sense	Q50	hsa-miR-4447	Self reported educational attainment,Mathematical ability,Antibody measurement,Late-onset alzheimers disease,Vision disorder,Self reported educational attainment; Intelligence,Forced expiratory volume; Smoking status measurement,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	RDX	IFNL1
ENSG00000254682	NA	-2.39249273375908	0.0018640833501555	M1_vs_M0	HSALNG0085472	anti_sense	Not conserved	NA	Vitamin d measurement,-	NADSYN1	ENSG00000234775
ENSG00000254693	CD82-AS1	5.17952150591201	0.0092844082425456	M1_vs_M0	HSALNG0083881	anti_sense	Q75	hsa-miR-370-3p	-,White matter microstructure measurement	TP53I11	CD82-AS1
ENSG00000254703	SENCR	-2.47263096574668	1.1150150268226801e-10	M1_vs_M0	HSALNG0088110	intronic_antisense	Q90	hsa-miR-4472,hsa-miR-6803-5p	Platelet count; Platelet crit,Basophil count,-	ETS1	GPN1
ENSG00000254777	NA	-6.37658996215047	3.10226523079338e-6	M1_vs_M0	HSALNG0150218	integenic	Not conserved	hsa-miR-574-5p	NA	CHD7	ENSG00000286333
ENSG00000255028	NA	5.01059851688465	0.0117149132587465	M1_vs_M0	HSALNG0087023	overlap_antisense,sense	Q50	hsa-miR-4447	Self reported educational attainment,Mathematical ability,Antibody measurement,Late-onset alzheimers disease,Vision disorder,Self reported educational attainment; Intelligence,Forced expiratory volume; Smoking status measurement,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	RDX	NME8
ENSG00000255045	NA	-7.002576851666	3.3447707240255503e-10	M1_vs_M0	HSALNG0087906	anti_sense	Q50	hsa-miR-593-5p,hsa-miR-1237-3p,hsa-miR-6792-3p	Anorexia nervosa; Self reported educational attainment; Intelligence; Autism spectrum disorder; Obsessive-compulsive disorder; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder; Tourette syndrome,Smoking status measurement,-	VSIG2	LINC02861
ENSG00000255046	NA	1.72881102650889	0.0102632511172436	M1_vs_M0	HSALNG0063460	anti_sense	Q50	hsa-miR-619-5p	Alkaline phosphatase measurement,C-reactive protein measurement; Alkaline phosphatase measurement; Serum non-albumin protein measurement,Triglyceride measurement; Mean reticulocyte volume; Mean corpuscular volume,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Monocyte count; Ejection fraction measurement; Neuroticism measurement,Non-melanoma skin carcinoma,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,-	CTSB	FAM120C
ENSG00000255050	NA	-2.47101801955973	4.49478855977016e-6	M1_vs_M0	HSALNG0069297	anti_sense	Q50	hsa-miR-4505,hsa-miR-6744-3p	Interleukin 18 measurement	GSDMD	ASAP2
ENSG00000255121	CENATAC-DT	-2.07855247320156	4.0550250240178e-7	M1_vs_M0	HSALNG0087593	integenic	Not conserved	NA	-	RPS25	XYLT2
ENSG00000255139	NA	2.44130547711535	8.77848395582079e-4	M1_vs_M0	HSALNG0084419	anti_sense	Q90	hsa-miR-4447,hsa-miR-3960,hsa-miR-6085	Protein measurement,-,Igf-1 measurement	OR4D9	ENSG00000290124
ENSG00000255224	NA	2.14061158017204	6.14776137667409e-18	M1_vs_M0	HSALNG0069369	anti_sense	Q75	NA	Mean corpuscular hemoglobin,-	OPLAH	KLHL30
ENSG00000255269	LINC02710	3.09791214820461	0.0235795071927999	M1_vs_M0	HSALNG0083975	integenic	Q50	hsa-miR-619-5p,hsa-miR-6089	Reaction time measurement,Venous thromboembolism,Fev/fec ratio; Response to bronchodilator	PHF21A	SIX4
ENSG00000255299	NA	3.32756898546591	6.40651097260715e-7	M1_vs_M0	HSALNG0084342	sense	Q50	NA	Chronotype measurement,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	OR5B21	DHX16
ENSG00000255306	NA	1.33875496327924	0.0381681348368484	M1_vs_M0	HSALNG0085208	anti_sense	Not conserved	NA	Uric acid measurement,-	UNC93B1	ARRDC3-AS1
ENSG00000255320	NA	-1.76736544527388	0.0201120773140645	M1_vs_M0	HSALNG0084993	anti_sense	Q50	hsa-miR-644a,hsa-miR-4508	-	YIF1A	ENSG00000278330
ENSG00000255337	TMEM123-DT	2.43533236575803	4.56472532975115e-8	M1_vs_M0	HSALNG0086787	anti_sense	Not conserved	hsa-miR-7113-3p	-	BIRC2	PLEKHA7
ENSG00000255355	PATL1-DT	5.36798443185989	0.0196253810177537	M1_vs_M0	HSALNG0084422	integenic	Not conserved	hsa-miR-619-5p	NA	STX3	ADGRF2
ENSG00000255366	NA	-1.45116616536456	5.51323715368792e-4	M1_vs_M0	HSALNG0065054	integenic	Not conserved	NA	-	SPIDR	FAM167B
ENSG00000255410	NA	-1.86928820853772	0.0256798246287834	M1_vs_M0	HSALNG0082460	anti_sense	Q90	hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-1587,hsa-miR-4644,hsa-miR-6124	Platelet crit,Hemoglobin measurement,-	ILK	MTREX
ENSG00000255422	NA	-3.52667152948692	3.3103441714799805e-15	M1_vs_M0	HSALNG0087571	anti_sense	Q90	NA	-	PHLDB1	PKP3
ENSG00000255446	NA	-4.21897820978294	7.15055525492492e-6	M1_vs_M0	HSALNG0084600	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-6879-5p	Bmi-adjusted waist-hip ratio,Waist-hip ratio,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Waist-hip ratio; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Lymphocyte count,Reticulocyte count; Reticulocyte measurement,Bmi-adjusted waist circumference,Comparative body size at age 10, self-reported,Chronic obstructive pulmonary disease; Cc16 measurement,-	AHNAK	ENSG00000184566
ENSG00000255491	NA	-2.45069494322826	2.4302021037650396e-89	M1_vs_M0	HSALNG0068289	integenic	Q50	hsa-miR-363-5p,hsa-miR-4505,hsa-miR-6089,hsa-miR-6754-5p	Platelet component distribution width,Triacylglycerol 58:6 measurement,Left ventricular ejection fraction measurement; Dilated cardiomyopathy; Left ventricular structural measurement; Left ventricular systolic function measurement; Hematocrit; Heart function measurement,Reticulocyte measurement,Hematocrit; Hemoglobin measurement; Pr interval,Pr interval; Left ventricular structural measurement; Atrial fibrillation,Left ventricular systolic function measurement,Platelet crit; Heart relative wall thickness; Left ventricular ejection fraction measurement; Fractional shortening; Left ventricular diastolic function measurement; Left ventricular systolic function measurement; Electrocardiography; Ejection fraction measurement,-	MTSS1	PBXIP1
ENSG00000255553	LINC02733	7.46408665081912	1.29738681970692e-13	M1_vs_M0	HSALNG0084581	integenic	Not conserved	NA	Alkaline phosphatase measurement,Phosphatidylcholine measurement,-	FTH1	PRMT2
ENSG00000255557	NA	4.61038119400747	0.0397762408721535	M1_vs_M0	HSALNG0084943	integenic	Not conserved	NA	Atopic eczema,Blood urea nitrogen measurement; Creatinine measurement; Glomerular filtration rate; Chronic kidney disease,Glomerular filtration rate	OVOL1	COL18A1
ENSG00000255559	ZNF252P-AS1	-1.86852223545642	0.02307620998543	M1_vs_M0	HSALNG0069500	integenic	Not conserved	hsa-miR-6803-5p,hsa-miR-6858-5p,hsa-miR-6878-3p	-	C8orf33	KIAA0753
ENSG00000255571	MIR9-3HG	-2.91951527574917	0.00309678869898097	M1_vs_M0	HSALNG0108036	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-1228-5p,hsa-miR-3178,hsa-miR-4529-5p,hsa-miR-4667-3p,hsa-miR-4710,hsa-miR-6089,hsa-miR-6736-5p,hsa-miR-6810-3p,hsa-miR-6816-5p,hsa-miR-6826-3p,hsa-miR-6887-3p	White matter microstructure measurement,Cortical surface area measurement; Cigarettes per day measurement,Mathematical ability,Body mass index,Comparative body size at age 10, self-reported,Dental caries; Dentures,-	FANCI	ENSG00000250132
ENSG00000255666	LINC02700	-1.2317926613825	1.39477626076377e-6	M1_vs_M0	HSALNG0086530	integenic	Not conserved	hsa-miR-382-5p	Allantoin measurement	PIWIL4	FAM227A
ENSG00000255680	NA	-2.62898952897876	0.0214745297711672	M1_vs_M0	HSALNG0082458	anti_sense	Q90	NA	-	ILK	ENSG00000267940
ENSG00000255775	NA	-3.35837188717847	0.00511233138759539	M1_vs_M0	HSALNG0088821	integenic	Not conserved	hsa-miR-210-5p,hsa-miR-619-5p,hsa-miR-4258,hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-6089	Platelet component distribution width,Reticulocyte count; Reticulocyte measurement,Platelet count,Mean platelet volume; Platelet-to-lymphocyte ratio,Mean platelet volume,-	VWF	SLC4A3
ENSG00000255874	PRECSIT	1.52298295750203	3.12784484065404e-5	M1_vs_M0	HSALNG0141617	integenic	Not conserved	NA	Sitting height ratio	ANKRD10	CGGBP1
ENSG00000255921	NA	6.00831586220821	6.22569377226471e-57	M1_vs_M0	HSALNG0089886	anti_sense	Not conserved	hsa-miR-6763-5p,hsa-miR-7847-3p	-	IRAG2	CYGB
ENSG00000255980	LINC02953	-1.07040850111699	5.239963738652391e-9	M1_vs_M0	HSALNG0143008	integenic	Q50	NA	NA	MYEOV	CRY1
ENSG00000256139	NA	-4.89381419720616	0.0105851465463696	M1_vs_M0	HSALNG0093875	sense	Q50	hsa-miR-8077	-	UNG	ENSG00000287586
ENSG00000256262	USP30-AS1	6.41147639596437	1.5781341014232199e-28	M1_vs_M0	HSALNG0093872	anti_sense	Not conserved	hsa-miR-4467,hsa-miR-3960	Platelet-to-lymphocyte ratio; Platelet count; Platelet crit,-	SVOP	LINC01050
ENSG00000256268	LINC02454	-1.53046665105186	7.39929460781423e-8	M1_vs_M0	HSALNG0091990	integenic	Q75	NA	Differentiated thyroid carcinoma; Papillary thyroid carcinoma,Heel bone mineral density,Fev/fec ratio; Response to bronchodilator,-	MSRB3	ENSG00000232043
ENSG00000256433	NA	1.95018964081406	0.0289972955415699	M1_vs_M0	HSALNG0088854	integenic	Not conserved	NA	Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Eosinophil count; Sclerosing cholangitis,Lymphocyte count; Platelet crit; Leukocyte count; Neutrophil-to-lymphocyte ratio; Platelet count,Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes; Lymphocyte count; Platelet crit	LTBR	FRMD1
ENSG00000256955	NA	-2.29925563429782	0.019985225919164	M1_vs_M0	HSALNG0095244	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4534,hsa-miR-6784-5p,hsa-miR-8073	NA	MMP17	ENSG00000273162
ENSG00000257027	NA	1.48344638977404	5.89902089066648e-12	M1_vs_M0	HSALNG0089164	integenic	Not conserved	NA	NA	CLEC2D	SDAD1
ENSG00000257038	ARHGEF17-AS1	-3.23530384234642	0.00921502486927172	M1_vs_M0	HSALNG0143218	anti_sense	Q90	NA	-	FAM168A	ENSG00000203392
ENSG00000257167	TMPO-AS1	-2.55619220915627	7.114130628582641e-17	M1_vs_M0	HSALNG0093383	anti_sense	Q90	hsa-miR-762,hsa-miR-877-5p,hsa-miR-3960	-	IKBIP	ANKRD36
ENSG00000257178	NA	-4.67870678130718	0.0351655487498426	M1_vs_M0	HSALNG0145317	sense	Q90	NA	-	HOXB3	ENSG00000257178
ENSG00000257242	LINC01619	1.98627008073993	5.38418634765354e-6	M1_vs_M0	HSALNG0093041	sense	Q75	hsa-miR-619-5p	Obstructive sleep apnea,Age at menarche,Rosacea severity measurement,Neutrophil percentage of granulocytes; Eosinophil percentage of granulocytes; Heel bone mineral density; Basophil count; Eosinophil percentage of leukocytes; Eosinophil count,Eosinophil count,Eosinophil percentage of leukocytes,Eosinophil count; Body height,-	BTG1	LKAAEAR1
ENSG00000257258	NA	-2.91503282776505	2.8034768981906096e-31	M1_vs_M0	HSALNG0090086	anti_sense	Q50	hsa-miR-3960,hsa-miR-6744-3p,hsa-miR-4433b-3p	Fructose measurement; Glucose measurement; Galactose measurement,-	ERGIC2	SPC25
ENSG00000257551	HLX-AS1	1.84443254510458	8.44117712914342e-8	M1_vs_M0	HSALNG0010765	anti_sense	Q90	hsa-miR-23a-5p,hsa-miR-6735-3p	Heart failure,Body height,Heel bone mineral density,Apolipoprotein b measurement,Urate measurement,Serum albumin measurement,Monocyte count,Neutrophil percentage of leukocytes,Leukocyte count,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,Eosinophil count; Basophil count,Lymphocyte count,Neutrophil count,Fetal hemoglobin measurement,C-reactive protein measurement; Vital capacity,C-reactive protein measurement; Total cholesterol measurement,-	RAB3GAP2	PDE8A
ENSG00000257557	PPP1R12A-AS1	1.13635635973012	9.9810799907669e-4	M1_vs_M0	HSALNG0092662	anti_sense	Q50	hsa-miR-619-5p	Platelet count,Reticulocyte count; Reticulocyte measurement,-	OTOGL	BPNT1
ENSG00000257595	LINC02356	-3.60537873860308	7.1285782087739e-11	M1_vs_M0	HSALNG0094035	integenic	Q75	hsa-miR-30b-3p,hsa-miR-3194-5p	Platelet count,Lean body mass,Eosinophil count; Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes,Parental genotype effect measurement; Eosinophil count; Protein measurement; Intraocular pressure measurement; Systolic blood pressure; C-x-c motif chemokine 10 measurement; Hba1c measurement; Monokine induced by gamma interferon measurement; Preeclampsia; Rheumatoid arthritis; Peripheral arterial disease; Vitiligo,Triglyceride measurement; Epilepsy; Alcohol dependence measurement; Alcohol consumption measurement,Lymphocyte count,Diastolic blood pressure; Smoking status measurement; Systolic blood pressure,-	SH2B3	DCTN6-DT
ENSG00000257599	OVCH1-AS1	2.28464651020229	9.52886466321808e-6	M1_vs_M0	HSALNG0090102	anti_sense	Q90	hsa-miR-517-5p,hsa-miR-619-5p,hsa-miR-6071	Age at onset,Protein measurement,Gut microbiome measurement,-	FAR2	FTH1P4
ENSG00000257702	LBX2-AS1	1.12456759297323	1.38214693531715e-19	M1_vs_M0	HSALNG0016063	anti_sense	Q90	hsa-miR-4492,hsa-miR-6726-5p	-	TTC31	FAM107B
ENSG00000257761	NA	3.2272230866273	0.00886898846179613	M1_vs_M0	HSALNG0092343	anti_sense	Q50	hsa-miR-6731-5p	-	ZFC3H1	LYSET
ENSG00000257924	LINC02416	5.0039105271442	0.0154022352284252	M1_vs_M0	HSALNG0090757	integenic	Not conserved	hsa-miR-619-5p	-	PCED1B	IFNL1
ENSG00000258035	NA	6.06942088468153	9.25689562927127e-5	M1_vs_M0	HSALNG0093159	anti_sense	Q90	hsa-miR-296-5p	-	CEP83	CAMSAP1
ENSG00000258056	CD63-AS1	1.03777872280334	2.94840790663533e-9	M1_vs_M0	HSALNG0091431	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3158-3p,hsa-miR-3195,hsa-miR-6792-3p	-	RDH5	ACOXL-AS1
ENSG00000258082	NA	-1.87360617516538	7.78764076461857e-4	M1_vs_M0	HSALNG0011660	integenic	Q50	hsa-miR-6089,hsa-miR-6769b-3p	Serum gamma-glutamyl transferase measurement,Platelet count,Monocyte percentage of leukocytes; Monocyte count,Apolipoprotein a 1 measurement,Low density lipoprotein cholesterol measurement,Response to vaccine; Cytokine measurement,Cognitive function measurement,-	TOMM20	PABPC4L
ENSG00000258101	NA	-2.95210313721336	0.0310399839759081	M1_vs_M0	HSALNG0090930	anti_sense	Q75	NA	Ovarian serous carcinoma; Squamous cell lung carcinoma; Colorectal cancer; Estrogen-receptor negative breast cancer; Breast carcinoma; Ovarian endometrioid carcinoma; Ovarian carcinoma; Lung carcinoma; Lung adenocarcinoma; Prostate carcinoma; Reaction time measurement,Mean platelet volume; Platelet count; Heel bone mineral density,Bone density,-	TUBA1A	ENSG00000235813
ENSG00000258183	LINC02392	1.2998686530707	3.79769328527883e-5	M1_vs_M0	HSALNG0092974	integenic	Not conserved	hsa-miR-6756-5p,hsa-miR-6803-5p	Interleukin 2 receptor antagonist measurement,Heel bone mineral density,Family history of lung cancer; Lung adenocarcinoma,-	TMTC3	PGAM1P8
ENSG00000258294	NA	-1.89765603164161	0.00138094752000397	M1_vs_M0	HSALNG0092412	integenic	Q90	NA	Adipose tissue measurement,-	ZFC3H1	ENSG00000258302
ENSG00000258317	NA	1.61019090992833	0.0243061873158836	M1_vs_M0	HSALNG0091499	anti_sense	Q90	NA	Systemic scleroderma,-	SMARCC2	ENSG00000234622
ENSG00000258413	FBXO34-AS1	4.15345734670003	1.18160144026941e-5	M1_vs_M0	HSALNG0101458	anti_sense	Q75	hsa-miR-4707-5p,hsa-miR-6763-3p,hsa-miR-6764-3p,hsa-miR-6791-3p,hsa-miR-6803-5p	Platelet count; Red blood cell distribution width,Eosinophil count,-	DLGAP5	ENSG00000230736
ENSG00000258457	AJUBA-DT	-1.46220450334957	0.0283235668820353	M1_vs_M0	HSALNG0099995	anti_sense	Q90	hsa-miR-7113-5p	Macula measurement,Gut microbiome measurement,Odontogenesis; Tooth eruption,Systolic blood pressure,Cognitive function measurement,-	PSMB11	POU6F1
ENSG00000258458	OXA1L-DT	-1.9451539665729	0.0140618299128654	M1_vs_M0	HSALNG0099968	anti_sense	Q90	hsa-miR-4296	Susceptibility to infectious disease measurement,-	SLC7A7	FLNB
ENSG00000258521	NA	7.01274864759892	1.65056023859754e-105	M1_vs_M0	HSALNG0103731	anti_sense	Not conserved	NA	NA	SLC25A47	C1S
ENSG00000258623	NA	-5.39360500928926	0.00115908363188778	M1_vs_M0	HSALNG0102098	anti_sense	Q50	hsa-miR-1227-5p,hsa-miR-4308,hsa-miR-6869-3p	Cognitive function measurement,Monoclonal gammopathy,Prostate carcinoma,Body height,Coronary artery calcification,Bmi-adjusted waist-hip ratio; Gut microbiome measurement,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Balding measurement,High density lipoprotein cholesterol measurement,Diabetic nephropathy,-	ZFP36L1	C1QTNF12
ENSG00000258667	HIF1A-AS3	1.87121789778172	7.936522405665671e-9	M1_vs_M0	HSALNG0101781	anti_sense	Q50	hsa-miR-619-5p	-	TMEM30B	RGS20
ENSG00000258673	LINC01397	6.07352247626991	1.86092611819066e-5	M1_vs_M0	HSALNG0005950	integenic	Not conserved	NA	NA	UBL4B	CD226
ENSG00000258733	LINC02328	2.68189823305542	1.41270870963119e-31	M1_vs_M0	HSALNG0102968	integenic	Not conserved	NA	NA	FLRT2	C19orf47
ENSG00000258738	BAZ1A-AS1	1.4251320499169	6.19057753001759e-4	M1_vs_M0	HSALNG0100538	anti_sense	Q90	NA	Heel bone mineral density,Monocyte count,Reticulocyte measurement,-	SRP54	ENSG00000271830
ENSG00000258754	LINC01579	-2.77902215745382	5.05493379213472e-4	M1_vs_M0	HSALNG0144618	integenic	Q75	NA	-	RGMA	LZTS2
ENSG00000258777	HIF1A-AS1	5.32402896182222	0.00498095308619962	M1_vs_M0	HSALNG0101776	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-5088-5p	Cd40 ligand measurement,Creatinine measurement,-	TMEM30B	NME8
ENSG00000258807	NA	-1.39316462336006	8.80219540631746e-6	M1_vs_M0	HSALNG0103005	sense	Q50	hsa-miR-129-1-3p,hsa-miR-129-2-3p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6838-5p	Suicide,Borderline personality disorder,Epstein-barr virus infection,Breast carcinoma,Body height; Body mass index,-	GALC	FAM3B
ENSG00000258859	LINC02296	-2.21786862269341	0.00171262482627232	M1_vs_M0	HSALNG0103005	sense	Q50	hsa-miR-129-1-3p,hsa-miR-129-2-3p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6838-5p	Suicide,Borderline personality disorder,Epstein-barr virus infection,Breast carcinoma,Body height; Body mass index,-	GALC	MINDY2-DT
ENSG00000258976	NA	-5.76418306681824	1.79796437666718e-4	M1_vs_M0	HSALNG0102446	integenic	Q50	NA	NA	LTBP2	ABLIM3
ENSG00000259038	NA	-4.42749492162401	0.0442986704858627	M1_vs_M0	HSALNG0102098	anti_sense	Q50	hsa-miR-1227-5p,hsa-miR-4308,hsa-miR-6869-3p	Cognitive function measurement,Monoclonal gammopathy,Prostate carcinoma,Body height,Coronary artery calcification,Bmi-adjusted waist-hip ratio; Gut microbiome measurement,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Balding measurement,High density lipoprotein cholesterol measurement,Diabetic nephropathy,-	ZFP36L1	KCNJ12
ENSG00000259081	NA	-3.05556254791416	2.9713432567906094e-11	M1_vs_M0	HSALNG0102584	anti_sense	Not conserved	NA	NA	ANGEL1	TENT5B
ENSG00000259188	NA	-4.42742107330736	0.0481653754724477	M1_vs_M0	HSALNG0105854	anti_sense	Q75	NA	-	DTWD1	KCNJ12
ENSG00000259219	NA	-4.67941596190783	0.0285692342210621	M1_vs_M0	HSALNG0108568	anti_sense	Not conserved	NA	NA	MEF2A	MNS1
ENSG00000259238	NA	2.33888398112632	0.010476936568461	M1_vs_M0	HSALNG0106306	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-6784-5p	-	GCNT3	TMEM105
ENSG00000259248	USP3-AS1	1.32443139714319	0.0208402576447685	M1_vs_M0	HSALNG0106502	anti_sense	Q90	hsa-miR-612,hsa-miR-1226-5p,hsa-miR-3176,hsa-miR-4472,hsa-miR-6769b-5p	Self reported educational attainment; Mathematical ability,Bmi-adjusted waist circumference,Bmi-adjusted waist-hip ratio,Forced expiratory volume; Fev/fec ratio; Peak expiratory flow,Electrocardiography,Thyroxine measurement,Qrs duration,Aortic root size,Reticulocyte count; Reticulocyte measurement,Inflammatory biomarker measurement; Ykl40 measurement,Heel bone mineral density,-	HERC1	CCDC115
ENSG00000259250	NA	-1.86289872916185	2.41451348113566e-8	M1_vs_M0	HSALNG0106240	anti_sense	Q50	NA	-	LIPC	ZNF594
ENSG00000259291	ZNF710-AS1	-1.53296324645494	2.3687805521510603e-10	M1_vs_M0	HSALNG0108098	anti_sense	Q90	NA	Body height,Comparative body size at age 10, self-reported,-	IDH2	LINC02234
ENSG00000259319	JDP2-AS1	1.2315625279196	3.76712181629521e-4	M1_vs_M0	HSALNG0102519	anti_sense	Q75	hsa-miR-663b	-	ERG28	DNM1L
ENSG00000259321	NA	2.43418691865599	3.96861356370983e-8	M1_vs_M0	HSALNG0100096	anti_sense,sense	Q90	hsa-miR-619-5p	Serum igg glycosylation measurement,-	PSME1	RAB2A
ENSG00000259354	NA	9.08504139161809	1.710014220416e-38	M1_vs_M0	HSALNG0105653	intronic_antisense	Not conserved	NA	NA	C15orf48	DSE
ENSG00000259476	NA	-4.89613018574633	0.0321006545122581	M1_vs_M0	HSALNG0106235	sense	Q50	NA	NA	LIPC	PADI1
ENSG00000259583	ALDH1A3-AS1	-3.16315192398427	2.16091570648665e-7	M1_vs_M0	HSALNG0108607	anti_sense	Q90	NA	-	CHSY1	USB1
ENSG00000259590	LINC02244	3.94957478815204	5.437033222561031e-47	M1_vs_M0	HSALNG0108537	anti_sense	Q75	NA	-	TTC23	TEX29
ENSG00000259668	NA	3.01924080641024	1.02801725963583e-8	M1_vs_M0	HSALNG0105911	anti_sense	Q75	hsa-miR-4443	C-reactive protein measurement,Body mass index,Self reported educational attainment,-,Waist-hip ratio; Smoking behavior; Body mass index,Body fat percentage	GLDN	RIOK1
ENSG00000259712	NA	1.35502016817535	0.0234514328440165	M1_vs_M0	HSALNG0105950	anti_sense	Not conserved	NA	Adolescent idiopathic scoliosis,C-reactive protein measurement,Rostral middle frontal gyrus volume measurement,Heel bone mineral density,Fat body mass,Uric acid measurement; Response to allopurinol,-	BCL2L10	LINC02785
ENSG00000259732	NA	-1.50291633928197	0.0342989513400502	M1_vs_M0	HSALNG0106282	anti_sense,sense	Not conserved	NA	-	CCNB2	FAM124B
ENSG00000259760	NA	3.70780077573439	2.10316845634239e-63	M1_vs_M0	HSALNG0108537	anti_sense	Q75	NA	-	TTC23	NR1H3
ENSG00000259810	NA	2.69156846715694	0.00851864933848958	M1_vs_M0	HSALNG0110903	sense	Not conserved	NA	NA	KRBOX5	LINC02041
ENSG00000259865	NA	1.56879201590717	2.29308854502427e-7	M1_vs_M0	HSALNG0012240	integenic	Not conserved	NA	-	ZNF124	MUC20P1
ENSG00000259869	NA	-3.71904185264221	9.79602436723877e-7	M1_vs_M0	HSALNG0077502	integenic	Not conserved	NA	-	ZNF33B	TCAF2
ENSG00000259881	NA	-6.80494360621016	9.51479398870595e-9	M1_vs_M0	HSALNG0113555	anti_sense	Q50	hsa-miR-1224-3p,hsa-miR-7108-3p	Non-melanoma skin carcinoma,-	TRAPPC2L	PHTF2
ENSG00000259928	NA	-6.63655870915555	2.09686045170585e-7	M1_vs_M0	HSALNG0115645	integenic	Not conserved	hsa-miR-940	NA	CRLF3	ENSG00000237250
ENSG00000260086	NA	-2.19563797722714	5.59977653991407e-4	M1_vs_M0	HSALNG0111257	integenic	Not conserved	NA	NA	LONP2	TMEM44-AS2
ENSG00000260101	AFTPH-DT	-1.30218342099437	2.1559091036406e-4	M1_vs_M0	HSALNG0015480	anti_sense	Q90	NA	Epithelial cell adhesion molecule measurement,Gut microbiome measurement,-	SERTAD2	TMEM192
ENSG00000260121	NA	-2.03943761094228	7.655205396445081e-9	M1_vs_M0	HSALNG0144821	anti_sense	Q90	hsa-miR-4685-5p,hsa-miR-6848-5p	Reticulocyte count; Hba1c measurement; Bilirubin measurement,-	CTU2	LOXHD1
ENSG00000260135	MMP2-AS1	8.93870948880427	1.31043047556244e-29	M1_vs_M0	HSALNG0111641	anti_sense	Q90	NA	Abnormality of refraction,Age-related hearing impairment,-	CES1	LRRC38
ENSG00000260148	CPNE2-DT	-6.37686268302894	5.36347320832758e-6	M1_vs_M0	HSALNG0144937	integenic	Not conserved	hsa-miR-6852-5p	NA	PSME3IP1	CPNE2-DT
ENSG00000260188	NA	-1.11442222689512	5.28748076008225e-8	M1_vs_M0	HSALNG0052706	anti_sense	Q50	hsa-miR-2113,hsa-miR-874-3p,hsa-miR-1268b,hsa-miR-4456,hsa-miR-4778-3p,hsa-miR-6089	Hba1c measurement,Heel bone mineral density,Arachidonic acid measurement,Alpha peak frequency measurement; Electroencephalogram measurement; Alpha wave measurement,-	CDC40	TGFB1I1
ENSG00000260196	NA	-1.20655601929422	0.0093682902008656	M1_vs_M0	HSALNG0082946	integenic	Not conserved	NA	Pulse pressure measurement; Body mass index; Systolic blood pressure; Bmi-adjusted waist-hip ratio; Social communication impairment,Systolic blood pressure; Alcohol drinking	NCR3LG1	ENSG00000224413
ENSG00000260197	NA	-1.55314573359646	0.0428449043746976	M1_vs_M0	HSALNG0141379	integenic	Not conserved	NA	NA	KDM5D	PEX10
ENSG00000260231	KDM7A-DT	2.21244376504341	1.45013930896164e-12	M1_vs_M0	HSALNG0061777	anti_sense	Q90	NA	NA	TBXAS1	SLC1A1
ENSG00000260256	NA	1.27480862974589	0.0164658349339264	M1_vs_M0	HSALNG0133530	integenic	Not conserved	hsa-miR-1178-5p	-	CFAP410	ZBTB38
ENSG00000260260	SNHG19	-1.49285182780481	5.25780579316481e-6	M1_vs_M0	HSALNG0108990	anti_sense	Q50	NA	-	PKD1	PPP1R35
ENSG00000260265	LINC02562	6.56515661390474	4.9320431536334e-7	M1_vs_M0	HSALNG0035237	anti_sense	Q75	NA	Nephrotic syndrome,Calcium measurement,C-x-c motif chemokine 10 measurement,Qt interval,-	BTC	NME8
ENSG00000260273	NA	-1.50617763238421	5.23995392269668e-8	M1_vs_M0	HSALNG0052637	integenic	Q50	hsa-miR-4447,hsa-miR-6803-5p	-	SMPD2	TP53AIP1
ENSG00000260274	NA	-1.55626755607001	2.89649783337989e-4	M1_vs_M0	HSALNG0107284	anti_sense	Q75	hsa-miR-1301-3p,hsa-miR-1207-3p,hsa-miR-6813-5p,hsa-miR-7156-3p	-	NEIL1	ENSG00000274270
ENSG00000260288	NA	2.37339821165589	0.0486826032591197	M1_vs_M0	HSALNG0107318	integenic	Not conserved	hsa-miR-676-5p,hsa-miR-4723-3p,hsa-miR-4734,hsa-miR-6763-5p,hsa-miR-7108-3p	Myopathy; Protein measurement; Response to simvastatin,Glaucoma,-	ODF3L1	ENSG00000289942
ENSG00000260303	NA	-1.32216248520747	1.38599296858796e-4	M1_vs_M0	HSALNG0037692	integenic	Q50	NA	Cortical surface area measurement,-	ZNF827	RNF145
ENSG00000260329	TMEM263-DT	-2.84499423045537	2.74744939920814e-4	M1_vs_M0	HSALNG0093754	anti_sense	Q50	NA	Aging,Alkaline phosphatase measurement	MTERF2	ACSS2
ENSG00000260367	NA	1.2231957117844	0.00650046632540973	M1_vs_M0	HSALNG0110551	anti_sense	Q50	hsa-miR-4800-3p	Body mass index,-	RABEP2	MADCAM1
ENSG00000260430	NA	1.95842424072478	4.5911773993739796e-11	M1_vs_M0	HSALNG0109982	sense	Not conserved	hsa-miR-6809-3p,hsa-miR-8072	Corneal astigmatism,Diastolic blood pressure,-	COQ7	REXO4
ENSG00000260441	NA	-5.08201240897469	0.0189461074158836	M1_vs_M0	HSALNG0112270	anti_sense	Q50	hsa-miR-23a-5p,hsa-miR-328-5p,hsa-miR-4447,hsa-miR-3960	Intelligence,Comparative body size at age 10, self-reported; Serum metabolite measurement,Self reported educational attainment; Cognitive function measurement; Glomerular filtration rate,-	ESRP2	PALM
ENSG00000260448	LCMT1-AS1	1.37699921545616	0.0430822231904135	M1_vs_M0	HSALNG0110334	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4467,hsa-miR-1587,hsa-miR-3960,hsa-miR-7108-3p	-	ARHGAP17	BTF3L4
ENSG00000260479	NA	-2.90867166541371	1.57422401897381e-4	M1_vs_M0	HSALNG0112882	sense	Q75	NA	NA	WWOX	VPS45
ENSG00000260498	NA	2.85309742349946	1.03357154976399e-5	M1_vs_M0	HSALNG0113423	integenic	Not conserved	hsa-miR-4448,hsa-miR-4456,hsa-miR-6732-5p	NA	KLHDC4	ZP3
ENSG00000260583	NA	3.40943521746387	1.9791240258389e-7	M1_vs_M0	HSALNG0147166	integenic	Not conserved	NA	NA	MRPL39	RHOQ-AS1
ENSG00000260630	SNAI3-AS1	-1.02463157805434	1.39441059388986e-7	M1_vs_M0	HSALNG0113528	anti_sense	Q50	hsa-miR-665,hsa-miR-3195,hsa-miR-6089	Airway imaging measurement,Hair colour measurement,Reticulocyte count; Reticulocyte measurement,-	CTU2	TTC14
ENSG00000260641	TSPAN5-DT	-2.29758685792261	0.0182879149174276	M1_vs_M0	HSALNG0035964	integenic	Q50	hsa-miR-6090,hsa-miR-6769b-5p,hsa-miR-7704	Alcohol use disorder measurement,-	RAP1GDS1	ZSCAN16
ENSG00000260751	NA	1.36849256169021	0.0145565843389263	M1_vs_M0	HSALNG0110262	sense	Not conserved	hsa-miR-619-5p	NA	UBFD1	TOX-DT
ENSG00000260778	MIR3677HG	-1.50323952088148	0.0345905563434574	M1_vs_M0	HSALNG0108999	anti_sense	Not conserved	hsa-miR-1343-3p,hsa-miR-6089,hsa-miR-6791-5p	Bmi-adjusted hip circumference,-	DNASE1L2	ENSG00000287593
ENSG00000260792	LINC02280	-3.85063131425658	3.09900340305624e-4	M1_vs_M0	HSALNG0104115	integenic	Not conserved	hsa-miR-4649-5p	Peripheral arterial disease; Traffic air pollution measurement,-	TMEM179	SYT9-AS1
ENSG00000260804	LINC01963	-1.66925606826505	2.6799817222739e-15	M1_vs_M0	HSALNG0022112	integenic	Q50	NA	NA	XRCC5	PPP1R3C
ENSG00000260807	CEROX1	5.5872181871146	9.52762972242026e-4	M1_vs_M0	HSALNG0108830	sense	Q50	hsa-miR-505-5p,hsa-miR-615-5p,hsa-miR-762,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-7106-3p,hsa-miR-7160-3p	Body height,-	LMF1	ENSG00000289110
ENSG00000260868	LINC01960	1.93516761639323	2.06253322118192e-5	M1_vs_M0	HSALNG0146267	integenic	Q75	NA	NA	SP9	HMSD
ENSG00000260876	LINC01229	-1.23224263000039	2.1815904236553098e-11	M1_vs_M0	HSALNG0112914	integenic	Q90	NA	NA	WWOX	LMLN
ENSG00000260898	ADPGK-AS1	2.23151062184259	7.196181667907181e-10	M1_vs_M0	HSALNG0107094	anti_sense	Q75	hsa-miR-484,hsa-miR-6089,hsa-miR-6848-5p,hsa-miR-8485	Urate measurement,Grip strength measurement,Body weight,Vital capacity,Body mass index,Body mass index; Visceral adipose tissue measurement,Triglyceride measurement; Body mass index,-	BBS4	MIR124-1HG
ENSG00000260911	NA	1.69433902780113	0.0264977567565075	M1_vs_M0	HSALNG0110810	integenic	Not conserved	NA	NA	STX4	MIER2
ENSG00000260912	NA	-3.4516219972807	4.13729839090238e-28	M1_vs_M0	NA	NA	NA	NA	NA	ACER2	PXMP2
ENSG00000260941	LINC00622	2.13646483885101	3.2764998176164e-11	M1_vs_M0	HSALNG0006500	integenic	Not conserved	NA	NA	ZNF697	CAP1P2
ENSG00000260997	NA	8.0567676857421	7.052433153090279e-19	M1_vs_M0	NA	NA	NA	NA	NA	MYO1G	WARS1
ENSG00000261036	NA	3.4138426291082	1.38949154668355e-58	M1_vs_M0	HSALNG0044432	integenic	Not conserved	NA	NA	DTWD2	PTPN1
ENSG00000261064	LINC02256	-2.39291202546797	3.24192961634223e-4	M1_vs_M0	HSALNG0104864	integenic	Not conserved	NA	NA	GOLGA8N	ENSG00000284719
ENSG00000261253	NA	-4.68685779573642	1.50414135230765e-14	M1_vs_M0	HSALNG0113602	anti_sense	Not conserved	hsa-miR-505-5p,hsa-miR-1587,hsa-miR-3972,hsa-miR-6812-5p	Carotid plaque build	ZNF778	PGM2
ENSG00000261296	NA	2.55623489896205	2.85994994463464e-4	M1_vs_M0	HSALNG0106417	integenic	Q50	NA	-	TLN2	DUSP8P5
ENSG00000261338	NA	-1.3583946059042	5.81198625022297e-4	M1_vs_M0	NA	NA	NA	NA	NA	ARPC2	MIR223HG
ENSG00000261416	CORO1A-AS1	-1.57629985439153	5.88791996322288e-4	M1_vs_M0	HSALNG0110699	anti_sense	Q75	hsa-miR-92a-2-5p,hsa-miR-3178,hsa-miR-4308,hsa-miR-3689a-3p,hsa-miR-3689b-3p,hsa-miR-4447,hsa-miR-3689c,hsa-miR-4505,hsa-miR-4690-5p,hsa-miR-4734,hsa-miR-5787,hsa-miR-6085,hsa-miR-6737-5p,hsa-miR-7152-5p	-	BOLA2B	BEST4
ENSG00000261420	MPC1-DT	-3.23522568673187	0.00915558106033494	M1_vs_M0	HSALNG0055096	integenic	Q50	hsa-miR-619-5p	NA	CEP43	VSIG10
ENSG00000261451	NA	-2.75142946887844	5.11732934361539e-5	M1_vs_M0	HSALNG0063368	integenic	Not conserved	NA	Neuroticism measurement	MSRA	ERFE
ENSG00000261468	NA	-4.43032219094774	6.078054300630369e-12	M1_vs_M0	HSALNG0024922	integenic	Not conserved	hsa-miR-6165	NA	TGFBR2	HTR1B
ENSG00000261485	PAN3-AS1	-1.45324487854528	3.93527507474022e-13	M1_vs_M0	HSALNG0095998	anti_sense	Q90	NA	-	FLT3	TSPYL5
ENSG00000261512	NA	1.13406199536706	0.00260902761982929	M1_vs_M0	NA	NA	NA	NA	NA	SHCBP1	ENSG00000286366
ENSG00000261618	LINC02605	8.91015811138575	2.02509132912375e-34	M1_vs_M0	HSALNG0150243	integenic	Not conserved	NA	Platelet-to-lymphocyte ratio; Lymphocyte count	ZC2HC1A	C1QTNF1
ENSG00000261644	CYLD-AS1	3.49062943597143	1.56784483632993e-33	M1_vs_M0	HSALNG0111361	anti_sense	Q50	hsa-miR-6089,hsa-miR-8485	Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	SNX20	DGKZ
ENSG00000261659	NA	-2.0337239119601	9.05582453292896e-4	M1_vs_M0	NA	NA	NA	NA	NA	STUB1	SETD9
ENSG00000261671	NA	-2.82925482205295	0.00408652255417897	M1_vs_M0	HSALNG0076631	integenic	Q75	NA	-	COMMD3	ENSG00000267251
ENSG00000261770	NA	1.89067510556549	0.00267956669743912	M1_vs_M0	HSALNG0125113	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-920	Testicular germ cell tumor,-	UQCRFS1	IL17RD
ENSG00000261795	NA	-2.63468767770315	6.75138566547339e-25	M1_vs_M0	HSALNG0055499	integenic	Not conserved	NA	NA	PDGFA	RNPEP
ENSG00000261798	NA	-3.18690468742836	3.5161501245519196e-42	M1_vs_M0	HSALNG0002807	integenic	Q75	hsa-miR-619-5p,hsa-miR-659-5p,hsa-miR-6089,hsa-miR-1273h-5p	Hemorrhoid,-	PPIE	RAD54L
ENSG00000261801	LOXL1-AS1	2.49706951521619	0.00371148499274807	M1_vs_M0	HSALNG0107133	anti_sense	Q50	hsa-miR-3194-5p,hsa-miR-500b-3p,hsa-miR-4667-3p,hsa-miR-6089	Feeling """"fed-up"""" measurement,Body height,Bmi-adjusted waist circumference,Bmi-adjusted waist circumference; Body height,Exfoliation syndrome,-	STOML1	TFAP2A
ENSG00000261824	LINC00662	3.58743817369417	2.64660851448808e-224	M1_vs_M0	HSALNG0125113	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-920	Testicular germ cell tumor,-	UQCRFS1	PDE4D
ENSG00000261879	ZNF594-DT	-2.62171531463404	0.0235230498068469	M1_vs_M0	HSALNG0114109	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4492,hsa-miR-6089	Head and neck squamous cell carcinoma,Family history of alzheimer’s disease,-	USP6	ENSG00000231181
ENSG00000261889	NA	2.0849925675835	4.46232135139215e-5	M1_vs_M0	HSALNG0109131	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-7704	Vital capacity,-	ZSCAN10	GTF3C2
ENSG00000261971	MMP25-AS1	2.12975971161473	5.4075450732857605e-61	M1_vs_M0	HSALNG0109107	anti_sense	Q75	hsa-miR-455-3p,hsa-miR-619-5p,hsa-miR-3178,hsa-miR-4286,hsa-miR-4472,hsa-miR-4498,hsa-miR-3960,hsa-miR-4787-5p,hsa-miR-6132,hsa-miR-6767-5p,hsa-miR-6779-5p,hsa-miR-6803-5p,hsa-miR-6836-5p,hsa-miR-6860,hsa-miR-8072	-	BICDL2	OSBPL8
ENSG00000262001	DLGAP1-AS2	1.1673059189191901	6.3069925639381504e-9	M1_vs_M0	HSALNG0119714	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4481,hsa-miR-4505,hsa-miR-1587,hsa-miR-6089,hsa-miR-7111-5p,hsa-miR-7150	Mean corpuscular volume,Mean reticulocyte volume,Blood urea nitrogen measurement; Serum urea measurement,Fat body mass,Mean reticulocyte volume; Mean corpuscular volume,Lip morphology measurement,Alanine measurement; Amino acid measurement,-	TGIF1	CEP85
ENSG00000262089	NA	1.15918721774162	0.00575753990751244	M1_vs_M0	HSALNG0114242	integenic	Not conserved	hsa-miR-3944-5p	NA	SLC16A11	ZNF285
ENSG00000262097	LINC02185	-4.24520493177459	3.33944144537302e-98	M1_vs_M0	HSALNG0109713	integenic	Q50	hsa-miR-645,hsa-miR-4330,hsa-miR-4453	-	PARN	STMN1
ENSG00000262185	LINC02861	-5.24601969069789	0.0039649207299388	M1_vs_M0	HSALNG0109194	integenic	Q50	hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-6089	Breast carcinoma,Cleft lip; Cleft palate	ADCY9	H2AZ2P1
ENSG00000262223	LINC03048	3.52957995002491	6.75244562771912e-6	M1_vs_M0	HSALNG0119251	integenic	Q50	hsa-miR-132-5p,hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-6769b-5p,hsa-miR-4433b-3p	Dental caries; Bmi-adjusted hip circumference; Dentures,Self reported educational attainment,Body height,Systolic blood pressure,Beta blocking agent use measurement,-	SLC38A10	TAPBPL
ENSG00000262580	NA	2.9821753924654	4.8494907997309e-30	M1_vs_M0	HSALNG0119173	anti_sense	Q50	NA	Fasting blood glucose measurement,-,Psoriasis; Hirschsprung disease	SGSH	MN1
ENSG00000262691	NA	-2.0973110949528	0.042650078768257	M1_vs_M0	NA	NA	NA	NA	NA	SLC9A5	SLC45A4
ENSG00000262712	NA	1.22608197516761	4.54531165996261e-6	M1_vs_M0	NA	NA	NA	NA	NA	PAM16	TMEM60
ENSG00000262898	NA	-2.39026134166071	0.0458879368242742	M1_vs_M0	HSALNG0145192	integenic	Not conserved	NA	NA	METRNL	NPBWR1
ENSG00000262979	NA	5.56880465720385	0.00121980045418115	M1_vs_M0	HSALNG0119186	sense	Not conserved	NA	-	RNF213	NNMT
ENSG00000263069	RNF213-AS1	3.36467788015289	3.25803073648329e-32	M1_vs_M0	HSALNG0119191	anti_sense	Q50	NA	-	NPTX1	FBXO39
ENSG00000263443	NA	-5.08031424264201	0.012972898595865	M1_vs_M0	HSALNG0068121	integenic	Q50	hsa-miR-4281,hsa-miR-4284,hsa-miR-4463,hsa-miR-4632-5p,hsa-miR-4758-5p,hsa-miR-6873-3p	Sleep duration,Body weight,Chin morphology measurement,Complement factor h-related protein 5 measurement,Atherosclerosis,Cortical surface area measurement,Common carotid intimal medial thickness,Age at onset,Autism spectrum disorder,Diabetic nephropathy,Cadasil; White matter hyperintensity measurement,-	DERL1	ENSG00000259219
ENSG00000263731	NA	-1.29433611163975	0.0430685329084628	M1_vs_M0	HSALNG0119325	integenic	Not conserved	NA	NA	ALYREF	BROX
ENSG00000263766	KPNB1-DT	1.53220913810549	0.00321965407976133	M1_vs_M0	HSALNG0117016	integenic	Not conserved	hsa-miR-4463,hsa-miR-4492,hsa-miR-6089	Mathematical ability	OSBPL7	DPY19L1P1
ENSG00000264345	LINC01894	3.54357393286548	0.00139953427987262	M1_vs_M0	HSALNG0120527	integenic	Q90	NA	-	ZNF521	MOV10L1
ENSG00000264660	NA	3.19533724755073	3.70855900064093e-6	M1_vs_M0	HSALNG0115236	integenic	Not conserved	NA	NA	DHRS7B	ADGRL1
ENSG00000265010	NA	-4.42776226153779	0.0477315895034362	M1_vs_M0	HSALNG0145150	sense	Not conserved	NA	-	C17orf80	TMEM200B
ENSG00000265100	NA	3.87955244686455	1.33298488626101e-4	M1_vs_M0	HSALNG0118356	anti_sense	Not conserved	hsa-miR-6089	NA	SLC16A6	AKR1C3
ENSG00000265494	NA	7.39873802507651	4.48554785078124e-13	M1_vs_M0	NA	NA	NA	NA	NA	COX10	TP53INP2
ENSG00000265519	NA	1.89024637943485	7.58075266604197e-7	M1_vs_M0	HSALNG0114816	integenic	Not conserved	hsa-miR-1224-3p	-	TRIM16	BNIP3L
ENSG00000265688	MILIP	-1.02865810530321	0.001327948053884	M1_vs_M0	HSALNG0119342	integenic	Not conserved	hsa-miR-5585-3p	-	NPB	MFSD9
ENSG00000265728	NA	-2.80338178948684	1.37069387624938e-16	M1_vs_M0	HSALNG0120011	integenic	Not conserved	NA	3-hydroxypropylmercapturic acid measurement,-	NAPG	NIT1
ENSG00000265975	NA	1.25149541651923	2.30224067073489e-4	M1_vs_M0	HSALNG0114480	integenic	Not conserved	NA	NA	NTN1	HSD11B1L
ENSG00000266088	NA	-3.76922846651271	5.0145128243382e-7	M1_vs_M0	HSALNG0116373	integenic	Q50	hsa-miR-4463,hsa-miR-6803-5p,hsa-miR-7108-3p,hsa-miR-8485	-	IGFBP4	FAM20C
ENSG00000266389	PIK3R5-DT	1.64466211023617	2.54080680416598e-5	M1_vs_M0	HSALNG0114479	integenic	Q75	hsa-miR-4492,hsa-miR-6810-3p,hsa-miR-6845-5p	NA	NTN1	HOXA5
ENSG00000266402	SNHG25	-2.17277016034298	1.93226666977525e-6	M1_vs_M0	HSALNG0118080	anti_sense	Q75	hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6716-5p	-	PRR29	SSNA1
ENSG00000266473	HELZ-AS1	-2.95095937277495	0.0413958114024098	M1_vs_M0	HSALNG0118281	anti_sense	Q75	hsa-miR-3663-5p,hsa-miR-4447,hsa-miR-1343-3p,hsa-miR-6089,hsa-miR-6803-5p,hsa-miR-7704,hsa-miR-8485	Lymphocyte count,Protein measurement,Sex hormone-binding globulin measurement,-	PITPNC1	ZNF785
ENSG00000266718	NA	-3.56233640847812	8.52144494772728e-15	M1_vs_M0	HSALNG0115789	anti_sense	Not conserved	NA	Nicotine dependence symptom count	CDK5R1	GPC2
ENSG00000266913	LINC01841	5.68775515287102	8.01243538236077e-4	M1_vs_M0	HSALNG0124294	integenic	Not conserved	hsa-miR-766-3p,hsa-miR-4323	NA	DDX39A	SLC25A47
ENSG00000266947	NA	1.21720751175645	3.51489841426397e-7	M1_vs_M0	HSALNG0115929	integenic	Not conserved	hsa-miR-619-5p	-	SLC35G3	FAM184A
ENSG00000266970	SOCS3-DT	5.9957154414024	1.47995714513163e-4	M1_vs_M0	HSALNG0119032	integenic	Q50	hsa-miR-619-5p,hsa-miR-4472,hsa-miR-4639-3p,hsa-miR-6089,hsa-miR-6794-5p,hsa-miR-6803-5p	Creativity measurement,Heel bone mineral density,C-reactive protein measurement,-	PGS1	TPD52
ENSG00000266976	NA	1.48902956847617	1.43179202268526e-9	M1_vs_M0	HSALNG0145715	integenic	Not conserved	NA	NA	VSTM2B	TSGA10
ENSG00000267026	NA	-5.65098345512142	3.75202612964868e-4	M1_vs_M0	HSALNG0073203	anti_sense	Not conserved	hsa-miR-6729-3p	NA	ANKS6	CENPF
ENSG00000267040	ATP8B1-AS1	1.12294130438375	0.0070389118152661	M1_vs_M0	HSALNG0121780	anti_sense	Q50	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-4273,hsa-miR-4768-5p,hsa-miR-6089	Serum alanine aminotransferase measurement; Hemoglobin measurement; Gallstones; Serum gamma-glutamyl transferase measurement; Hematocrit; Red blood cell density measurement; Aspartate aminotransferase measurement,Low density lipoprotein cholesterol measurement; Cholelithiasis,Hemoglobin measurement,Erythrocyte count,Aspartate aminotransferase to alanine aminotransferase ratio; Serum gamma-glutamyl transferase measurement; Serum alanine aminotransferase measurement,Red blood cell density measurement,Hemoglobin measurement; Erythrocyte count,Serum alanine aminotransferase measurement; Hemoglobin measurement; Serum gamma-glutamyl transferase measurement; Hematocrit; Erythrocyte count,-	ONECUT2	FAT2
ENSG00000267074	NA	8.39444750300107	2.1354189220272197e-25	M1_vs_M0	HSALNG0115953	sense	Not conserved	NA	Macrophage inflammatory protein 1b measurement	SLFN12L	GBP1
ENSG00000267101	NA	-5.08030250988166	0.00467652006115957	M1_vs_M0	HSALNG0121248	anti_sense	Q50	hsa-miR-1229-5p,hsa-miR-4281,hsa-miR-6089,hsa-miR-6728-3p	Smoking status measurement,Smoking behavior,Alopecia,Self reported educational attainment,Balding measurement,Bmi-adjusted waist-hip ratio,Waist-hip ratio,Intelligence,Bmi-adjusted hip circumference,Smoking initiation,Urate measurement,Biological sex,Uric acid measurement,Cognitive function measurement; Parental longevity,Creatinine measurement,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,-	EPG5	LGI4
ENSG00000267121	FMNL1-DT	1.42332718641905	2.35566834703604e-47	M1_vs_M0	HSALNG0116830	anti_sense	Q75	hsa-miR-30b-3p,hsa-miR-185-3p,hsa-miR-619-5p,hsa-miR-675-5p,hsa-miR-5589-5p,hsa-miR-6089,hsa-miR-6791-5p,hsa-miR-7108-3p,hsa-miR-8485	Body fat distribution,White matter microstructure measurement,Body height,Thyroid stimulating hormone measurement,Bmi-adjusted hip circumference,-	SPATA32	TM7SF3
ENSG00000267122	NA	-2.73192655113461	0.0147855797763534	M1_vs_M0	HSALNG0123136	anti_sense	Q90	hsa-miR-125a-5p,hsa-miR-4324,hsa-miR-1343-3p	Gamma-linolenic acid measurement,Bmi-adjusted hip circumference,-	PLEKHJ1	WNT7B
ENSG00000267136	NA	-1.46222101672556	0.0283235668820353	M1_vs_M0	HSALNG0120178	anti_sense	Not conserved	NA	-	FAM210A	CTBP2
ENSG00000267247	NA	-3.93193506744417	3.4320456325078e-11	M1_vs_M0	HSALNG0120096	anti_sense	Q50	hsa-miR-874-3p,hsa-miR-1343-3p,hsa-miR-6728-3p,hsa-miR-6852-3p,hsa-miR-7155-5p	-	AFG3L2	PRG4
ENSG00000267262	NA	-1.46222097352552	0.0283235668820353	M1_vs_M0	HSALNG0123520	anti_sense	Q75	hsa-miR-619-5p	-	ACSBG2	LINC01588
ENSG00000267272	LINC01140	-2.24473101855747	9.55480772918496e-10	M1_vs_M0	HSALNG0004949	sense	Q90	NA	Smoking behavior,Cortical surface area measurement,-	NA	BRI3
ENSG00000267279	NA	-5.24369878861954	0.00987990768871111	M1_vs_M0	HSALNG0121939	anti_sense	Q75	hsa-miR-4307,hsa-miR-6071,hsa-miR-6124	Serum alanine aminotransferase measurement; Aspartate aminotransferase measurement,Energy intake,Glomerular filtration rate,Sex hormone-binding globulin measurement,Reticulocyte count,Reticulocyte measurement,Creatinine measurement,Creatinine measurement; Glomerular filtration rate,-	RNF152	ENSG00000289091
ENSG00000267280	TBX2-AS1	-3.1035167662482	0.0278842655839533	M1_vs_M0	HSALNG0117877	anti_sense	Q90	hsa-miR-615-5p,hsa-miR-615-3p,hsa-miR-4447,hsa-miR-4505,hsa-miR-4747-3p,hsa-miR-6754-5p,hsa-miR-8485	Gout,Nephrolithiasis; Hemoglobin measurement; Gout,Glomerular filtration rate; Urate measurement; Creatinine measurement; Hematocrit; Erythrocyte count,Gout; Erythrocyte count,Creatinine measurement; Glomerular filtration rate,Red blood cell density measurement,Chronic kidney disease; Urolithiasis; Glomerular filtration rate; Vitamin c measurement; Cystatin c measurement; Renal system measurement; Beta blocking agent use measurement; Creatinine measurement; Calcium measurement; Hematocrit; Uric acid measurement; Hemoglobin measurement; Erythrocyte count; Red blood cell density measurement; Urate measurement,Urolithiasis; Glomerular filtration rate; Protein measurement; Blood metabolite measurement; Amino acid measurement; Urate measurement,Bmi-adjusted waist circumference; Myopia,Bmi-adjusted waist circumference,Body height,Reticulocyte count; Agents acting on the renin-angiotensin system use measurement,Pulse pressure measurement; Diastolic blood pressure; Hypertension; Systolic blood pressure; Mean arterial pressure; Creatinine measurement,Abnormality of refraction; Cardiovascular disease; Diuretic use measurement; Refractive error,Age-related hearing impairment,Calcium measurement,Diastolic blood pressure; Pulse pressure measurement; Mean arterial pressure; Systolic blood pressure; Calcium channel blocker use measurement,Fibroblast growth factor 23 measurement; Glomerular filtration rate; Calcium channel blocker use measurement,Spontaneous preterm birth,Urolithiasis; Coronary artery disease; Systolic blood pressure,Corneal hysteresis; Agents acting on the renin-angiotensin system use measurement; Corneal resistance factor,Creatinine measurement,Diastolic blood pressure; Mean arterial pressure,Bmi-adjusted waist circumference; Chloride measurement; Potassium measurement,-,Pulse pressure measurement; Diastolic blood pressure; Hypertension; Mean arterial pressure; Systolic blood pressure	NACA2	HNRNPA1L3
ENSG00000267287	NA	-2.98050159897139	4.07125915207298e-21	M1_vs_M0	HSALNG0122765	integenic	Not conserved	hsa-miR-3197,hsa-miR-4664-5p	Heel bone mineral density,Lean mass-adjusted fat body mass; Femoral neck bone mineral density,Maximum cigarettes per day measurement,-	NFATC1	ENSG00000279907
ENSG00000267344	NA	-1.55360362343643	0.0424115552039002	M1_vs_M0	HSALNG0116858	anti_sense	Q50	hsa-miR-6816-3p	Neuroticism measurement,-	FMNL1	TRIM59
ENSG00000267365	KCNJ2-AS1	-2.18067227942383	2.39034601729102e-12	M1_vs_M0	HSALNG0118455	anti_sense	Q50	NA	Body weight,-	ABCA5	ZNF500
ENSG00000267387	NA	4.27367710862448	3.64442354757775e-6	M1_vs_M0	HSALNG0123890	anti_sense	Q75	NA	-	ANGPTL6	HSD3BP5
ENSG00000267432	DNAH17-AS1	2.15238074197316	1.67749794951981e-11	M1_vs_M0	HSALNG0119037	anti_sense	Q90	hsa-miR-515-3p,hsa-miR-3197,hsa-miR-1268b,hsa-miR-6089,hsa-miR-6165,hsa-miR-6879-3p,hsa-miR-7843-5p	-	PGS1	MRPL46
ENSG00000267475	NUDT19-DT	-2.39387835541288	3.34872455844423e-8	M1_vs_M0	HSALNG0125387	anti_sense	Q50	NA	Mean corpuscular volume,-	ANKRD27	ZNF32
ENSG00000267543	NA	2.97086397996257	0.0264880991503486	M1_vs_M0	HSALNG0118851	anti_sense,sense	Q75	hsa-miR-363-5p,hsa-miR-1205,hsa-miR-378g,hsa-miR-4505,hsa-miR-6089	Colorectal cancer,Adolescent idiopathic scoliosis,Macular telangiectasia type 2,Pulse pressure measurement,Reaction time measurement,Leukocyte count; Neutrophil count,Mathematical ability,Eye measurement,Diabetic nephropathy; Moderate albuminuria,-,Blood protein measurement	PRCD	RNF24
ENSG00000267546	NA	2.31785490244118	0.00247179102511506	M1_vs_M0	HSALNG0118852	anti_sense,sense	Q90	hsa-miR-331-3p,hsa-miR-619-5p,hsa-miR-5587-3p,hsa-miR-6803-5p	Diabetic nephropathy; Moderate albuminuria,-	CYGB	TOX-DT
ENSG00000267607	ICAM4-AS1	4.02171761881132	3.82150532774535e-5	M1_vs_M0	HSALNG0123921	anti_sense	Q50	hsa-miR-361-3p,hsa-miR-4472,hsa-miR-4632-3p,hsa-miR-6803-5p,hsa-miR-7111-3p	Icam-1 measurement,Covid-19; Blood protein measurement,Icam-1 measurement; Adhesion molecule measurement,-,Protein measurement,Blood protein measurement; Sex hormone-binding globulin measurement	ZGLP1	DOCK10
ENSG00000267655	NA	1.93673773334875	1.17316287885289e-4	M1_vs_M0	HSALNG0122734	sense	Not conserved	NA	NA	ATP9B	LCMT1-AS1
ENSG00000267659	LINC01482	4.60945142935238	0.027863241466563	M1_vs_M0	HSALNG0118381	integenic	Not conserved	NA	Chromosome-type aberration frequency	PRKAR1A	NME8
ENSG00000267712	LINC01539	6.97565347505515	6.76288983554696e-10	M1_vs_M0	HSALNG0121712	integenic	Q75	hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-7108-3p	Risk-taking behaviour,Risky sexual behaviour measurement,Smoking status measurement,Smoking initiation,Smoking behavior; Smoking status measurement,Diabetic retinopathy,Self reported educational attainment; Mathematical ability,Diverticular disease,Unipolar depression,Hiv-1 infection,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,Systolic blood pressure; Smoking behaviour measurement,-	TCF4	NAT8
ENSG00000267751	BSG-AS1	-1.1895881146208	0.0235105249843214	M1_vs_M0	HSALNG0122891	integenic	Not conserved	NA	NA	POLRMT	DYNLRB2
ENSG00000267801	NA	5.01536289870407	0.0110267653314566	M1_vs_M0	HSALNG0118795	anti_sense	Q90	hsa-miR-874-3p,hsa-miR-3178	Brain measurement,-	UNK	ENSG00000267801
ENSG00000267882	NA	4.82038128600555	0.0309970026209415	M1_vs_M0	NA	NA	NA	NA	NA	EYA2	TMEM25
ENSG00000267886	NA	-5.24739491917089	0.0110828743381601	M1_vs_M0	HSALNG0125019	sense	Not conserved	hsa-miR-4281,hsa-miR-4673	NA	ZNF730	HAND2-AS1
ENSG00000267940	NA	-2.39294206152314	3.25576388799285e-4	M1_vs_M0	HSALNG0082398	anti_sense	Q75	NA	-	FHIP1B	ITPR1-DT
ENSG00000267980	NA	2.80767235150401	1.80176974872829e-5	M1_vs_M0	HSALNG0145651	anti_sense	Q90	NA	-	MPND	MT-TF
ENSG00000268027	NA	-7.74420945178258	1.13870059774259e-16	M1_vs_M0	HSALNG0126205	sense	Not conserved	hsa-miR-619-5p,hsa-miR-6803-5p	NA	CEACAM21	CD28
ENSG00000268205	NA	1.16935274927008	6.70396278365493e-15	M1_vs_M0	HSALNG0127823	integenic	Not conserved	NA	NA	ZNF460	ASTE1
ENSG00000268362	NA	-1.10435774213594	3.02268339561535e-5	M1_vs_M0	HSALNG0125076	sense	Not conserved	hsa-miR-363-5p,hsa-miR-619-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-6089,hsa-miR-6090	Response to paclitaxel,Adolescent idiopathic scoliosis	ZNF254	SGO1
ENSG00000268516	ZNF8-DT	-1.37880794893691	0.00783336602965677	M1_vs_M0	HSALNG0127940	anti_sense	Not conserved	hsa-miR-6769a-3p	Attention deficit hyperactivity disorder,-	A1BG	AUH
ENSG00000269220	LINC00528	-1.59572104097375	4.94056461506856e-5	M1_vs_M0	HSALNG0133922	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-1247-5p,hsa-miR-4257,hsa-miR-6089,hsa-miR-6877-3p	Response to diisocyanate,Adiponectin measurement	BCL2L13	ZDHHC11
ENSG00000269246	NA	-2.82925480495801	0.00408739221374968	M1_vs_M0	HSALNG0125993	overlap_antisense,overlap_sense,anti_sense	Not conserved	hsa-miR-6089	Eotaxin measurement,Lung adenocarcinoma,Serum alanine aminotransferase measurement,Physical activity,-	GMFG	PYCR3
ENSG00000269399	NA	-1.42469803489845	3.21511649834095e-4	M1_vs_M0	HSALNG0124446	anti_sense	Not conserved	hsa-miR-6089	Eosinophil count,Leukocyte count	C19orf44	STEEP1
ENSG00000269420	PLA2G4C-AS1	1.86318011714953	0.0497301509574524	M1_vs_M0	HSALNG0126825	anti_sense	Q50	hsa-miR-6803-5p	-	ELSPBP1	ENSG00000253667
ENSG00000269439	PGLS-DT	1.44672901733393	2.5098423407478e-9	M1_vs_M0	HSALNG0124531	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-1182,hsa-miR-4723-3p,hsa-miR-6727-3p,hsa-miR-7160-3p	Gut microbiome measurement,-	NXNL1	DPH1
ENSG00000269446	NA	2.77768085013366	1.60106841808999e-8	M1_vs_M0	HSALNG0062712	integenic	Not conserved	NA	NA	UBE3C	MAP3K6
ENSG00000269534	NA	3.23550674024194	0.0146591216572625	M1_vs_M0	HSALNG0126833	anti_sense	Q50	NA	-	ZSWIM9	HSD3BP5
ENSG00000269553	NA	-2.75123516576193	5.14490062981124e-5	M1_vs_M0	HSALNG0125598	intronic_sense	Not conserved	NA	NA	CD22	ENSG00000288778
ENSG00000269688	NA	1.306532869886	0.0336745564601759	M1_vs_M0	HSALNG0125952	sense	Not conserved	hsa-miR-619-5p,hsa-miR-4505	NA	HNRNPL	DHRS11
ENSG00000269821	KCNQ1OT1	-2.12375693855432	3.24266268169629e-30	M1_vs_M0	HSALNG0082235	anti_sense	Q75	hsa-miR-6510-5p	Qt interval,Qt interval; Electrocardiography; T wave morphology measurement,Electrocardiography,Bmi-adjusted waist-hip ratio,Familial long qt syndrome,Trauma exposure measurement,Platelet aggregation,Body height,Anthranilic acid measurement,Lip morphology measurement,Birth weight,Drugs used in diabetes use measurement,Parental genotype effect measurement; Birth weight,Platelet count; Platelet crit,Mean platelet volume,Stressful life event measurement; Depressive symptom measurement,Mouth morphology measurement; Nose morphology measurement,Mean arterial pressure; Response to high sodium diet; Systolic blood pressure,Glucose measurement; Hba1c measurement,-,Hyperuricemia; Creatinine measurement; Glomerular filtration rate; Chronic kidney disease	TRPM5	TRIP6
ENSG00000269826	NA	4.60955033573997	0.0287968085795212	M1_vs_M0	HSALNG0113288	integenic	Q75	NA	Response to statin,-	FOXF1	NME8
ENSG00000269934	NA	-1.1141090518236	6.05856337762096e-5	M1_vs_M0	HSALNG0011224	anti_sense	Not conserved	NA	-	TRIM11	CENATAC-DT
ENSG00000269952	NA	5.89498055433736	2.33689740845759e-4	M1_vs_M0	HSALNG0077270	sense	Q50	NA	NA	CREM	MMP17
ENSG00000269970	NA	-1.75262396516672	0.0106358161362908	M1_vs_M0	HSALNG0074238	sense	Not conserved	NA	NA	PTGS1	H2AZ2-DT
ENSG00000270049	ATP6V0D1-DT	-1.66603703113368	1.28279173889966e-7	M1_vs_M0	HSALNG0112213	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4433a-3p,hsa-miR-4740-3p	Agouti-related protein measurement,Mean corpuscular hemoglobin concentration,Mean reticulocyte volume; Mean corpuscular volume; Mean corpuscular hemoglobin,-	RIPOR1	BHLHE40-AS1
ENSG00000270055	NA	-3.66282797422777	1.94223595912489e-11	M1_vs_M0	HSALNG0104765	integenic	Not conserved	NA	NA	GOLGA8Q	BCKDHB
ENSG00000270084	GAS5-AS1	-1.78717829679966	0.0368911657986467	M1_vs_M0	HSALNG0008546	integenic	Not conserved	hsa-miR-6089	Intelligence,Body height	DARS2	DUT
ENSG00000270108	NA	-1.40152997138371	0.0429639275164352	M1_vs_M0	HSALNG0104021	sense	Not conserved	NA	NA	KLC1	TDH
ENSG00000270112	ST8SIA5-DT	-4.26562827918105	3.4866312064835e-40	M1_vs_M0	HSALNG0121346	anti_sense	Q75	hsa-miR-4667-3p,hsa-miR-6089,hsa-miR-6803-5p	Adolescent idiopathic scoliosis,-	KATNAL2	ERVMER34-1
ENSG00000270120	NA	4.49856523616894	1.55975928685485e-12	M1_vs_M0	HSALNG0111360	sense	Q50	NA	NA	NOD2	ENSG00000288954
ENSG00000270127	NA	1.26562121504394	9.69412110058781e-6	M1_vs_M0	HSALNG0108582	integenic	Not conserved	NA	NA	CERS3	SPRED1
ENSG00000270164	LINC01480	-1.87175403725113	0.00403368935646173	M1_vs_M0	HSALNG0126205	sense	Not conserved	hsa-miR-619-5p,hsa-miR-6803-5p	NA	CEACAM21	CXXC1
ENSG00000270194	GOLGA4-AS1	2.45564268203824	6.089278284883101e-16	M1_vs_M0	HSALNG0025176	anti_sense	Q90	NA	-	LRRFIP2	POMGNT2
ENSG00000270332	SMC2-DT	-4.40155316487214	5.33084351353972e-6	M1_vs_M0	HSALNG0073384	integenic	Q75	NA	-	OR13C4	LINC00513
ENSG00000270419	CAHM	-1.46383701014381	4.09745782204175e-5	M1_vs_M0	HSALNG0054937	anti_sense	Q50	hsa-miR-1237-5p,hsa-miR-3178,hsa-miR-4651,hsa-miR-5587-3p,hsa-miR-7108-3p,hsa-miR-10394-3p	-	PRKN	DNAJC3
ENSG00000270426	NA	2.63278614663946	2.25703012370307e-7	M1_vs_M0	HSALNG0039018	sense	Q90	NA	NA	IRF2	ZNF71
ENSG00000270504	NA	-1.41922858356711	0.00528048243601684	M1_vs_M0	HSALNG0047648	anti_sense	Q50	hsa-miR-30b-3p,hsa-miR-6133	-	FAM50B	MIR4500HG
ENSG00000270605	NA	-1.52412775156459	0.00276944919336815	M1_vs_M0	HSALNG0002045	anti_sense	Q50	hsa-miR-19b-2-5p,hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-4508,hsa-miR-1587,hsa-miR-5693,hsa-miR-5787,hsa-miR-6089	Aspartate aminotransferase measurement,-	DNAJC8	SIGLEC14
ENSG00000271216	LINC01050	6.82381426602514	1.1383532515415498e-76	M1_vs_M0	HSALNG0096679	anti_sense	Q75	hsa-miR-6735-3p	Cognitive decline measurement,-	EPSTI1	EFCAB3
ENSG00000271259	NA	5.00764555336057	0.00834504620201809	M1_vs_M0	HSALNG0092941	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4312,hsa-miR-4447,hsa-miR-548an,hsa-miR-8485	Attention deficit hyperactivity disorder,Self reported educational attainment; Attention deficit hyperactivity disorder,Body mass index,Brain volume measurement,Self reported educational attainment; Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body mass index; Attention deficit hyperactivity disorder; Body fat percentage; Waist-hip ratio; Unipolar depression; Visceral adipose tissue measurement; High density lipoprotein cholesterol measurement; Platelet count; Aspartate aminotransferase measurement,Body weight; Body mass index,Sleep quality,Eosinophil count,Monocyte count,Hair colour measurement,Blood protein measurement; Lymphocyte count,Lymphocyte count,Attention deficit hyperactivity disorder; Cannabis use,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,Systolic blood pressure; Diastolic blood pressure; Mean arterial pressure; Alcohol drinking,-	TMTC3	DUSP28
ENSG00000271344	NA	1.35501975601656	0.0234514328440165	M1_vs_M0	HSALNG0061234	integenic	Not conserved	NA	NA	GARIN1A	ENSG00000288771
ENSG00000271474	UNC5C-AS1	4.79245552780755	2.0827859043737e-9	M1_vs_M0	HSALNG0035909	anti_sense	Q50	NA	-	PDHA2	CDIN1
ENSG00000271780	NA	-1.10174785122403	0.0315649098174521	M1_vs_M0	HSALNG0103867	sense	Not conserved	hsa-miR-363-5p,hsa-miR-6089,hsa-miR-7160-3p	Body mass index,-,Age at menopause	DYNC1H1	SLC39A5
ENSG00000271830	NA	2.2506688869981	9.52512391984465e-4	M1_vs_M0	HSALNG0067527	anti_sense,sense	Q90	hsa-miR-1233-5p,hsa-miR-6089,hsa-miR-6726-3p,hsa-miR-6748-3p,hsa-miR-7150,hsa-miR-8485	-	NA	TMEM220
ENSG00000271848	SYNPO2L-AS1	-5.76587080990337	8.16815042971352e-4	M1_vs_M0	HSALNG0078853	anti_sense	Q90	hsa-miR-4436a	Atrial fibrillation,Pr interval,Heart failure,Atrial fibrillation; Systolic blood pressure,Electrocardiography,Serum gamma-glutamyl transferase measurement,Systolic blood pressure,-	SEC24C	ZBTB46-AS1
ENSG00000271857	NA	1.2837958271072	2.9231356011478494e-11	M1_vs_M0	HSALNG0050324	anti_sense	Q90	hsa-miR-4467,hsa-miR-4686	-	SUPT3H	MAN2B1
ENSG00000271869	DCTN6-DT	-1.3725117983317	0.0352762420634646	M1_vs_M0	HSALNG0064342	anti_sense	Not conserved	NA	NA	MBOAT4	LINC02356
ENSG00000271882	NA	1.33078717377407	2.39127463151884e-5	M1_vs_M0	HSALNG0067354	anti_sense	Q75	hsa-miR-6722-3p	-	GRHL2	GGCT
ENSG00000271913	TAGAP-AS1	2.83814562004505	1.14268189094298e-24	M1_vs_M0	HSALNG0054719	anti_sense	Q50	hsa-miR-485-5p,hsa-miR-4467,hsa-miR-4516,hsa-miR-4530,hsa-miR-3960,hsa-miR-4707-3p,hsa-miR-6791-5p,hsa-miR-6858-3p,hsa-miR-7108-3p,hsa-miR-7112-5p	Leukocyte count,Lymphocyte count,Myeloid white cell count; Celiac disease,Lipoprotein a measurement,Nicotine dependence symptom count,Autoimmune disease; Systemic lupus erythematosus; Celiac disease,Hypothyroidism,Leukocyte count; Neutrophil count,Neutrophil count; Leukocyte count; Neutrophil percentage of leukocytes; Eosinophil count; Granulocyte count,Eczema,Crohn's disease; Inflammatory bowel disease; Celiac disease,Rheumatoid arthritis; Crohn's disease,Gut microbiome measurement,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Rheumatoid arthritis; Sclerosing cholangitis,Celiac disease,Rheumatoid arthritis,Rheumatoid arthritis; Celiac disease,-,Systemic lupus erythematosus,Cognitive inhibition measurement,Eosinophil percentage of leukocytes	FNDC1	NR4A2
ENSG00000271936	NA	-1.34459070349289	0.00548034526686175	M1_vs_M0	HSALNG0013623	anti_sense	Q50	NA	Appendicular lean mass,Body height,Age at menarche,Bmi-adjusted waist circumference,Bmi-adjusted hip circumference,Susceptibility to pneumonia measurement,Body mass index,Reticulocyte count,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,C-reactive protein measurement,-	CENPO	KLHL25
ENSG00000271992	NA	4.08734764808401	2.11589058421223e-5	M1_vs_M0	HSALNG0004379	integenic	Not conserved	NA	NA	CTH	DUOX1
ENSG00000272068	BCAN-AS1	-2.89427477696802	4.8947854047349095e-25	M1_vs_M0	HSALNG0007612	anti_sense	Q75	hsa-miR-4722-5p,hsa-miR-6511a-3p	Blood protein measurement,-	NES	WDR5
ENSG00000272115	NA	-2.3909873937025	0.0420174933674155	M1_vs_M0	HSALNG0069415	anti_sense	Not conserved	hsa-miR-8072	NA	ADCK5	KIFBP
ENSG00000272142	LYRM4-AS1	-1.30548780627639	0.00319215047604139	M1_vs_M0	HSALNG0047777	integenic	Not conserved	NA	NA	PPP1R3G	MCM4
ENSG00000272168	CASC15	-3.13771541365074	1.15496152833864e-5	M1_vs_M0	HSALNG0048556	integenic	Not conserved	NA	NA	HDGFL1	ENSG00000232995
ENSG00000272255	NA	1.01040592073896	0.0232280233061022	M1_vs_M0	HSALNG0045260	anti_sense	Q50	hsa-miR-3178	-	STING1	PCGF1
ENSG00000272269	NUP153-AS1	1.27170759666079	0.00921949510129597	M1_vs_M0	HSALNG0048366	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-3960,hsa-miR-4787-5p,hsa-miR-6769b-5p	-	FAM8A1	COX18
ENSG00000272275	NA	-2.30108687036576	0.0196717885163302	M1_vs_M0	HSALNG0013001	anti_sense	Q75	hsa-miR-619-5p	-	PDIA6	NPC1L1
ENSG00000272316	NA	-1.29433740288715	0.0430685329084628	M1_vs_M0	HSALNG0050860	integenic	Not conserved	NA	NA	RAB23	ENSG00000227076
ENSG00000272341	NA	-1.46859940035449	0.00739889212549008	M1_vs_M0	HSALNG0048332	anti_sense	Q75	hsa-miR-6799-5p	-	STMND1	MPL
ENSG00000272405	NA	-3.63182379690184	7.00019744167831e-201	M1_vs_M0	HSALNG0007612	anti_sense	Q75	hsa-miR-4722-5p,hsa-miR-6511a-3p	Blood protein measurement,-	NES	PCYOX1L
ENSG00000272425	NA	-1.35448507537779	0.00128142145817561	M1_vs_M0	HSALNG0066560	anti_sense	Not conserved	hsa-miR-3195,hsa-miR-4508	-	PMP2	DISP1
ENSG00000272449	NA	2.94156838263608	5.19639451221673e-21	M1_vs_M0	HSALNG0000274	integenic	Not conserved	hsa-miR-8485	NA	TNFRSF14	BET1L
ENSG00000272468	NA	2.49988386460249	4.95711466092044e-4	M1_vs_M0	HSALNG0048836	integenic	Not conserved	NA	NA	H2BC11	PPP3R1
ENSG00000272476	NA	-1.28762893831127	3.96597510560741e-4	M1_vs_M0	HSALNG0052540	anti_sense	Q90	hsa-miR-504-3p,hsa-miR-4467,hsa-miR-3960	-	NR2E1	ENSG00000287784
ENSG00000272482	NA	-3.30793129939526	1.19279353387122e-4	M1_vs_M0	HSALNG0000950	integenic	Q90	hsa-miR-6756-5p	NA	DHRS3	ENSG00000289483
ENSG00000272502	NA	-1.86936164848988	3.02322500628072e-8	M1_vs_M0	HSALNG0068084	anti_sense	Not conserved	NA	NA	MTBP	AAGAB
ENSG00000272505	NA	-1.09338751173135	2.87882207565985e-5	M1_vs_M0	HSALNG0063375	anti_sense	Not conserved	NA	Bmi-adjusted waist circumference; White matter microstructure measurement,Bmi-adjusted waist-hip ratio,Neuroticism measurement,Bmi-adjusted waist circumference,-	PRSS55	CLDN4
ENSG00000272512	NA	5.40066870680478	1.24953356046316e-14	M1_vs_M0	HSALNG0000065	integenic	Not conserved	NA	Apolipoprotein a 1 measurement,Parental longevity,-	HES4	CETP
ENSG00000272516	NA	-4.67993230830375	0.0288232290581097	M1_vs_M0	NA	NA	NA	NA	NA	BMI1	ENSG00000275833
ENSG00000272541	NA	-4.68125874141367	0.0443415861013275	M1_vs_M0	HSALNG0050853	integenic	Not conserved	hsa-miR-1293	-	RAB23	ENSG00000266313
ENSG00000272666	KLHDC7B-DT	5.89646887647159	8.92493064055227e-5	M1_vs_M0	HSALNG0136305	integenic	Q50	hsa-miR-5589-5p	Erythrocyte count,Monocyte count	SYCE3	KLHDC7B-DT
ENSG00000272669	NA	1.92215216935232	2.32209913512583e-10	M1_vs_M0	HSALNG0135442	anti_sense	Not conserved	hsa-miR-210-5p,hsa-miR-6763-3p	NA	GTPBP1	FAM151B
ENSG00000272695	GAS6-DT	-1.84249478375051	1.77857873407255e-6	M1_vs_M0	HSALNG0099631	integenic	Q50	hsa-miR-1268b	NA	TMEM255B	GPR146
ENSG00000272711	HK2-DT	2.50881932363083	1.25701227599395e-13	M1_vs_M0	HSALNG0016101	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-3196,hsa-miR-6132,hsa-miR-6758-5p,hsa-miR-7108-3p	-	M1AP	DNMT3A
ENSG00000272716	SLC30A6-DT	-4.67941127520568	0.0215678008198597	M1_vs_M0	HSALNG0014059	anti_sense	Q90	hsa-miR-619-5p	Blood protein measurement,Response to bisphosphonate; Atypical femoral fracture,Apolipoprotein a 1 measurement,-	NLRC4	SLC30A6-DT
ENSG00000272720	NA	-2.26199033464133	5.5938765871417696e-11	M1_vs_M0	HSALNG0135382	anti_sense	Q75	hsa-miR-363-5p,hsa-miR-1238-5p,hsa-miR-3196,hsa-miR-3620-5p,hsa-miR-4446-3p,hsa-miR-4463,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-3960,hsa-miR-4722-5p,hsa-miR-4758-5p	White matter microstructure measurement,Age-related hearing impairment,Tinnitus,Glioma; Central nervous system cancer; Glioblastoma multiforme,-	PICK1	KLHL32
ENSG00000272767	JMJD1C-AS1	-2.36064987115516	3.6840279330527497e-11	M1_vs_M0	HSALNG0078365	anti_sense	Q50	hsa-miR-211-3p,hsa-miR-874-3p	Sex hormone-binding globulin measurement,-	REEP3	ZNF629
ENSG00000272823	NA	1.64982962380454	3.1706093128004e-8	M1_vs_M0	HSALNG0010765	anti_sense	Q90	hsa-miR-23a-5p,hsa-miR-6735-3p	Heart failure,Body height,Heel bone mineral density,Apolipoprotein b measurement,Urate measurement,Serum albumin measurement,Monocyte count,Neutrophil percentage of leukocytes,Leukocyte count,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,Eosinophil count; Basophil count,Lymphocyte count,Neutrophil count,Fetal hemoglobin measurement,C-reactive protein measurement; Vital capacity,C-reactive protein measurement; Total cholesterol measurement,-	RAB3GAP2	LINC01191
ENSG00000272839	NA	-2.08787242169033	0.00508355584268395	M1_vs_M0	HSALNG0062763	anti_sense	Not conserved	hsa-miR-4463	NA	DNAJB6	RRP9
ENSG00000272841	MAP3K4-AS1	3.0720484178793	3.0491257439778e-36	M1_vs_M0	NA	NA	NA	NA	NA	AGPAT4	ENSG00000288162
ENSG00000272842	NA	-3.47216444136867	0.00329759041628721	M1_vs_M0	HSALNG0070291	anti_sense	Q75	NA	-	RPS6	POLB
ENSG00000272848	NA	-2.51258180532589	0.0311399552070473	M1_vs_M0	HSALNG0055353	sense	Not conserved	hsa-miR-7976	Astigmatism,Insomnia,Coronary artery calcification,-	NA	ENSG00000272953
ENSG00000272908	NA	-1.07075622294156	2.50669061267333e-4	M1_vs_M0	HSALNG0057329	integenic	Not conserved	NA	-	TARP	PCDHGC5
ENSG00000272914	NA	1.44736521146075	0.0111237184197204	M1_vs_M0	HSALNG0077069	sense	Q90	NA	Body height,Neuroimaging measurement; Brain measurement,Neuroimaging measurement; Cortical thickness,-	ZNF438	GADD45A
ENSG00000272931	LRRC8D-DT	-2.37651070368078	2.3576113595685397e-11	M1_vs_M0	HSALNG0005094	anti_sense	Q75	hsa-miR-6746-3p,hsa-miR-6800-3p	-	GBP5	TBRG4
ENSG00000272941	NA	4.98527258148293	9.97418308302485e-66	M1_vs_M0	HSALNG0061535	anti_sense	Q50	NA	-	TMEM140	ENSG00000275993
ENSG00000272953	NA	-2.77891165538788	5.79909415745298e-4	M1_vs_M0	HSALNG0055874	anti_sense	Q50	hsa-miR-326,hsa-miR-762,hsa-miR-3195,hsa-miR-4505,hsa-miR-4632-3p,hsa-miR-5787,hsa-miR-6803-5p	Pcsk9 protein measurement,-	SLC29A4	ENSG00000272848
ENSG00000273002	ARHGEF2-AS2	1.35826676250521	9.867013903140981e-9	M1_vs_M0	HSALNG0007540	anti_sense	Q75	NA	Comparative body size at age 10, self-reported,-	RXFP4	SH2D4A
ENSG00000273124	NA	5.57941190216284	4.42971151808839e-4	M1_vs_M0	HSALNG0079637	integenic	Q50	hsa-miR-4650-5p,hsa-miR-6132,hsa-miR-6763-5p	Fibroblast growth factor basic measurement,-	ANKRD1	ENSG00000273124
ENSG00000273143	DUSP5-DT	1.64052322235523	1.12111973102255e-4	M1_vs_M0	HSALNG0080582	integenic	Q50	NA	Heel bone mineral density,Bone density,-	SMNDC1	ACOT1
ENSG00000273174	NA	1.7138869304803	5.13993120691704e-18	M1_vs_M0	HSALNG0028857	anti_sense	Q50	NA	-	GP9	GPT2
ENSG00000273243	NA	3.54286788511052	0.0014930642833144	M1_vs_M0	HSALNG0135916	integenic	Q50	hsa-miR-4492,hsa-miR-6763-5p	Mean corpuscular hemoglobin concentration,-	KIAA0930	FAM174B
ENSG00000273253	TRABD-AS1	-2.01786464407037	0.00876791581651639	M1_vs_M0	HSALNG0147439	anti_sense	Q50	hsa-miR-4508	Mitochondrial dna measurement,Platelet count,-	TUBGCP6	OPRL1
ENSG00000273272	NA	5.45644719823753	9.63969683400303e-4	M1_vs_M0	HSALNG0147331	integenic	Not conserved	NA	Monocyte count	KLHDC7B	ENSG00000286501
ENSG00000273306	NA	-1.56641908980819	0.0222359287849977	M1_vs_M0	HSALNG0017259	anti_sense	Not conserved	NA	NA	EIF5B	GPRC5A
ENSG00000273314	NA	1.70900200904032	9.964753142852961e-15	M1_vs_M0	HSALNG0062087	anti_sense	Q50	hsa-miR-668-5p	NA	EZH2	CLDN23
ENSG00000273341	NA	3.32231877125705	7.361978781938039e-18	M1_vs_M0	HSALNG0059115	anti_sense	Q50	hsa-miR-4466,hsa-miR-7703	Body mass index,Gut microbiome measurement,Hba1c measurement,Hemoglobin a1 measurement,-	CCDC146	ALG1
ENSG00000273382	TMEM167B-DT	-2.25031082936686	2.45367742516137e-24	M1_vs_M0	HSALNG0005853	anti_sense	Q75	hsa-miR-619-5p	Apolipoprotein b measurement,Leukocyte count,-	TAF13	GRAP2
ENSG00000273473	NA	-5.86906174720626	1.33249535561555e-4	M1_vs_M0	HSALNG0150744	integenic	Not conserved	NA	-	WDR5	ZNF362
ENSG00000273486	NA	-2.16714784678762	3.88103953799925e-7	M1_vs_M0	HSALNG0029189	anti_sense	Q90	hsa-miR-23a-5p,hsa-miR-135a-3p,hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-4447,hsa-miR-3960,hsa-miR-6089	Lymphocyte count,Body mass index,-	STAG1	SOBP
ENSG00000273487	NA	-2.18220257644569	5.38418634765354e-6	M1_vs_M0	HSALNG0005192	sense	Q50	NA	Serum alanine aminotransferase measurement,Aspartate aminotransferase measurement,-	BTBD8	ADGRL1-AS1
ENSG00000273669	NA	-5.95809293678289	2.8986683749172802e-21	M1_vs_M0	HSALNG0122476	integenic	Q50	hsa-miR-4650-5p,hsa-miR-4695-5p,hsa-miR-6763-5p	Total blood protein measurement; Insomnia,-	ZNF407	ARHGDIA
ENSG00000273729	NA	1.10391541497685	0.0262880890165047	M1_vs_M0	HSALNG0102621	anti_sense	Q50	hsa-miR-615-5p,hsa-miR-4290,hsa-miR-1268b,hsa-miR-4467,hsa-miR-3960,hsa-miR-4685-3p,hsa-miR-6795-3p,hsa-miR-6838-5p	Response to anticonvulsant,Smoking status measurement; Smoking behaviour measurement,Triglyceride measurement,Feeling nervous measurement,Sleep quality; Mathematical ability,C-reactive protein measurement,Serum alanine aminotransferase measurement; Aspartate aminotransferase measurement,Fev/fec ratio; Systolic blood pressure,Serum alanine aminotransferase measurement,Body weight,Serum albumin measurement,Body mass index,Smoking status measurement,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,-,Body mass index; Aspartate aminotransferase measurement	CIPC	SAP30
ENSG00000273824	NA	5.58043483211887	9.21003386043698e-4	M1_vs_M0	HSALNG0092162	integenic	Not conserved	hsa-miR-6089	NA	MDM1	CCDC198
ENSG00000273855	NA	-2.65262394516959	6.1159460876626e-14	M1_vs_M0	HSALNG0105214	sense	Q75	hsa-miR-4293,hsa-miR-5088-3p	NA	PLCB2	MIR210HG
ENSG00000273972	NA	4.86991910669799	5.74893401915463e-10	M1_vs_M0	HSALNG0105662	integenic	Not conserved	NA	-	SQOR	ZFHX3-AS1
ENSG00000274104	NA	2.71218241252754	5.46748350313865e-5	M1_vs_M0	HSALNG0125517	anti_sense	Not conserved	hsa-miR-1343-3p,hsa-miR-6748-3p,hsa-miR-6873-3p	NA	ZNF599	PCDHB1-AS1
ENSG00000274213	NA	2.17542203758261	7.0529186442711705e-9	M1_vs_M0	HSALNG0117605	integenic	Not conserved	hsa-miR-500b-3p	-	DGKE	ENSG00000279144
ENSG00000274225	LINC03038	2.34718449800293	0.017336823656505	M1_vs_M0	HSALNG0133544	integenic	Not conserved	hsa-miR-612	NA	LRRC3	SLC49A3
ENSG00000274270	NA	-1.53391545657392	0.00157374978157368	M1_vs_M0	HSALNG0097105	anti_sense	Q50	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-4286,hsa-miR-4710,hsa-miR-7152-5p,hsa-miR-8485	Bmi-adjusted waist-hip ratio,Appendicular lean mass; Monocyte count,Sex hormone-binding globulin measurement,Body height,Serum alanine aminotransferase measurement; Forced expiratory volume; Lean body mass; Body height; Vital capacity; Triglyceride measurement,Intelligence,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Glomerular filtration rate; Creatinine measurement; Bmi-adjusted waist-hip ratio,Bmi-adjusted hip circumference,Monocyte percentage of leukocytes; Monocyte count,Diabetic maculopathy,Body height; Bmi-adjusted hip circumference,Basophil count,Lymphocyte percentage of leukocytes; Lymphocyte count,Leukocyte count,Electrocardiography,Psoriasis,Psoriasis; Bmi-adjusted hip circumference; Primary biliary cirrhosis; Bmi-adjusted waist-hip ratio; Autoimmune disease,Appendicular lean mass,Hematocrit; Hemoglobin measurement; Erythrocyte count,Hypothyroidism,Snoring measurement; Aortic root size,Eczema; Allergic rhinitis,High density lipoprotein cholesterol measurement,Celiac disease,Leukocyte count; Lymphocyte count,Tnf-related apoptosis-inducing ligand measurement,Fatty acid measurement,Diffuse large b-cell lymphoma; Bmi-adjusted hip circumference; Chronic lymphocytic leukemia; Triglyceride measurement,Hematocrit; Hemoglobin measurement,Thyroid peroxidase antibody measurement,Lipoprotein a measurement,Creatinine measurement; Glomerular filtration rate,Eosinophil count; Eosinophil percentage of granulocytes; Eosinophil percentage of leukocytes,Adiponectin measurement,Bmi-adjusted adiponectin measurement,Body mass index,Low density lipoprotein cholesterol measurement,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Triglyceride measurement,Left ventricular structural measurement,Fear of severe pain measurement,Hemoglobin measurement,Gamma-aminoisobutyric acid measurement,Eosinophil count,Heel bone mineral density,Prostate carcinoma,Grip strength measurement,Prostate specific antigen measurement,Blood urea nitrogen measurement; Forced expiratory volume,Grip strength measurement; Appendicular lean mass,Magnesium measurement,Caudal anterior cingulate cortex volume measurement,Blood urea nitrogen measurement,Breast carcinoma,Puberty; Heel bone mineral density; Bmi-adjusted hip circumference; Body height; Height growth measurement,Body height; Diastolic blood pressure; Systolic blood pressure,Hip circumference,Body height; Cardiovascular disease; Bmi-adjusted hip circumference; Systolic blood pressure,Transforming growth factor beta measurement,Primary biliary cirrhosis,Appendicular lean mass; Bmi-adjusted hip circumference,Body weight,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Protein measurement,Tumor necrosis factor-alpha measurement,Urinary albumin to creatinine ratio,Body height; Attention deficit hyperactivity disorder,Hematocrit,Bmi-adjusted waist circumference,Osteosarcoma; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio; Inguinal hernia,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Waist-hip ratio; Bmi-adjusted waist-hip ratio,Interleukin 9 measurement,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Triglyceride measurement,Snoring measurement,Sphingomyelin 22:0 measurement,Platelet component distribution width,Lymphocyte count,Total blood protein measurement,Hematocrit; Odontogenesis,Blood phosphate measurement,Platelet count,Reticulocyte count; Reticulocyte measurement,Reticulocyte measurement,Hemorrhoid,Anthropometric measurement; Brachial circumference,Bipolar disorder; Unipolar depression,Benign prostatic hyperplasia; Lower urinary tract symptom,Platelet-to-lymphocyte ratio,Eosinophil count; Eosinophil percentage of leukocytes,Total cholesterol measurement,Adolescent idiopathic scoliosis,-	KCNRG	ENSG00000286431
ENSG00000274272	NA	-1.51636071429661	3.07601596471086e-5	M1_vs_M0	HSALNG0060024	sense	Not conserved	NA	-	LRCH4	RNF26
ENSG00000274370	NA	-1.00794430914816	0.0299263875674077	M1_vs_M0	HSALNG0119502	integenic	Not conserved	hsa-miR-6784-5p	NA	METRNL	ENSG00000271780
ENSG00000274414	NA	-1.79222746202202	3.45126393849856e-5	M1_vs_M0	HSALNG0129378	integenic	Q50	NA	Response to diisocyanate,Cystatin c measurement,-	ABHD12	YAE1
ENSG00000274565	NA	-1.96631862830819	8.87476007512217e-6	M1_vs_M0	HSALNG0117970	anti_sense	Q75	NA	-	MARCHF10	LNX1
ENSG00000274776	NA	-2.39026156663761	0.0458997786277898	M1_vs_M0	HSALNG0121350	integenic	Not conserved	NA	NA	PIAS2	LINC00106
ENSG00000274818	NA	2.19241997147195	2.88244529375547e-6	M1_vs_M0	HSALNG0102246	integenic	Q75	NA	NA	MAP3K9	SVIL
ENSG00000274833	NA	4.82103645106187	0.0242094033714889	M1_vs_M0	HSALNG0119253	integenic	Q50	hsa-miR-1296-3p,hsa-miR-4508,hsa-miR-7106-5p	Dental caries; Bmi-adjusted hip circumference; Dentures	BAHCC1	KRTAP5-1
ENSG00000275202	NA	-1.47442107392725	6.28644644455776e-7	M1_vs_M0	HSALNG0097019	anti_sense	Q75	hsa-miR-4268,hsa-miR-4280,hsa-miR-3960,hsa-miR-4707-5p	-	CAB39L	ENSG00000227615
ENSG00000275278	NA	-2.89523106405018	4.0235596132807e-8	M1_vs_M0	HSALNG0090086	anti_sense	Q50	hsa-miR-3960,hsa-miR-6744-3p,hsa-miR-4433b-3p	Fructose measurement; Glucose measurement; Galactose measurement,-	ERGIC2	ENSG00000285793
ENSG00000275532	NA	3.22460929877807	0.0110972918450617	M1_vs_M0	HSALNG0116178	anti_sense	Q75	hsa-miR-4281,hsa-miR-4508,hsa-miR-5088-3p,hsa-miR-7151-5p,hsa-miR-8072	Cognitive decline measurement,Cortical surface area measurement,Leukocyte count	PCGF2	ENSG00000282988
ENSG00000275630	NA	2.66216922528291	9.51764626641155e-5	M1_vs_M0	HSALNG0102240	integenic	Not conserved	NA	NA	PCNX1	ECPAS
ENSG00000275763	ZNF516-DT	-1.81195658545779	8.3557689411577e-5	M1_vs_M0	HSALNG0145503	integenic	Q75	NA	-	ZNF236	TBC1D24
ENSG00000275765	NA	-1.67825846416292	0.00156604281866734	M1_vs_M0	HSALNG0045934	anti_sense,sense	Q50	hsa-miR-6783-3p,hsa-miR-6789-3p	Red blood cell distribution width,-	ATOX1	ENSG00000235978
ENSG00000275830	NA	-4.71279207975544	7.782383509982231e-15	M1_vs_M0	HSALNG0099354	integenic	Not conserved	hsa-miR-4472	Erosive tooth wear measurement,Cup-to-disc ratio measurement,Sleep duration,Igfbp-3 measurement,Diastolic blood pressure change measurement; Response to diuretic,-	COL4A1	CCL4
ENSG00000275880	NA	1.62517346442931	0.0413032030091239	M1_vs_M0	HSALNG0099381	integenic	Not conserved	hsa-miR-619-5p	NA	CARS2	JAZF1
ENSG00000276116	FUT8-AS1	-1.14331389972218	0.00301814913902352	M1_vs_M0	HSALNG0144243	anti_sense	Q75	NA	Serum igg glycosylation measurement,-	MAX	ZNF154
ENSG00000276170	NA	-5.00103443857476	8.788408365384919e-11	M1_vs_M0	HSALNG0116158	intronic_antisense	Q50	hsa-miR-939-3p,hsa-miR-4312,hsa-miR-6812-3p	Red blood cell distribution width	SRCIN1	SRSF2
ENSG00000276570	NA	-1.24878329306614	0.00148224337408758	M1_vs_M0	HSALNG0145984	sense	Q50	NA	Systemic lupus erythematosus; Mean reticulocyte volume,Phosphatidylethanolamine ether measurement,-	TMEM86B	RPS2P36
ENSG00000276649	NA	1.14903488871664	0.00314412265989422	M1_vs_M0	HSALNG0128155	anti_sense	Q75	hsa-miR-361-3p,hsa-miR-762,hsa-miR-4710,hsa-miR-5008-5p,hsa-miR-6845-3p	Uridine diphosphate galactose measurement; Uridine diphosphate glucose measurement,-	PDYN	CAMLG
ENSG00000276672	NA	-1.9662841593161	0.00458267825732383	M1_vs_M0	HSALNG0096294	sense	Not conserved	NA	NA	RFC3	GGA2
ENSG00000276814	NA	5.01041363891283	0.0105865554026745	M1_vs_M0	HSALNG0090822	integenic	Q90	hsa-miR-4269	NA	SENP1	PINK1
ENSG00000276855	NA	1.9908265108756	1.45340962252478e-6	M1_vs_M0	HSALNG0114817	integenic	Not conserved	hsa-miR-6803-5p	NA	TBC1D26	FOXP1
ENSG00000277142	LINC00235	-1.57606974686608	5.91767306783123e-4	M1_vs_M0	HSALNG0108743	anti_sense	Not conserved	hsa-miR-1182	NA	METTL26	EPS8L1
ENSG00000277228	NA	-2.78901968289742	2.2337956594912703e-9	M1_vs_M0	HSALNG0096883	integenic	Q50	hsa-miR-4492	-	LRCH1	THOC2
ENSG00000277232	GTSE1-DT	-2.47804172745662	0.00521460601064959	M1_vs_M0	HSALNG0136018	integenic	Q50	hsa-miR-939-3p	-	PKDREJ	STIMATE-MUSTN1
ENSG00000277283	NA	-1.34462312941146	0.00549499453654671	M1_vs_M0	HSALNG0094493	anti_sense	Not conserved	hsa-miR-1233-3p	NA	BICDL1	HMBS
ENSG00000277511	NA	3.29884611570091	2.8366862565162697e-19	M1_vs_M0	HSALNG0115754	integenic	Not conserved	hsa-miR-6089,hsa-miR-7847-3p	-	RHOT1	ENSG00000291263
ENSG00000277534	NA	-1.63051423571442	0.00782699017510063	M1_vs_M0	HSALNG0120572	sense	Not conserved	NA	NA	KCTD1	ENSG00000225280
ENSG00000277548	NA	2.21000484356811	9.66000684639717e-5	M1_vs_M0	HSALNG0106069	anti_sense,sense	Not conserved	NA	NA	CCPG1	ANGPT2
ENSG00000277559	NA	-2.44996598043031	9.43778106875615e-18	M1_vs_M0	HSALNG0111560	anti_sense	Q90	hsa-miR-4456	Tonsillectomy risk measurement,Self reported educational attainment; Intelligence,-	FTO	ENSG00000289589
ENSG00000277566	NA	-3.37516213795734	6.42847362818419e-5	M1_vs_M0	HSALNG0094145	sense	Not conserved	NA	NA	TPCN1	SLC4A1AP
ENSG00000277715	NA	2.82270929692	0.0452795557928278	M1_vs_M0	HSALNG0093735	intronic_antisense	Q50	hsa-miR-609,hsa-miR-939-3p,hsa-miR-3960,hsa-miR-6791-3p,hsa-miR-6880-3p,hsa-miR-8072	Body height,-	TCP11L2	STXBP4
ENSG00000277782	NA	-1.20036605319199	0.0078265189132528	M1_vs_M0	HSALNG0107630	anti_sense	Q90	hsa-miR-5787	-	MESD	ENSG00000228302
ENSG00000277851	LINC02391	-2.51296351867868	0.0243061873158836	M1_vs_M0	HSALNG0143695	integenic	Not conserved	NA	Smoking behaviour measurement	BTG1	POMT2
ENSG00000277954	NA	-2.6733508304921	4.49188853307627e-9	M1_vs_M0	HSALNG0112888	anti_sense	Q75	NA	Bmi-adjusted waist circumference,Body height,-	MAF	TRPM1
ENSG00000277969	NA	2.31792404839618	1.2366102048107498e-45	M1_vs_M0	HSALNG0116179	integenic	Q75	hsa-miR-1247-5p,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6721-5p	NA	MLLT6	ATP6V1F
ENSG00000277978	NA	-1.50295592093642	2.1867021759711e-4	M1_vs_M0	HSALNG0112104	anti_sense	Q50	hsa-miR-4433a-3p,hsa-miR-4492,hsa-miR-4433b-3p	-	TK2	ENSG00000215835
ENSG00000278017	NA	1.69507370861471	0.0269520634570834	M1_vs_M0	HSALNG0121991	anti_sense	Q90	NA	NA	PIGN	GATA6
ENSG00000278058	NA	-2.1423894308918	3.35864310687896e-6	M1_vs_M0	HSALNG0112904	anti_sense	Q50	hsa-miR-7109-5p	Eosinophil count,Eosinophil count; Eosinophil percentage of leukocytes,Uric acid measurement,Uric acid measurement; Renal system measurement,-	WWOX	DPP9
ENSG00000278214	LINC02139	-3.00608593921944	0.00153230782281455	M1_vs_M0	HSALNG0113191	integenic	Not conserved	NA	-	GSE1	ZNF891
ENSG00000278607	NA	-3.76532415536632	4.05855299942903e-4	M1_vs_M0	HSALNG0122474	anti_sense	Not conserved	NA	Total blood protein measurement; Insomnia,-	PTGR3	TLCD3B
ENSG00000278709	NKILA	6.30849652988677	1.31987938098424e-5	M1_vs_M0	HSALNG0131196	anti_sense	Q50	hsa-miR-6763-3p	-	PCK1	ART3
ENSG00000278910	BANCR	6.45272834989011	5.20526676994996e-6	M1_vs_M0	HSALNG0071734	integenic	Not conserved	NA	-	APBA1	ENSG00000288954
ENSG00000278970	HEIH	1.61849103085628	4.41886796792205e-27	M1_vs_M0	HSALNG0047200	integenic	Not conserved	hsa-miR-4707-5p,hsa-miR-6726-5p,hsa-miR-6731-5p,hsa-miR-6736-5p	Asthma exacerbation measurement	MGAT1	AATK
ENSG00000279833	NA	-1.89433323617083	2.75593985900535e-4	M1_vs_M0	NA	NA	NA	NA	NA	APOBEC3H	DIP2A
ENSG00000279968	CCDC28A-AS1	-1.21454620028523	0.0421377881246622	M1_vs_M0	HSALNG0053839	sense	Q75	NA	NA	NHSL1	INSIG2
ENSG00000280007	NA	-2.29170842864097	2.57176809568369e-21	M1_vs_M0	HSALNG0133953	anti_sense	Not conserved	hsa-miR-619-5p	Atrial fibrillation,T-tau measurement,Carotid plaque build,-,Mean platelet volume	MICAL3	PALLD
ENSG00000280213	UCKL1-AS1	1.04471526565003	0.00599831957536571	M1_vs_M0	HSALNG0146891	anti_sense	Q75	NA	Urate measurement,-	DNAJC5	SPATA46
ENSG00000280383	NA	-1.2213578770545	0.0137591316809789	M1_vs_M0	HSALNG0135964	integenic	Q50	hsa-miR-1237-5p,hsa-miR-6089	Tonsillectomy risk measurement,Fev/fec ratio,-	ATXN10	ENSG00000289138
ENSG00000280560	LINC01374	-3.10021833039685	0.0171347689044577	M1_vs_M0	HSALNG0079606	integenic	Q50	hsa-miR-6803-5p	Carotid plaque build,Functional brain measurement,Myopia,Bone mineral content measurement,Coronary artery calcification,Systolic blood pressure change measurement,Cryptococcosis,Economic and social preference,Growth rate measurement,Hearing threshold measurement; Hearing measurement,Forced expiratory volume; Response to bronchodilator,Hiv-1 infection; Peripheral neuropathy; Response to reverse transcriptase inhibitor,Peripheral arterial disease; Traffic air pollution measurement,-	KIF20B	RABL2A
ENSG00000280693	SH3PXD2A-AS1	-5.08303793318938	0.0219956361852354	M1_vs_M0	HSALNG0080389	anti_sense	Not conserved	hsa-miR-4291	NA	NEURL1	ENSG00000283183
ENSG00000280721	LINC01943	-4.71275418073162	8.05943017892646e-15	M1_vs_M0	HSALNG0016641	integenic	Not conserved	hsa-miR-6803-5p	-	RGPD2	EIF4G2
ENSG00000280832	GSEC	-2.25907708159156	1.9899322573597998e-12	M1_vs_M0	HSALNG0088026	anti_sense	Q50	NA	Neutrophil count,Low density lipoprotein cholesterol measurement,-	KIRREL3	ENSG00000289586
ENSG00000281005	LINC00921	-2.65499656131505	3.4380476590513496e-20	M1_vs_M0	HSALNG0109143	sense	Not conserved	hsa-miR-3925-3p	NA	NA	ENSG00000285973
ENSG00000281103	TRG-AS1	-3.03602872962693	9.13942747394468e-56	M1_vs_M0	HSALNG0057335	integenic	Not conserved	NA	NA	STARD3NL	ALDH3B1
ENSG00000281162	LINC01127	3.36640646012948	6.56064941103005e-15	M1_vs_M0	HSALNG0017393	integenic	Q50	hsa-miR-939-3p,hsa-miR-6728-3p,hsa-miR-6737-3p	Eosinophil count,Protein measurement,St2 protein measurement,Neutrophil count,-	IL1R2	NTN1
ENSG00000281189	GHET1	-1.49899671600651	0.00874561691888401	M1_vs_M0	HSALNG0062110	integenic	Not conserved	NA	NA	ZNF398	CCDC90B
ENSG00000281357	ARRDC3-AS1	1.27165588198115	0.00926045970956062	M1_vs_M0	HSALNG0043456	integenic	Not conserved	NA	NA	ADGRV1	ENSG00000255306
ENSG00000281398	SNHG4	-1.66490915454511	6.50828195345772e-36	M1_vs_M0	HSALNG0045213	anti_sense,sense	Q50	hsa-miR-3170,hsa-miR-6089,hsa-miR-6736-5p	-	MATR3	ZNF134
ENSG00000281404	LINC01176	2.05102320022281	3.4872296297617e-20	M1_vs_M0	HSALNG0149630	sense	Not conserved	NA	NA	NA	NMI
ENSG00000281468	NA	-1.68931995812524	0.016952554049653	M1_vs_M0	HSALNG0125122	integenic	Not conserved	hsa-miR-762,hsa-miR-3155b,hsa-miR-5047,hsa-miR-6797-5p,hsa-miR-6858-3p	-	VSTM2B	ENSG00000253983
ENSG00000281501	SEPSECS-AS1	-1.70747716787233	1.8636059021837703e-9	M1_vs_M0	HSALNG0033386	anti_sense,sense	Q75	hsa-miR-6089,hsa-miR-6816-5p	Idiopathic osteonecrosis of the femoral head,Cannabis dependence measurement,-	PI4K2B	WIPF3
ENSG00000281756	C2-AS1	4.53845969773923	2.57941576491986e-18	M1_vs_M0	HSALNG0049350	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4492	Age-related macular degeneration,Von willebrand factor measurement,Bmi-adjusted waist circumference; Autism spectrum disorder,Blood protein measurement,Atrophic macular degeneration; Age-related macular degeneration; Wet macular degeneration,-	NELFE	C1R
ENSG00000281769	LINC01230	-2.32278274591058	0.00314412265989422	M1_vs_M0	HSALNG0069570	integenic	Q50	NA	-	DMRT2	CTNNA2
ENSG00000281920	NA	5.31790388393743	0.00543106523963653	M1_vs_M0	HSALNG0015543	integenic	Q90	hsa-miR-128-2-5p,hsa-miR-194-3p,hsa-miR-619-5p,hsa-miR-3190-5p,hsa-miR-4258,hsa-miR-4447,hsa-miR-4685-3p,hsa-miR-4763-3p,hsa-miR-6130,hsa-miR-6132,hsa-miR-6730-5p,hsa-miR-6752-3p,hsa-miR-6858-5p	Systemic lupus erythematosus,Neutrophil percentage of leukocytes,Crohn's disease; Inflammatory bowel disease,Lymphocyte percentage of leukocytes; Myeloid white cell count; Granulocyte count,Monocyte percentage of leukocytes; Monocyte count,Bell's palsy,Body height; Bipolar disorder,Bipolar disorder,Body height,Pulse pressure measurement,Systolic blood pressure,Waist-hip ratio,Protein measurement,Iron biomarker measurement,Nicotine dependence symptom count,Cognitive decline measurement,Neuroimaging measurement,Fev/fec ratio,Brain volume measurement,Isthmus cingulate cortex volume measurement,Bmi-adjusted waist circumference,Bmi-adjusted hip circumference,Cortical surface area measurement,Cortical surface area measurement; Cortical thickness,Facial morphology measurement; Gut microbiome measurement,Serum gamma-glutamyl transferase measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Serum gamma-glutamyl transferase measurement; Vital capacity,White matter microstructure measurement,Bmi-adjusted waist-hip ratio,Waist-hip ratio; Smoking behavior; Bmi-adjusted waist-hip ratio,Calcium measurement,Sex hormone-binding globulin measurement,Susceptibility to chickenpox measurement,Sex interaction measurement; Age at assessment; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Waist-hip ratio,Myocardial infarction,Heel bone mineral density,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Electroencephalogram measurement; Theta wave measurement,Squamous cell lung carcinoma; Family history of lung cancer,Covid-19; Mortality,Forced expiratory volume; Response to bronchodilator,Post-operative delirium; Response to surgery,Neuroimaging measurement; Brain measurement,Cortical surface area measurement; Neuroimaging measurement; Brain measurement,Cortical surface area measurement; Neuroimaging measurement,Bipolar disorder; Body mass index,Response to ketamine; Dissociation measurement,-	ACTR2	LOXL3
ENSG00000282572	FAM157D	-3.47064808812213	0.00268989122061762	M1_vs_M0	HSALNG0055481	integenic	Not conserved	hsa-miR-30b-3p,hsa-miR-6089	-	PDGFA	SHISA5
ENSG00000282851	BISPR	2.08719307738228	4.36546053524385e-69	M1_vs_M0	HSALNG0124521	sense	Not conserved	hsa-miR-6775-3p	Blood phosphate measurement,-	MVB12A	R3HCC1L
ENSG00000282885	NA	-1.62325735665713	0.0273773467513874	M1_vs_M0	HSALNG0101122	integenic	Q90	hsa-miR-328-5p,hsa-miR-619-5p,hsa-miR-4430,hsa-miR-4747-5p,hsa-miR-5585-3p	-	NEMF	STK31
ENSG00000283064	NA	5.17196160169469	0.00426474822174744	M1_vs_M0	HSALNG0048737	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-6089	Bmi-adjusted waist circumference; Body height; Bmi-adjusted waist-hip ratio,C-reactive protein measurement,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Smoking status measurement; Mathematical ability,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference,Brain volume measurement,-	H4C4	DDX43
ENSG00000283183	NA	-4.68128656499839	0.0450628469995673	M1_vs_M0	HSALNG0032158	integenic	Q90	hsa-miR-619-5p,hsa-miR-4430	NA	PDE6B	ITPKB-IT1
ENSG00000283384	NA	5.01339772626976	4.4364919236113e-11	M1_vs_M0	HSALNG0099263	integenic	Not conserved	hsa-miR-331-3p,hsa-miR-505-5p,hsa-miR-619-5p,hsa-miR-1207-3p,hsa-miR-4483,hsa-miR-4650-5p,hsa-miR-6763-5p	Granulocyte percentage of myeloid white cells; Leukocyte count; Blood protein measurement; Serum non-albumin protein measurement; Monocyte percentage of leukocytes,Serum non-albumin protein measurement,Monocyte count,Leukocyte count; Neutrophil count; Monocyte count,Venous thromboembolism,Blood protein measurement; Serum non-albumin protein measurement,Tonsillectomy risk measurement,Alcohol dependence measurement,Fev/fec ratio; Response to bronchodilator,-	TNFSF13B	SLC11A1
ENSG00000283504	NA	7.80362132127273	1.65094824622698e-16	M1_vs_M0	HSALNG0062073	anti_sense	Q50	hsa-miR-6791-3p	Protein measurement,Parkinson's disease symptom measurement,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Gut microbiome measurement,Crohn's disease,Asparagine measurement,Uterine fibroid measurement,Chronic kidney disease; Diabetic nephropathy,Cardiovascular event measurement; Response to angiotensin-converting enzyme inhibitor; Response to angiotensin receptor blocker,-	EZH2	USP18
ENSG00000283646	LINC02009	5.04713159466761	2.3555662068709e-11	M1_vs_M0	HSALNG0025684	integenic	Not conserved	hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-6786-5p,hsa-miR-6828-3p	Macula measurement; Lymphocyte percentage of leukocytes; Inflammatory bowel disease; Ulcerative colitis; Protein measurement; Neutrophil-to-lymphocyte ratio; Platelet-to-lymphocyte ratio; Macrophage inflammatory protein 1b measurement,Oral ulcer,Ccl2 measurement,Monocyte count,Monocyte percentage of leukocytes,Eotaxin measurement,Bmi-adjusted hip circumference	LTF	PSEN1
ENSG00000283648	NA	6.35702599540561	1.1761983598602899e-60	M1_vs_M0	HSALNG0062073	anti_sense	Q50	hsa-miR-6791-3p	Protein measurement,Parkinson's disease symptom measurement,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Gut microbiome measurement,Crohn's disease,Asparagine measurement,Uterine fibroid measurement,Chronic kidney disease; Diabetic nephropathy,Cardiovascular event measurement; Response to angiotensin-converting enzyme inhibitor; Response to angiotensin receptor blocker,-	EZH2	CCL7
ENSG00000283689	NA	-2.17250162514275	2.1229406142504602e-06	M1_vs_M0	HSALNG0111560	anti_sense	Q90	hsa-miR-4456	Tonsillectomy risk measurement,Self reported educational attainment; Intelligence,-	FTO	SETD4
ENSG00000284196	NA	-4.46117335077616	3.09309408871935e-12	M1_vs_M0	HSALNG0098167	integenic	Q75	hsa-miR-552-5p,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587	Sleep duration,Cortical surface area measurement,Atopic eczema,Thrombocytopenia,Interleukin-6 measurement,Body height,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Body mass index; Fasting blood insulin measurement,Cleft lip; Cleft palate,-	SPRY2	LNPK
ENSG00000284391	NA	-5.34625421525114	1.5777121699221199e-22	M1_vs_M0	HSALNG0138430	anti_sense	Q90	NA	NA	TEX11	LAMA4
ENSG00000284602	NA	1.43689506461797	0.00156665972800982	M1_vs_M0	HSALNG0001782	integenic	Q50	hsa-miR-3620-5p,hsa-miR-1587	Mean corpuscular hemoglobin concentration; Mean corpuscular volume; Platelet count; Platelet crit,-	RHD	DUSP5-DT
ENSG00000284669	NA	1.86801482504005	7.495992179974911e-9	M1_vs_M0	HSALNG0025266	anti_sense	Q90	hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-1587,hsa-miR-6850-3p	Sex hormone-binding globulin measurement,Memory performance; Paragraph delayed recall measurement,-	TTC21A	NTSR1
ENSG00000284677	NA	2.31736746838863	0.0024916543587623	M1_vs_M0	HSALNG0002871	integenic	Not conserved	NA	-	COL9A2	CHD3
ENSG00000284678	LINC02811	-2.01872505199715	0.00902137609000989	M1_vs_M0	HSALNG0002808	integenic	Not conserved	hsa-miR-619-5p	Hemorrhoid	BMP8B	ENSG00000212556
ENSG00000284693	LINC02606	-1.48461287124005	0.0011470108238194	M1_vs_M0	HSALNG0000694	integenic	Q75	hsa-miR-1237-5p,hsa-miR-4281,hsa-miR-4722-3p,hsa-miR-6089	Body height,Fev/fec ratio,Phosphatidylcholine 34:3 measurement,-	CLSTN1	PLBD1
ENSG00000284700	NA	-2.02745371351196	0.002715996649317	M1_vs_M0	HSALNG0003531	integenic	Q75	hsa-miR-6085	Triglyceride measurement,Testosterone measurement,-	ELAVL4	DHRSX
ENSG00000284719	NA	-1.46538849325424	5.90616909527286e-24	M1_vs_M0	HSALNG0002807	integenic	Q75	hsa-miR-619-5p,hsa-miR-659-5p,hsa-miR-6089,hsa-miR-1273h-5p	Hemorrhoid,-	PPIE	LINC02256
ENSG00000284734	NA	3.8165993575962	1.64352475235192e-7	M1_vs_M0	HSALNG0005052	anti_sense	Not conserved	NA	NA	GBP6	ENSG00000288765
ENSG00000284738	NA	-2.9020481581786	8.29130420611919e-6	M1_vs_M0	HSALNG0007353	anti_sense	Q75	NA	NA	CREB3L4	MTBP
ENSG00000285163	NA	-3.76659233349792	8.59256439298437e-4	M1_vs_M0	HSALNG0113249	integenic	Q50	hsa-miR-92a-2-5p,hsa-miR-525-5p,hsa-miR-4466,hsa-miR-6855-5p	Qrs duration,Monocyte count,Primary biliary cirrhosis,Systemic lupus erythematosus,Monocyte percentage of leukocytes; Monocyte count,Chronic lymphocytic leukemia,Systemic scleroderma,Systemic lupus erythematosus; Systemic scleroderma; Monocyte count,Granulocyte percentage of myeloid white cells; Monocyte count,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,Monocyte percentage of leukocytes,Neutrophil percentage of leukocytes; Neutrophil count,Neutrophil percentage of leukocytes,Bladder exstrophy; Monocyte percentage of leukocytes,Anti-centromere-antibody-positive systemic scleroderma; Limited scleroderma; Systemic scleroderma,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count,Ulcerative colitis; Monocyte count,Ulcerative colitis; Inflammatory bowel disease,Eosinophil count; Inflammatory bowel disease; Monocyte percentage of leukocytes,Crohn's disease,Systemic lupus erythematosus; Inflammatory bowel disease,Leukocyte count; Rheumatoid arthritis; Monocyte percentage of leukocytes,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Systemic lupus erythematosus; Crohn's disease; Sclerosing cholangitis,Neutrophil count; Granulocyte percentage of myeloid white cells; Myeloid white cell count; Leukocyte count; Monocyte count; Monocyte percentage of leukocytes,Lymphocyte count,Eosinophil count,Eosinophil percentage of leukocytes,Neutrophil percentage of granulocytes; Neutrophil percentage of leukocytes; Eosinophil percentage of granulocytes,Systemic lupus erythematosus; Biliary liver cirrhosis; Primary biliary cirrhosis,Rheumatoid arthritis,Rheumatoid arthritis; Monocyte count,Oral ulcer,Autoimmune disease; Systemic lupus erythematosus; Primary biliary cirrhosis,Behcet's syndrome,Hypothyroidism,Adolescent idiopathic scoliosis,Aspartate aminotransferase measurement,Unipolar depression,Fev/fec ratio,Rheumatoid arthritis; Systemic lupus erythematosus; Myositis; Systemic scleroderma,Hodgkins lymphoma; Chronic lymphocytic leukemia; Multiple myeloma,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-,Leukocyte count; Lymphocyte count	IRF8	RPS29
ENSG00000285280	NA	-1.68544758489609	0.00909584005529168	M1_vs_M0	HSALNG0142391	integenic	Not conserved	NA	NA	UCHL5	CRIP1
ENSG00000285331	NA	-2.3257936216517	1.88722781280483e-52	M1_vs_M0	HSALNG0106164	sense	Not conserved	NA	NA	NA	NEAT1
ENSG00000285492	NA	3.74386117078686	1.68718553691036e-26	M1_vs_M0	HSALNG0054723	sense	Q90	hsa-miR-7160-3p	Myeloid white cell count; Celiac disease,Lipoprotein a measurement,Nicotine dependence symptom count,Autoimmune disease; Systemic lupus erythematosus; Celiac disease,Hypothyroidism,Leukocyte count,Leukocyte count; Neutrophil count,Neutrophil count; Leukocyte count; Neutrophil percentage of leukocytes; Eosinophil count; Granulocyte count,Eczema,Crohn's disease; Inflammatory bowel disease; Celiac disease,Rheumatoid arthritis; Crohn's disease,Gut microbiome measurement,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Rheumatoid arthritis; Sclerosing cholangitis,Celiac disease,Rheumatoid arthritis,Myeloid white cell count; Neutrophil count; Basophil count,Psoriasis vulgaris,Rheumatoid arthritis; Celiac disease,Eosinophil percentage of leukocytes,-	TAGAP	ZNF777
ENSG00000285517	NA	-1.39613733709393	3.20043045918178e-8	M1_vs_M0	HSALNG0090154	integenic	Not conserved	hsa-miR-6780a-5p	NA	TSPAN11	SMURF1
ENSG00000285533	RELA-DT	-1.93239723487052	5.7534118829554e-9	M1_vs_M0	HSALNG0084930	anti_sense	Q50	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-762,hsa-miR-665,hsa-miR-4508,hsa-miR-6086	Urate measurement,Heel bone mineral density,Platelet count,-	SIPA1	LNMICC
ENSG00000285675	NA	-5.76126099370219	0.0034538027058366	M1_vs_M0	HSALNG0063365	anti_sense	Not conserved	NA	Venous thromboembolism	PRSS51	DOC2GP
ENSG00000285684	NA	-7.25593809326885	3.3792935442411696e-12	M1_vs_M0	HSALNG0098173	integenic	Q75	hsa-miR-671-5p,hsa-miR-6089	Cleft lip,Cleft lip; Oral cleft; Cleft palate,Cleft lip; Cleft palate; Progranulin measurement,Drugs used in diabetes use measurement,Diastolic blood pressure,Fev/fec ratio,Glucose measurement; Hemoglobin a1 measurement,Systolic blood pressure; Mean arterial pressure,Cleft lip; Cleft palate,-	SPRY2	ENSG00000273669
ENSG00000285693	NA	1.82165911010058	5.15663915701924e-5	M1_vs_M0	HSALNG0085586	sense	Q50	hsa-miR-4279,hsa-miR-4492,hsa-miR-5589-5p	Protein measurement,Platelet count,Aspartate aminotransferase measurement,Serum alanine aminotransferase measurement	STARD10	EFCAB2
ENSG00000285722	NA	-3.98619808534935	2.1151164659412402e-21	M1_vs_M0	HSALNG0136188	integenic	Q50	hsa-miR-4667-5p	-	ZBED4	SLF1
ENSG00000285725	NA	2.95726923804077	0.00244204609316959	M1_vs_M0	HSALNG0059775	integenic	Q90	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6089,hsa-miR-7113-3p	-	OCM2	PPP1R8
ENSG00000285744	NA	8.48256811187259	3.4554121425204094e-206	M1_vs_M0	HSALNG0066417	integenic	Not conserved	NA	NA	ZC2HC1A	HLA-DOA
ENSG00000285756	NA	-2.16574749574777	4.2363627202696997e-13	M1_vs_M0	HSALNG0136447	integenic	Not conserved	NA	NA	PRKX	MRPL46
ENSG00000285793	ANAPC1P2	1.30623980111042	0.00656066129405538	M1_vs_M0	HSALNG0016618	integenic	Not conserved	NA	NA	PLGLB1	ENSG00000275278
ENSG00000285813	NA	1.75428753471824	0.0040829033657668	M1_vs_M0	HSALNG0086900	anti_sense	Not conserved	NA	NA	GRIA4	ENSG00000237418
ENSG00000285823	LINC02793	4.99887578695927	0.013237106436829	M1_vs_M0	HSALNG0001761	integenic	Not conserved	hsa-miR-762,hsa-miR-4534,hsa-miR-4676-5p,hsa-miR-8485	Alopecia,-	CLIC4	ENSG00000228863
ENSG00000285888	NA	3.62006793262654	7.37716916374193e-46	M1_vs_M0	HSALNG0149144	anti_sense	Not conserved	hsa-miR-4492	Basophil percentage of leukocytes	RAB44	TMEM170A
ENSG00000285895	NA	6.30098652442302	9.18506334751593e-6	M1_vs_M0	HSALNG0143182	integenic	Not conserved	hsa-miR-363-5p,hsa-miR-1268b,hsa-miR-6089	NA	OR5B21	SNRNP27
ENSG00000285905	BMP8B-AS1	-2.89517971609872	3.98938412619473e-8	M1_vs_M0	HSALNG0002806	anti_sense	Q75	hsa-miR-4753-5p	-	PPIE	CAP1P1
ENSG00000285918	NA	-3.23453484554402	0.00917810972335189	M1_vs_M0	HSALNG0112888	anti_sense	Q75	NA	Bmi-adjusted waist circumference,Body height,-	MAF	ICOSLG
ENSG00000285936	NA	-6.05882530633829	2.4636661868842e-5	M1_vs_M0	HSALNG0144120	anti_sense	Q75	NA	NA	RGS6	SEPTIN10
ENSG00000285973	NA	-3.75038447062733	5.15011868359397e-15	M1_vs_M0	HSALNG0081190	anti_sense	Q50	hsa-miR-4277	Pathological myopia	NSMCE4A	CIP2A
ENSG00000286004	NA	1.7385498613907	2.97943891171498e-5	M1_vs_M0	HSALNG0031856	anti_sense	Not conserved	NA	Creatinine measurement; Glomerular filtration rate,-	MUC20	DENND2C
ENSG00000286017	NA	-3.28841604946888	1.68643115791135e-6	M1_vs_M0	HSALNG0031982	integenic	Not conserved	NA	NA	NCBP2AS2	SMIM8
ENSG00000286062	NA	2.79664378514227	8.98840536250594e-10	M1_vs_M0	HSALNG0042332	integenic	Q75	hsa-miR-508-5p	Sepsis; Mortality,Systolic blood pressure,-	SGTB	ENSG00000287263
ENSG00000286067	NA	-1.30281880663144	7.80036214297669e-4	M1_vs_M0	HSALNG0094501	anti_sense	Not conserved	hsa-miR-1227-5p,hsa-miR-6791-5p	NA	SIRT4	ENSG00000274776
ENSG00000286153	NA	2.96315491381117	5.19305239709454e-22	M1_vs_M0	HSALNG0132875	anti_sense	Not conserved	NA	Erythrocyte count; Response to vaccine; Mean corpuscular hemoglobin; Cognitive decline measurement; Monocyte percentage of leukocytes,Balding measurement,Alopecia,Eosinophil count,Monocyte count,-	CLIC6	METTL17
ENSG00000286162	NA	2.22545204124067	1.1695632061494399e-30	M1_vs_M0	HSALNG0069800	integenic	Q50	NA	NA	PLGRKT	PPP5C
ENSG00000286179	NA	2.5095650910116	5.97386275882876e-18	M1_vs_M0	HSALNG0146969	integenic	Not conserved	NA	NA	SULF2	CMKLR1
ENSG00000286216	NA	2.25055544810861	0.0190080767579658	M1_vs_M0	HSALNG0012258	integenic	Not conserved	hsa-miR-619-5p	-	ZNF496	HLA-W
ENSG00000286248	NA	5.84057859633586	1.1093494419653699e-35	M1_vs_M0	HSALNG0094569	anti_sense	Not conserved	hsa-miR-1268b	Interleukin-8 measurement; C-reactive protein measurement; Chronic obstructive pulmonary disease,C-reactive protein measurement,C-reactive protein measurement; Serum gamma-glutamyl transferase measurement,-	CAMKK2	PLSCR1
ENSG00000286326	NA	-3.10022305217658	0.0171141387239686	M1_vs_M0	HSALNG0134651	anti_sense	Q90	hsa-miR-23a-5p,hsa-miR-7113-3p,hsa-miR-8072	Triacylglycerol 52:2 measurement; Diacylglycerol 36:2 measurement,Linguistic error measurement; Specific language impairment,-	CRYBA4	TOM1L2
ENSG00000286333	NA	-4.19351256877477	6.24275044087211e-10	M1_vs_M0	HSALNG0102303	anti_sense	Q50	hsa-miR-4254	C-reactive protein measurement; Alkaline phosphatase measurement,C-reactive protein measurement; Sex hormone-binding globulin measurement; Alkaline phosphatase measurement; Testosterone measurement; Aspartate aminotransferase measurement,C-reactive protein measurement,Lysine measurement,-	DPF3	GOLGA8A
ENSG00000286369	NA	2.11955987316888	2.78625278019871e-5	M1_vs_M0	HSALNG0085227	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4281,hsa-miR-3665,hsa-miR-4443,hsa-miR-4453,hsa-miR-5047,hsa-miR-6089,hsa-miR-6510-5p	Body height	LRP5	TMEM50B
ENSG00000286393	NA	-4.42777257756424	0.0482923651945435	M1_vs_M0	HSALNG0136208	integenic	Q75	hsa-miR-140-3p,hsa-miR-1273h-5p	Low density lipoprotein cholesterol measurement,Monocyte percentage of leukocytes,Protein measurement,Nt-probnp measurement,-	BRD1	LINC02812
ENSG00000286431	NA	-1.9186933260077	8.01117869723331e-6	M1_vs_M0	HSALNG0136439	integenic	Not conserved	hsa-miR-619-5p	NA	ARSF	ENSG00000274270
ENSG00000286443	NA	-4.42748545774637	0.044744740708135	M1_vs_M0	HSALNG0116215	anti_sense	Q50	hsa-miR-4505,hsa-miR-4695-5p	-	RPL19	CABLES1
ENSG00000286471	NA	1.33213170571398	9.8272402823207e-4	M1_vs_M0	HSALNG0065372	integenic	Q50	hsa-miR-619-5p,hsa-miR-1229-5p,hsa-miR-6801-3p	-	SOX17	PGBD1
ENSG00000286501	NA	5.45623616436378	0.00120246809692638	M1_vs_M0	HSALNG0029771	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-3177-3p,hsa-miR-4269,hsa-miR-4472,hsa-miR-3972,hsa-miR-5587-3p	Total cholesterol measurement,T wave morphology measurement,Electrocardiography,Aging,Mosaic loss of chromosome y measurement,Sex hormone-binding globulin measurement,Myeloid white cell count,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Adiponectin measurement,Bmi-adjusted waist-hip ratio,Bmi-adjusted hip circumference,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Insulin measurement; Low density lipoprotein triglyceride measurement; Heel bone mineral density; Bmi-adjusted waist circumference; Apolipoprotein a 1 measurement; Body fat percentage; Waist-hip ratio; Bmi-adjusted hip circumference; Reticulocyte count; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Triglyceride measurement; Mean corpuscular volume; Erythrocyte count; Aspartate aminotransferase measurement,Open-angle glaucoma,Cognitive function measurement,Glaucoma; Open-angle glaucoma; Intraocular pressure measurement,Glaucoma,Hmg coa reductase inhibitor use measurement,Serum igg glycosylation measurement,Pulse pressure measurement; Sex hormone-binding globulin measurement; Cardiovascular disease; Waist-hip ratio; Hmg coa reductase inhibitor use measurement; Systolic blood pressure; Agents acting on the renin-angiotensin system use measurement; High density lipoprotein cholesterol measurement; Appendicular lean mass; Bmi-adjusted waist-hip ratio; Triglyceride measurement; Reticulocyte measurement,Self reported educational attainment,-	SERP1	ENSG00000286501
ENSG00000286540	NA	4.82077529131351	0.026620772296666	M1_vs_M0	HSALNG0053142	integenic	Not conserved	hsa-miR-619-5p	Temporal horn of lateral ventricle volume measurement,Chronic obstructive pulmonary disease; Resting heart rate	GJA1	ENSG00000286540
ENSG00000286548	NA	6.87349935059957	1.5033336340616898e-132	M1_vs_M0	HSALNG0005059	anti_sense	Q50	NA	Prostate carcinoma,Blood protein measurement,Total blood protein measurement,Mathematical ability,Adolescent idiopathic scoliosis,Bilirubin measurement,-	GBP5	APOBEC3A
ENSG00000286585	NA	-2.95246986044548	0.0302393703562216	M1_vs_M0	HSALNG0030033	anti_sense	Not conserved	hsa-miR-6089	-	GMPS	CYSRT1
ENSG00000286646	MAP3K5-AS2	-3.54992501488743	0	M1_vs_M0	HSALNG0053719	anti_sense	Q50	hsa-miR-619-5p	NA	PEX7	ADRA2B
ENSG00000286654	NA	-7.13477626806629	3.00246866253426e-11	M1_vs_M0	HSALNG0146167	anti_sense	Not conserved	hsa-miR-6765-3p	Cortical thickness	CNNM3	CLHC1
ENSG00000286796	NA	-6.05848677929339	3.2469076554949e-5	M1_vs_M0	HSALNG0014524	integenic	Q50	hsa-miR-4323,hsa-miR-4472,hsa-miR-6756-3p,hsa-miR-6783-3p,hsa-miR-6836-3p	Gastric carcinoma,Resistin measurement; Monocyte count,Monocyte count,Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes,Neutrophil count	MTA3	MAP1LC3C
ENSG00000286838	NA	5.45566723345455	0.00243103485542709	M1_vs_M0	HSALNG0002885	integenic	Not conserved	NA	-	RIMS3	C3orf14
ENSG00000286872	NA	2.85309327850202	1.03357154976399e-5	M1_vs_M0	HSALNG0107736	integenic	Not conserved	hsa-miR-4447,hsa-miR-4505	NA	HDGFL3	POLM
ENSG00000286940	MICB-DT	1.70001504975719	2.78579465494145e-4	M1_vs_M0	HSALNG0049272	anti_sense	Not conserved	hsa-miR-4701-3p,hsa-miR-6089	Renal system measurement,Myositis,Polymyositis; Physical activity measurement; Bmi-adjusted waist-hip ratio; Myositis,Eosinophil count; Platelet count,Squamous cell lung carcinoma; Mmr-related febrile seizures; Bmi-adjusted waist circumference; Lung carcinoma; Eosinophil count,Appendicular lean mass,Glucose measurement,Visual perception measurement,Carpal tunnel syndrome,Herpes zoster,Thyrotoxic periodic paralysis,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Eosinophil percentage of leukocytes,Bmi-adjusted hip circumference,Eosinophil count,Susceptibility to childhood ear infection measurement,Body height,Neonatal systemic lupus erythematosus; Myositis; Metabolic syndrome,Hodgkins lymphoma,Lymphocyte count; Basophil count; Myositis; Leukocyte count; Monocyte count,Ulcerative colitis,Atopic asthma,Serum alanine aminotransferase measurement,Bmi-adjusted waist-hip ratio; Mhc class i polypeptide-related sequence b measurement,Angina pectoris,Clinical treatment,Beta blocking agent use measurement,Blood protein measurement; Susceptibility to mumps measurement,Anti-tetanus toxoid igg measurement; Response to vaccine; Malaria,Arterial stiffness measurement,Bmi-adjusted waist circumference; Autism spectrum disorder; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Susceptibility to plantar warts measurement,Mhc class i polypeptide-related sequence a measurement,Mhc class i polypeptide-related sequence b measurement,Susceptibility to chickenpox measurement,Susceptibility to shingles measurement,Autism spectrum disorder,Alcohol use disorder measurement,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Cytokine measurement,Testosterone measurement,Monocyte count,Platelet crit,Lobe attachment; Lymphocyte count,Bmi-adjusted waist circumference,Response to thioamide; Drug-induced agranulocytosis,Prion disease; Psychotic symptoms,Response to bezlotoxumab; Clostridium difficile infection,Colorectal cancer; Colorectal adenoma,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Human papilloma virus infection; Oropharynx cancer,Blood protein measurement,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference	ATP6V1G2-DDX39B	PIK3R5-DT
ENSG00000286975	NA	2.58849751460469	0.0214778658039717	M1_vs_M0	HSALNG0119632	integenic	Q50	NA	3-hydroxypropylmercapturic acid measurement,-	METTL4	DCAF8
ENSG00000286981	NA	4.60714963791171	0.0299884122770737	M1_vs_M0	NA	NA	NA	NA	NA	PCGF5	DDX43
ENSG00000286989	NA	-1.97404437205911	2.81345112504446e-6	M1_vs_M0	HSALNG0000179	overlap_antisense	Q50	hsa-miR-338-3p,hsa-miR-4292,hsa-miR-4472,hsa-miR-1343-3p,hsa-miR-5572,hsa-miR-5587-3p,hsa-miR-6511b-3p,hsa-miR-6754-5p,hsa-miR-6803-5p,hsa-miR-6804-3p,hsa-miR-6890-3p	Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,-	MIB2	PNMA1
ENSG00000287016	NA	-4.89379235211648	0.0101297130023177	M1_vs_M0	HSALNG0078110	integenic	Not conserved	hsa-miR-619-5p	NA	CISD1	GPR3
ENSG00000287063	NA	-3.18971667300924	6.11697355590465e-6	M1_vs_M0	HSALNG0070806	integenic	Not conserved	hsa-miR-505-5p,hsa-miR-3960,hsa-miR-6765-5p	-	PRSS3	TMPOP2
ENSG00000287083	NA	-1.78804141122927	0.0409132629169186	M1_vs_M0	HSALNG0038801	integenic	Q50	hsa-miR-4467,hsa-miR-3960	Multiple myeloma,-	AGA	ZC4H2
ENSG00000287097	NA	7.50336294356966	4.46564355571427e-50	M1_vs_M0	HSALNG0052955	integenic	Q50	NA	Serum igg glycosylation measurement,Dna methylation,Carotid artery intima media thickness,-	MARCKS	KRT18P22
ENSG00000287100	NA	1.67748399903362	2.53402668946399e-4	M1_vs_M0	HSALNG0149240	integenic	Q75	NA	Stem cell growth factor beta measurement,-	ASF1A	DMGDH
ENSG00000287110	ACAD9-DT	-1.30731467319576	0.00802212731020644	M1_vs_M0	HSALNG0147926	integenic	Not conserved	NA	Heel bone mineral density,-	CFAP92	LINC00106
ENSG00000287125	NA	-3.23572229839655	0.0115015528258961	M1_vs_M0	HSALNG0113228	anti_sense	Not conserved	hsa-miR-3187-3p,hsa-miR-8072	NA	GSE1	LTB
ENSG00000287126	NA	-1.38650922790933	1.00468400806444e-7	M1_vs_M0	HSALNG0012585	integenic	Q75	hsa-miR-619-5p,hsa-miR-4505	-	NA	LPP-AS1
ENSG00000287133	NA	-4.67915425911064	0.0230733098804013	M1_vs_M0	HSALNG0146315	anti_sense	Q90	NA	-	CDK15	ENSG00000276900
ENSG00000287188	NA	2.24097979541205	5.33898133953948e-18	M1_vs_M0	HSALNG0038414	anti_sense	Q50	NA	-	DDX60	ZNF354B
ENSG00000287189	NA	3.24173412807609	2.17590552926138e-4	M1_vs_M0	NA	NA	NA	NA	NA	CEP43	LILRA5
ENSG00000287203	NA	-3.08842444523349	6.65342670865498e-4	M1_vs_M0	HSALNG0045515	integenic	Not conserved	hsa-miR-619-5p	Diabetic retinopathy	FGF1	KIF25
ENSG00000287222	NA	1.28478143162178	3.65880448833471e-4	M1_vs_M0	HSALNG0069338	anti_sense	Q75	hsa-miR-331-3p,hsa-miR-1237-5p,hsa-miR-3186-3p,hsa-miR-4508,hsa-miR-4734	-	IQANK1	ENSG00000289504
ENSG00000287245	NA	-2.39577412716614	6.79807704073355e-8	M1_vs_M0	HSALNG0087038	anti_sense	Not conserved	NA	NA	ZC3H12C	ENSG00000237529
ENSG00000287252	NA	-3.43828331864883	2.99348041004418e-5	M1_vs_M0	HSALNG0048904	integenic	Not conserved	hsa-miR-6089	NA	H2AC13	ENSG00000287616
ENSG00000287263	NA	1.03629494087576	4.16805359385259e-30	M1_vs_M0	HSALNG0041483	integenic	Not conserved	hsa-miR-6807-3p	Intelligence,Cytokine measurement	ANXA2R	ENSG00000286062
ENSG00000287264	NA	-4.89368987779547	0.00996468263272661	M1_vs_M0	HSALNG0084413	integenic	Q50	hsa-miR-619-5p,hsa-miR-3612,hsa-miR-4430,hsa-miR-4481	Body height,-	OR4D9	PGF
ENSG00000287278	NA	6.92987182269515	1.5851254208530802e-9	M1_vs_M0	HSALNG0077187	integenic	Q50	hsa-miR-6848-5p	Triglyceride measurement; High density lipoprotein cholesterol measurement,Apolipoprotein a 1 measurement; High density lipoprotein cholesterol measurement,Bmi-adjusted waist-hip ratio,Waist-hip ratio,Intelligence; Mathematical ability,Crohn's disease; Disease progression measurement,-	CCDC7	NFKB2
ENSG00000287299	NA	1.49453744577214	0.00295355521139408	M1_vs_M0	HSALNG0021467	anti_sense	Q75	hsa-miR-7703	Reaction time measurement,Urinary albumin to creatinine ratio,Alcoholic pancreatitis; Alcoholic liver cirrhosis,-	KCTD18	ANKFY1
ENSG00000287335	NA	8.05363379333194	1.2574647494748e-18	M1_vs_M0	HSALNG0130592	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6089	Seasonality measurement,-	NCOA3	TLX2
ENSG00000287346	NA	-2.95210889826881	0.0310033906829325	M1_vs_M0	HSALNG0104044	integenic	Q50	hsa-miR-619-5p,hsa-miR-4512,hsa-miR-6089	-	TDRD9	HGD
ENSG00000287367	NA	-4.67971863054573	0.0239554452638589	M1_vs_M0	HSALNG0041841	integenic	Q50	NA	-	SNX18	DAPL1
ENSG00000287385	NA	-4.2835709570677	6.13338778555364e-6	M1_vs_M0	HSALNG0102098	anti_sense	Q50	hsa-miR-1227-5p,hsa-miR-4308,hsa-miR-6869-3p	Cognitive function measurement,Monoclonal gammopathy,Prostate carcinoma,Body height,Coronary artery calcification,Bmi-adjusted waist-hip ratio; Gut microbiome measurement,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Balding measurement,High density lipoprotein cholesterol measurement,Diabetic nephropathy,-	ZFP36L1	ZNF785
ENSG00000287431	RENO1	-1.06170041804905	5.61541931688069e-7	M1_vs_M0	HSALNG0119244	integenic	Q90	NA	-	SLC38A10	ADRA1D
ENSG00000287480	NA	-1.14384660479627	0.0276120688174167	M1_vs_M0	HSALNG0069526	integenic	Not conserved	NA	NA	ZNG1A	ZCCHC12
ENSG00000287485	NA	5.69209019317112	5.63130862413043e-4	M1_vs_M0	HSALNG0050410	integenic	Q75	NA	NA	TNFRSF21	ENSG00000287485
ENSG00000287538	NA	2.50590754397087	2.9238529128474e-7	M1_vs_M0	HSALNG0084155	integenic	Not conserved	hsa-miR-6779-5p	NA	OR4C45	ARHGAP45
ENSG00000287543	NA	3.55698982331301	1.4938080529272899e-25	M1_vs_M0	HSALNG0144564	anti_sense	Q50	NA	Bmi-adjusted hip circumference,-	GOLGA6A	LRRC3B
ENSG00000287586	NA	-4.89412780810793	0.0231243841823422	M1_vs_M0	HSALNG0000406	anti_sense	Not conserved	NA	NA	C1orf174	ENSG00000287586
ENSG00000287616	NA	-3.10121630515388	0.0181665122683978	M1_vs_M0	HSALNG0052338	integenic	Q50	NA	-	HACE1	ENSG00000287252
ENSG00000287626	NA	6.58431447982399	5.8175797869523e-30	M1_vs_M0	HSALNG0048279	anti_sense	Not conserved	hsa-miR-6089,hsa-miR-6763-5p	Alkaline phosphatase measurement,Squamous cell carcinoma,Body height,-	JARID2	ENSG00000266947
ENSG00000287665	NA	1.94674582074978	0.0378368733900169	M1_vs_M0	HSALNG0149593	sense	Not conserved	NA	NA	FOXK1	TUBG1P
ENSG00000287687	NA	2.96460798682733	6.7941155314296e-9	M1_vs_M0	HSALNG0016092	integenic	Q50	hsa-miR-363-5p,hsa-miR-1268b,hsa-miR-5787	Pathological myopia,Eye measurement,-	M1AP	PTMAP9
ENSG00000287691	NA	3.10492431005228	0.014069138156097	M1_vs_M0	HSALNG0002358	anti_sense	Q50	hsa-miR-4448	Mosaic loss of chromosome y measurement,-	HPCA	ANKRD61
ENSG00000287733	NA	5.78516819135152	1.76509830735529e-208	M1_vs_M0	HSALNG0061536	integenic	Not conserved	hsa-miR-4761-3p	Monocyte count	TMEM140	TDO2
ENSG00000287736	PTCSC1	-4.67980935741771	0.0258486259856489	M1_vs_M0	HSALNG0068717	anti_sense,sense	Not conserved	NA	Eosinophil percentage of leukocytes	TG	ENSG00000275833
ENSG00000287743	NA	1.48939724202712	0.0122531432658561	M1_vs_M0	HSALNG0002890	anti_sense	Q75	NA	-	NFYC	SCML2
ENSG00000287787	NA	-3.28841115972828	1.68537439111367e-6	M1_vs_M0	HSALNG0113198	sense	Not conserved	NA	Balding measurement,Alopecia,Systolic blood pressure,Body weight,Triglyceride measurement; Response to diuretic	GSE1	ENSG00000260949
ENSG00000287789	NA	-6.03376323917163	9.01509129925555e-23	M1_vs_M0	HSALNG0149201	anti_sense	Q75	NA	NA	GJA10	RASGRP4
ENSG00000287825	NA	-2.83033551098402	2.61902510717388e-38	M1_vs_M0	HSALNG0050133	anti_sense	Q75	hsa-miR-619-5p	-	PEX6	ADCY6
ENSG00000287838	NA	-4.89332903491592	0.0264687320518891	M1_vs_M0	HSALNG0071161	integenic	Not conserved	hsa-miR-4650-5p	NA	SPATA31A1	CBR4
ENSG00000287910	NA	-4.68041804796275	0.0488243751181406	M1_vs_M0	HSALNG0114911	integenic	Q75	hsa-miR-619-5p	Cortical surface area measurement,-	TNFRSF13B	LINC01649
ENSG00000287991	NA	-5.08018603836698	0.00506249814612796	M1_vs_M0	HSALNG0144157	integenic	Q90	NA	-	CCNK	ENSG00000287991
ENSG00000287993	NA	-6.44578461095839	6.90111125559157e-7	M1_vs_M0	HSALNG0122517	integenic	Q75	NA	-	TSHZ1	GAS6-DT
ENSG00000287998	NA	-5.24860023380993	0.0169288359115312	M1_vs_M0	HSALNG0150225	integenic	Not conserved	hsa-miR-8485	-	BHLHE22	PADI1
ENSG00000288018	NA	-1.22474882751992	1.03564578800169e-4	M1_vs_M0	HSALNG0086321	integenic	Not conserved	NA	-	TYR	RPL7AP6
ENSG00000288046	NA	-3.54295090286735	2.0320772044446397e-12	M1_vs_M0	HSALNG0047831	integenic	Q75	hsa-miR-151a-5p,hsa-miR-151b,hsa-miR-4710	Serum alanine aminotransferase measurement,Reticulocyte count; Reticulocyte measurement,Bmi-adjusted hip circumference,Mean reticulocyte volume; Mean corpuscular volume; Erythrocyte count,Mean corpuscular volume,Monocyte count,Pelvic organ prolapse,Bmi-adjusted waist-hip ratio; Bmi-adjusted hip circumference; Urate measurement,-	LY86	HNRNPC
ENSG00000288098	NA	3.52874624655538	7.12214950568366e-6	M1_vs_M0	HSALNG0140454	integenic	Not conserved	NA	NA	MAGEC1	ENSG00000271855
ENSG00000288156	NA	-1.61508112665933	1.7413982062480197e-43	M1_vs_M0	HSALNG0123151	intronic_sense	Not conserved	NA	-	NA	SERTAD2
ENSG00000288162	NA	-2.0006415146883	1.58131161919256e-32	M1_vs_M0	HSALNG0055417	integenic	Not conserved	hsa-miR-1233-5p	Balding measurement,Glaucoma; Open-angle glaucoma; Lymphocyte count,-	FAM120B	OGFRL1
ENSG00000288600	NA	-3.23349572187281	0.0116765129929742	M1_vs_M0	HSALNG0096628	integenic	Q50	NA	Heel bone mineral density	RGCC	ZDHHC11B
ENSG00000288612	NA	-1.87689371784277	3.4662818544285e-7	M1_vs_M0	HSALNG0047550	sense	Q75	hsa-miR-1233-3p,hsa-miR-3943	NA	NQO2	RASSF3
ENSG00000288685	NA	4.82821620307033	0.0244682785617049	M1_vs_M0	HSALNG0036417	integenic	Q50	NA	NA	FAM241A	H1-3
ENSG00000288714	NA	-3.99689074132898	1.75055742893345e-8	M1_vs_M0	HSALNG0149266	integenic	Not conserved	NA	-	HECA	LINC00862
ENSG00000288720	NA	-4.67841791157014	0.0495966631571637	M1_vs_M0	HSALNG0147512	anti_sense	Not conserved	NA	Covid-19,Protein measurement	CCR9	KIAA1549L
ENSG00000288739	NA	-5.08189887288842	0.0165731834390211	M1_vs_M0	HSALNG0138120	anti_sense	Q90	hsa-miR-3960,hsa-miR-6805-5p,hsa-miR-6838-5p	-	MAGEH1	ENSG00000288739
ENSG00000288742	NA	1.33875434135081	0.0381681348368484	M1_vs_M0	HSALNG0127521	integenic	Not conserved	NA	NA	LAIR1	PALS2
ENSG00000288753	NA	-2.95334278153523	0.0388647486154228	M1_vs_M0	HSALNG0111796	anti_sense	Q75	NA	-	KIFC3	ENSG00000225806
ENSG00000288765	NA	4.22890168384163	1.88680170185117e-10	M1_vs_M0	NA	NA	NA	NA	NA	PCDH17	ENSG00000284734
ENSG00000288767	NA	6.23173878327298	5.08601042872061e-6	M1_vs_M0	HSALNG0096284	integenic	Not conserved	NA	NA	RFC3	TBL1XR1
ENSG00000288771	NA	-4.69610546817307	1.53995869970954e-20	M1_vs_M0	HSALNG0071712	anti_sense	Q50	NA	Fasting blood glucose measurement	PRKACG	PSMD7
ENSG00000288772	NA	-1.44225221916549	0.00626015535078912	M1_vs_M0	HSALNG0003091	anti_sense	Q75	NA	White matter microstructure measurement,Platelet count; Platelet crit,Igf-1 measurement,-	CDC20	MEST
ENSG00000288803	NA	5.80435525115139	6.92879925106941e-4	M1_vs_M0	HSALNG0005997	integenic	Q90	hsa-miR-619-5p	-	CD53	H1-3
ENSG00000288817	NA	-3.67430253750999	7.19575254379196e-4	M1_vs_M0	HSALNG0136685	integenic	Q75	NA	NA	FAM9C	TMEM42
ENSG00000288827	NA	2.02522272004552	3.54123664989145e-10	M1_vs_M0	NA	NA	NA	NA	NA	DHX34	ZIC5
ENSG00000288842	NA	-4.680421566835	0.0490301635489077	M1_vs_M0	HSALNG0133618	integenic	Q50	hsa-miR-92b-5p,hsa-miR-619-5p,hsa-miR-1205,hsa-miR-3692-5p,hsa-miR-3934-5p,hsa-miR-4472,hsa-miR-4505,hsa-miR-6751-3p,hsa-miR-6803-5p	Systemic lupus erythematosus,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,-	COL18A1	AK7
ENSG00000288845	NA	3.1049238563725	0.0140709283002417	M1_vs_M0	HSALNG0054719	anti_sense	Q50	hsa-miR-485-5p,hsa-miR-4467,hsa-miR-4516,hsa-miR-4530,hsa-miR-3960,hsa-miR-4707-3p,hsa-miR-6791-5p,hsa-miR-6858-3p,hsa-miR-7108-3p,hsa-miR-7112-5p	Leukocyte count,Lymphocyte count,Myeloid white cell count; Celiac disease,Lipoprotein a measurement,Nicotine dependence symptom count,Autoimmune disease; Systemic lupus erythematosus; Celiac disease,Hypothyroidism,Leukocyte count; Neutrophil count,Neutrophil count; Leukocyte count; Neutrophil percentage of leukocytes; Eosinophil count; Granulocyte count,Eczema,Crohn's disease; Inflammatory bowel disease; Celiac disease,Rheumatoid arthritis; Crohn's disease,Gut microbiome measurement,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Rheumatoid arthritis; Sclerosing cholangitis,Celiac disease,Rheumatoid arthritis,Rheumatoid arthritis; Celiac disease,-,Systemic lupus erythematosus,Cognitive inhibition measurement,Eosinophil percentage of leukocytes	FNDC1	PGAP2
ENSG00000288856	NA	-2.01212271032476	1.45106918593378e-13	M1_vs_M0	HSALNG0137398	anti_sense	Q50	NA	NA	ATP6AP2	SNORD48
ENSG00000288862	NA	-4.89417331943503	0.0267397465031507	M1_vs_M0	HSALNG0011323	integenic	Not conserved	hsa-miR-4290,hsa-miR-6728-3p	NA	RAB4A	ENSG00000288904
ENSG00000288885	NA	-2.01783640685233	0.00965982340406005	M1_vs_M0	HSALNG0133657	anti_sense	Not conserved	NA	NA	COL18A1	C10orf88B
ENSG00000288899	NA	5.00998964958615	0.00853526644954388	M1_vs_M0	HSALNG0127822	integenic	Not conserved	NA	NA	ZNF460	LINC02576
ENSG00000288904	NA	-4.89406239847789	0.0190537746358588	M1_vs_M0	HSALNG0047687	integenic	Not conserved	hsa-miR-3178	NA	FAM217A	ENSG00000288904
ENSG00000288919	NA	5.15497603121401	0.0142265718180501	M1_vs_M0	HSALNG0126003	integenic	Q75	hsa-miR-1237-5p,hsa-miR-4492,hsa-miR-6803-3p	-	MED29	ENSG00000262692
ENSG00000288926	NA	-1.23953526529131	0.0199051978615426	M1_vs_M0	HSALNG0024956	anti_sense	Q90	hsa-miR-4301	-	OSBPL10	MORC1
ENSG00000288927	NA	-1.82333276055106	1.4012956852323698e-11	M1_vs_M0	HSALNG0000949	anti_sense	Q90	NA	-	AADACL4	SNHG32
ENSG00000288928	NA	2.48493889807809	0.0084643049440864	M1_vs_M0	NA	NA	NA	NA	NA	HIF1A	ENSG00000254691
ENSG00000288940	NA	-6.69493014180039	9.27523195059923e-8	M1_vs_M0	HSALNG0148071	integenic	Q90	hsa-miR-4268,hsa-miR-6089	-	PCDH7	GYS1
ENSG00000288947	NA	1.95620746328797	7.31408421721316e-7	M1_vs_M0	NA	NA	NA	NA	NA	TBX20	TMEM123-DT
ENSG00000288951	NA	6.24172006577981	3.73802858483192e-5	M1_vs_M0	HSALNG0033010	integenic	Not conserved	NA	NA	BOD1L1	SLC22A1
ENSG00000288952	NA	3.90084665659405	4.81370938975138e-8	M1_vs_M0	HSALNG0024203	integenic	Q50	NA	NA	TIMP4	CA12
ENSG00000288954	NA	6.00137707419885	2.06759772325921e-4	M1_vs_M0	HSALNG0089060	integenic	Not conserved	hsa-miR-211-3p	Blood protein measurement,-	CLEC4E	BANCR
ENSG00000288966	NA	-3.417937407482	2.8709761426661703e-9	M1_vs_M0	HSALNG0066049	integenic	Q75	hsa-miR-149-3p,hsa-miR-3943,hsa-miR-4710,hsa-miR-4743-5p	Alkaline phosphatase measurement,-	XKR9	MRPL38
ENSG00000288983	NA	-1.22985249049908	0.0164863769753235	M1_vs_M0	HSALNG0110765	integenic	Not conserved	hsa-miR-619-5p	-	PRR14	TAFA3
ENSG00000288990	NA	-1.08547109425003	6.87140196657345e-16	M1_vs_M0	HSALNG0031952	anti_sense	Q50	NA	Inhalant adrenergic use measurement,Respiratory system disease,-	CEP19	TMSB4X
ENSG00000289000	NA	-4.42779776121067	0.0496775736154758	M1_vs_M0	HSALNG0074871	integenic	Not conserved	NA	Uric acid measurement; Urate measurement,Urate measurement	FAM78A	ADD3-AS1
ENSG00000289005	NA	4.6093255176229	0.0267340738771221	M1_vs_M0	HSALNG0029808	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-1249-5p,hsa-miR-4492,hsa-miR-6807-3p,hsa-miR-6871-5p	Breast carcinoma; Brcax breast cancer,Breast carcinoma,Brcax breast cancer,Non-alcoholic fatty liver disease severity measurement,Serum igg glycosylation measurement,Leukocyte count; Neutrophil count,Visual perception measurement,Asthma exacerbation measurement,Chronotype measurement,-	SELENOT	CDC42EP4
ENSG00000289007	NA	2.03304593824508	3.84946594907858e-18	M1_vs_M0	HSALNG0136377	integenic	Not conserved	hsa-miR-370-3p,hsa-miR-1228-5p,hsa-miR-6769b-5p	NA	DHRSX	UBQLN4
ENSG00000289055	NA	-4.42768635269169	0.0440068020478201	M1_vs_M0	HSALNG0012055	integenic	Q75	hsa-miR-4707-3p,hsa-miR-6803-5p,hsa-miR-8485	Mortality; Response to allogeneic hematopoietic stem cell transplant,-	AKT3	LINC02812
ENSG00000289070	NA	-1.97408697361352	2.81641311177665e-6	M1_vs_M0	HSALNG0118660	anti_sense	Q50	hsa-miR-619-5p	Blood protein measurement,-	CD300A	YARS2
ENSG00000289089	NA	2.27100945879282	1.16908375342882e-7	M1_vs_M0	NA	NA	NA	NA	NA	TBX20	ENSG00000252274
ENSG00000289104	NA	-3.67786270604445	0.00263011057233281	M1_vs_M0	HSALNG0064676	integenic	Q75	NA	Pancreatic carcinoma; Chronic mountain sickness; Platelet aggregation,-	TACC1	ZNF558
ENSG00000289110	NA	5.18111671964353	0.00549629904196	M1_vs_M0	NA	NA	NA	NA	NA	SYNRG	SLC10A6
ENSG00000289123	NA	-4.15627315617949	1.2180130179283202e-9	M1_vs_M0	HSALNG0072704	integenic	Q50	hsa-miR-619-5p,hsa-miR-644a,hsa-miR-4258,hsa-miR-4466,hsa-miR-4685-3p,hsa-miR-6803-5p,hsa-miR-6837-3p,hsa-miR-7704,hsa-miR-8069	Balding measurement,Platelet crit,Platelet count,Ulcerative colitis; Inflammatory bowel disease,Eczema,Bmi-adjusted waist-hip ratio,Waist-hip ratio,Neutrophil percentage of granulocytes,Eosinophil percentage of leukocytes,Eosinophil count,Parental genotype effect measurement; Gestational blood glucose measurement; Glycosuria,Leukocyte count,-	SYK	CCDC3
ENSG00000289135	NA	-2.00756777789452	2.8386964729101603e-9	M1_vs_M0	HSALNG0017086	anti_sense	Q50	hsa-miR-4488,hsa-miR-9899	Parental genotype effect measurement; Birth weight,-	ANKRD23	PPP5C
ENSG00000289161	NA	2.83929400249387	1.11814643061081e-162	M1_vs_M0	HSALNG0069294	anti_sense	Not conserved	hsa-miR-619-5p	-	MROH6	MRPL44
ENSG00000289173	NA	4.60616083670795	0.0323471247384435	M1_vs_M0	HSALNG0092178	integenic	Not conserved	hsa-miR-619-5p	-	CPM	ENSG00000289173
ENSG00000289194	NA	-1.87360855015381	7.78764076461857e-4	M1_vs_M0	NA	NA	NA	NA	NA	INCENP	ENSG00000287910
ENSG00000289198	NA	5.01033520320998	0.0101520793049653	M1_vs_M0	HSALNG0052920	integenic	Q90	NA	-	MARCKS	NME8
ENSG00000289217	NA	3.85933785287276	8.90085391300579e-8	M1_vs_M0	HSALNG0095701	integenic	Not conserved	hsa-miR-574-5p	Response to alcohol,Fasting blood glucose measurement,-	SGCG	DHRSX
ENSG00000289234	ZNF496-DT	1.50000248155754	1.5788963628362497e-30	M1_vs_M0	HSALNG0012257	integenic	Not conserved	hsa-miR-7156-3p	NA	NLRP3	OPLAH
ENSG00000289260	NA	3.10062582164673	5.07895318539702e-4	M1_vs_M0	HSALNG0044043	integenic	Not conserved	NA	-	FER	TLX3
ENSG00000289263	NA	-5.52884630632211	0.00235338078628278	M1_vs_M0	HSALNG0069085	integenic	Not conserved	hsa-miR-6848-3p	Systolic blood pressure,-	PTP4A3	RCOR2
ENSG00000289268	NA	-2.20330619178913	0.0265549332669637	M1_vs_M0	NA	NA	NA	NA	NA	FADS1	NBPF17P
ENSG00000289293	NA	1.32721257410374	2.62658107084947e-6	M1_vs_M0	HSALNG0117931	integenic	Q90	hsa-miR-4296,hsa-miR-4322,hsa-miR-4265,hsa-miR-3960	NA	MED13	ENSG00000280054
ENSG00000289295	NA	-1.18948434543707	0.0234720221670115	M1_vs_M0	NA	NA	NA	NA	NA	EXOSC3	EMILIN3
ENSG00000289307	NA	1.54646332297269	0.036700260325786	M1_vs_M0	HSALNG0111608	integenic	Q50	hsa-miR-619-5p,hsa-miR-4266,hsa-miR-6746-5p,hsa-miR-6754-5p,hsa-miR-10392-3p	Adolescent idiopathic scoliosis,Diet measurement; Body mass index,-	IRX3	ENSG00000281468
ENSG00000289317	NA	3.80161300833755	2.58309336677766e-4	M1_vs_M0	HSALNG0042985	integenic	Not conserved	hsa-miR-328-5p	NA	ANKRD34B	TENM4
ENSG00000289384	NA	4.15346332341526	1.18318906440811e-5	M1_vs_M0	HSALNG0143688	integenic	Q50	NA	-	KITLG	JAK3
ENSG00000289390	NA	2.25243774456107	0.0165637855479082	M1_vs_M0	HSALNG0047002	integenic	Not conserved	hsa-miR-5010-5p,hsa-miR-6798-5p	NA	PHYKPL	TMEM51-AS1
ENSG00000289407	NA	-3.9335061773991	1.049586950393e-4	M1_vs_M0	HSALNG0003260	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-6089	-	CCDC17	GLRB
ENSG00000289426	NA	3.06751996546079	2.15092211883388e-8	M1_vs_M0	HSALNG0008532	anti_sense	Q50	NA	Intelligence,-	TEX50	HMGB1P3
ENSG00000289440	NA	-1.49900013986977	0.00874561691888401	M1_vs_M0	HSALNG0072095	anti_sense	Q50	hsa-miR-378a-5p,hsa-miR-619-5p	-	GNAQ	CNTD1
ENSG00000289465	NA	1.69503093377067	0.0269520634570834	M1_vs_M0	HSALNG0087040	sense	Q50	hsa-miR-619-5p	NA	RDX	ADORA2A-AS1
ENSG00000289470	NA	5.53082924761812	1.81760343603936e-86	M1_vs_M0	HSALNG0062298	integenic	Not conserved	hsa-miR-4483	Testosterone measurement; Sex hormone-binding globulin measurement,-	TMEM176B	ENSG00000237927
ENSG00000289483	NA	-6.95549475909528	8.504044491168421e-10	M1_vs_M0	HSALNG0005183	anti_sense	Q90	NA	-	SETSIP	ENSG00000272482
ENSG00000289504	NA	-1.16730699619489	0.0109661675899233	M1_vs_M0	NA	NA	NA	NA	NA	MAPKAPK3	ENSG00000287222
ENSG00000289515	NA	-1.7481833034896	5.6344161273355e-7	M1_vs_M0	HSALNG0035305	anti_sense	Q90	NA	NA	CCDC158	ENSG00000279821
ENSG00000289581	NA	5.98094613517791	7.93080857052246e-5	M1_vs_M0	NA	NA	NA	NA	NA	RGL1	ENSG00000289426
ENSG00000289582	NA	8.84969828428764	1.77215459763625e-34	M1_vs_M0	NA	NA	NA	NA	NA	GBP2	CLEC4E
ENSG00000289588	NA	3.01385603121641	1.30083160132349e-35	M1_vs_M0	HSALNG0062635	integenic	Not conserved	hsa-miR-4731-5p	Caudate nucleus measurement; Functional brain measurement; Response to reward	SHH	AZIN2
ENSG00000289589	NA	3.5241177816893	3.36128993919116e-8	M1_vs_M0	HSALNG0008846	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-7108-5p	Eosinophil count; Eosinophil percentage of leukocytes,Eosinophil count,Neuroimaging measurement; Cortical thickness; Brain measurement,-	STX6	MTHFD1
ENSG00000289602	NA	-6.14545154699782	4.44375159075306e-5	M1_vs_M0	HSALNG0011006	integenic	Q75	hsa-miR-619-5p	NA	SRP9	NUP205
ENSG00000289839	NA	5.5841082294454	0.00101503596842745	M1_vs_M0	HSALNG0047169	integenic	Q50	NA	Ovarian carcinoma,-	CNOT6	RASEF
ENSG00000289880	NA	4.62366656130737	2.76054665194813e-8	M1_vs_M0	NA	NA	NA	NA	NA	FAM177B	HKDC1
ENSG00000289915	NA	5.59533328950905	7.510790532727911e-17	M1_vs_M0	HSALNG0126752	integenic	Q75	hsa-miR-378a-5p,hsa-miR-619-5p,hsa-miR-6726-3p,hsa-miR-6763-3p,hsa-miR-6873-3p	Body mass index,Leukocyte count,-	BBC3	RALGDS
ENSG00000289932	NA	-7.77156094862985	4.4977940883048205e-17	M1_vs_M0	HSALNG0113246	integenic	Not conserved	NA	Monocyte count,Monocyte percentage of leukocytes,Triglyceride measurement; Response to hydrochlorothiazide,-	IRF8	TNFRSF10A-DT
ENSG00000289947	NA	5.69337880089369	2.81139781200825e-4	M1_vs_M0	NA	NA	NA	NA	NA	ODF3B	LINC02100
ENSG00000289984	NA	-1.55555283062543	3.74768930615135e-4	M1_vs_M0	NA	NA	NA	NA	NA	ARHGEF15	CYB5B
ENSG00000289995	NA	-1.19478729103415	7.834705690664059e-22	M1_vs_M0	HSALNG0009283	integenic	Not conserved	NA	Colonic neoplasm; Overall survival	RGS13	CYTIP
ENSG00000290021	NA	2.74673560652597	2.8836727527579005e-10	M1_vs_M0	HSALNG0148005	anti_sense,sense	Q90	hsa-miR-4467	-	BCL6	HLA-L
ENSG00000290034	NA	-2.28763884796464	9.608840248345871e-15	M1_vs_M0	HSALNG0049994	anti_sense	Q50	hsa-miR-6728-3p,hsa-miR-8485	C-reactive protein measurement,Isoleucine measurement; Leucine measurement,Supraventricular ectopy,Family history of alzheimer’s disease; Late-onset alzheimers disease,Late-onset alzheimers disease,Aortic stenosis; Aortic valve calcification,-	TREML4	CYP46A1
ENSG00000290041	NA	4.21221115742756	5.41425435007059e-6	M1_vs_M0	HSALNG0003215	anti_sense,sense	Q75	hsa-miR-619-5p	Soluble triggering receptor expressed on myeloid cells 2 measurement,Intraocular pressure measurement,-	BTBD19	LINC01506
ENSG00000290060	NA	5.32173682759889	0.00191952783114017	M1_vs_M0	HSALNG0022124	integenic	Q75	NA	NA	SMARCAL1	FRMD6
ENSG00000290062	NA	-2.63460496950268	0.0379294083630605	M1_vs_M0	HSALNG0149078	anti_sense	Q50	hsa-miR-5587-3p	NA	TMEM170B	ENSG00000228201
ENSG00000290085	NA	-1.36767824694491	0.00168396812932678	M1_vs_M0	HSALNG0016448	integenic	Q75	hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-3960,hsa-miR-1199-3p,hsa-miR-6085	NA	TRABD2A	DRC7
ENSG00000290091	NA	-1.62715010648676	0.0142830537477676	M1_vs_M0	HSALNG0055874	anti_sense	Q50	hsa-miR-326,hsa-miR-762,hsa-miR-3195,hsa-miR-4505,hsa-miR-4632-3p,hsa-miR-5787,hsa-miR-6803-5p	Pcsk9 protein measurement,-	SLC29A4	H2AZP2
ENSG00000290399	NA	-2.00520009291747	0.0250113828866576	M1_vs_M0	HSALNG0104477	integenic	Not conserved	NA	NA	NIPA1	C3orf52
ENSG00000290404	NA	-4.43032690968984	5.99361298819532e-12	M1_vs_M0	NA	NA	NA	NA	NA	GOSR1	PAQR6
ENSG00000290441	NA	3.02174651141926	1.09876897992709e-6	M1_vs_M0	HSALNG0148215	integenic	Not conserved	hsa-miR-4505,hsa-miR-1587	NA	TLR2	TEF
ENSG00000290525	GBP1P1	11.9860225254231	1.3073524523872198e-224	M1_vs_M0	NA	NA	NA	NA	NA	GBP6	ENSG00000258521
ENSG00000290578	NA	6.37391034704404	3.96972287119614e-6	M1_vs_M0	HSALNG0142325	integenic	Not conserved	hsa-miR-4492,hsa-miR-6873-5p,hsa-miR-6873-3p	NA	PPIAL4H	ENG
ENSG00000290712	DSTNP2	1.90302490776483	8.32226016102679e-5	M1_vs_M0	NA	NA	NA	NA	NA	LRRC23	IL17C
ENSG00000290727	ALMS1P1	8.14065735033716	2.36931635768209e-20	M1_vs_M0	HSALNG0015975	anti_sense	Not conserved	NA	Serum metabolite measurement; Urinary metabolite measurement,-	ALMS1	FGF10-AS1
ENSG00000290735	NA	3.02174411767782	1.09876897992709e-6	M1_vs_M0	HSALNG0006949	integenic	Not conserved	NA	NA	H3-7	CLIC2
ENSG00000290737	NA	-1.52050901495019	0.0185497704598539	M1_vs_M0	HSALNG0078861	integenic	Not conserved	NA	NA	AGAP5	NCDN
ENSG00000290763	SDHAP1	-1.04146915766566	0.0073294233157642	M1_vs_M0	HSALNG0031873	integenic	Not conserved	NA	NA	TFRC	PSME3
ENSG00000290790	NA	1.76650154789635	5.25568216780596e-6	M1_vs_M0	HSALNG0006964	integenic	Not conserved	hsa-miR-6743-5p	NA	H2BC18	TFAP2A
ENSG00000290793	NA	2.52853418631201	7.93162088072378e-10	M1_vs_M0	NA	NA	NA	NA	NA	AMZ2	FLVCR2
ENSG00000290835	NA	1.30400524781882	1.3935809947569e-8	M1_vs_M0	HSALNG0056000	integenic	Not conserved	hsa-miR-619-5p	Neutrophil count,Leukocyte count; Myeloid white cell count,Ejection fraction measurement,Hematocrit; Hemoglobin measurement,Apoe carrier status,-	RSPH10B2	CAMKK2
ENSG00000290838	NCF1B	7.75199421539195	4.55241617811939e-16	M1_vs_M0	HSALNG0058823	integenic	Not conserved	hsa-miR-619-5p	NA	FKBP6	SDAD1-AS1
ENSG00000290862	NMRAL2P	4.82493411329243	0.0158250618110944	M1_vs_M0	NA	NA	NA	NA	NA	SENP2	H1-3
ENSG00000290865	RRN3P3	1.41210084881406	2.05560363858893e-14	M1_vs_M0	HSALNG0110195	intronic_sense	Not conserved	hsa-miR-6763-5p	NA	CDR2	TMEM44
ENSG00000290872	NA	-1.15517459444882	0.0011703826328318	M1_vs_M0	NA	NA	NA	NA	NA	PGAM2	MRPL3
ENSG00000290879	NA	-3.60540713670244	6.83193859749176e-11	M1_vs_M0	NA	NA	NA	NA	NA	APBA2	KLC1
ENSG00000290880	NA	-3.42424030329367	2.23528044273524e-15	M1_vs_M0	NA	NA	NA	NA	NA	APBA2	ENSG00000290979
ENSG00000290915	KLKP1	4.60936314762052	0.0270503708767083	M1_vs_M0	NA	NA	NA	NA	NA	KLK4	NME8
ENSG00000290926	LINC03006	-1.50275177131783	0.0344058505927711	M1_vs_M0	HSALNG0058555	integenic	Not conserved	NA	NA	GUSB	ENSG00000229422
ENSG00000290927	NA	2.64298944833093	4.02392198997321e-50	M1_vs_M0	HSALNG0110892	integenic	Not conserved	hsa-miR-210-5p,hsa-miR-320a-5p,hsa-miR-4289,hsa-miR-6132,hsa-miR-6722-3p,hsa-miR-6776-5p	-	KRBOX5	ENSG00000279861
ENSG00000290933	NA	-2.32361814819595	0.00312622518668333	M1_vs_M0	NA	NA	NA	NA	NA	LAIR2	ANO10
ENSG00000290965	OR7E47P	-4.42768673256299	0.0440219340103781	M1_vs_M0	NA	NA	NA	NA	NA	SMIM41	FUT11
ENSG00000290979	NA	-5.09266275775642	6.09380499428765e-27	M1_vs_M0	NA	NA	NA	NA	NA	TNFRSF13B	ENSG00000290880
ENSG00000290994	FAM86C2P	-1.46363950917025	9.75679435116668e-4	M1_vs_M0	HSALNG0085186	integenic	Not conserved	hsa-miR-619-5p	Hair colour measurement,Bmi-adjusted waist circumference,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference,Bmi-adjusted hip circumference,Body height,Interleukin 18 measurement,Qrs duration,Sex interaction measurement,-	ALDH3B2	EXOSC7
ENSG00000291003	NA	-1.41994951904586	1.1031443374573e-27	M1_vs_M0	HSALNG0104483	integenic	Not conserved	NA	NA	GOLGA6L22	GOSR2
ENSG00000291006	NA	-2.91381339368959	1.01874788019225e-81	M1_vs_M0	NA	NA	NA	NA	NA	TMEM14A	ABCC5
ENSG00000291015	NA	-1.80175597194669	5.36493582706787e-5	M1_vs_M0	HSALNG0135407	sense	Not conserved	NA	NA	TPTEP2-CSNK1E	GOLGA8S
ENSG00000291019	AACSP1	2.59569983565227	0.0141874540997786	M1_vs_M0	HSALNG0149043	integenic	Not conserved	NA	-	ZNF354A	CCDC125
ENSG00000291027	UBE2Q2P1	-2.72877816667941	0.0105318472785889	M1_vs_M0	HSALNG0107792	integenic	Not conserved	NA	Bmi-adjusted waist circumference; Bmi-adjusted hip circumference,Bmi-adjusted waist circumference,Bmi-adjusted hip circumference,Coronary artery disease,Body height,Appendicular lean mass,Bipolar disorder,-	WDR73	LINC03081
ENSG00000291028	LINC00933	-4.67940953753981	0.0196691998689197	M1_vs_M0	HSALNG0107794	integenic	Not conserved	hsa-miR-766-3p,hsa-miR-4749-3p	Appendicular lean mass,Bmi-adjusted waist circumference,Bipolar disorder,-	ZSCAN2	NEURL1B
ENSG00000291029	FKBP9P1	-2.39189824192693	0.00910214872039903	M1_vs_M0	HSALNG0058201	integenic	Not conserved	NA	-	SEPTIN14	KIAA1143
ENSG00000291034	NA	5.32552665512452	0.00247614203158222	M1_vs_M0	HSALNG0141205	integenic	Not conserved	hsa-miR-1273h-5p	NA	UTY	ACAN
ENSG00000291038	NA	-4.71273729512687	7.754985998964511e-15	M1_vs_M0	NA	NA	NA	NA	NA	APEX1	PCYOX1L
ENSG00000291043	GLUD1P3	-1.941421320442	1.80317516493136e-24	M1_vs_M0	HSALNG0078866	integenic	Not conserved	NA	-	SEC24C	SOD1
ENSG00000291048	NA	1.12851466803193	6.75804889390867e-17	M1_vs_M0	HSALNG0063241	integenic	Not conserved	hsa-miR-331-3p,hsa-miR-4418,hsa-miR-378g,hsa-miR-6089,hsa-miR-6132,hsa-miR-7703,hsa-miR-8077	Heel bone mineral density,Body weight; Neuroticism measurement; Red blood cell distribution width,Bmi-adjusted waist-hip ratio,Diet measurement,Neuroticism measurement,Systemic lupus erythematosus; Basophil count,Bmi-adjusted waist circumference,Red blood cell distribution width,-	PRAG1	METTL13
ENSG00000291054	NA	2.05301053076904	0.00165435529699826	M1_vs_M0	HSALNG0140357	integenic	Q50	NA	NA	CD40LG	CHPF2
ENSG00000291058	NA	-3.42377565643776	1.1170611958727699e-36	M1_vs_M0	HSALNG0104695	integenic	Not conserved	NA	-	APBA2	TTLL5
ENSG00000291061	NA	-5.3916671834202	0.0062174397099432	M1_vs_M0	HSALNG0071141	anti_sense	Not conserved	hsa-miR-4492	Ischemic stroke,-	ALDH1B1	RNU6-1016P
ENSG00000291064	RPL23AP7	-1.1641129365039	5.13323235932101e-6	M1_vs_M0	HSALNG0136334	anti_sense	Not conserved	hsa-miR-4469	NA	ACR	LINC02937
ENSG00000291069	BMS1P1	-3.16623791692117	4.15872251066886e-4	M1_vs_M0	HSALNG0077766	integenic	Not conserved	NA	NA	PTPN20	FIZ1
ENSG00000291073	NA	1.78084601021373	1.83490761860305e-4	M1_vs_M0	HSALNG0110122	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4673	NA	NPIPB3	PIGC
ENSG00000291077	NA	3.25681594858304	1.7068767949357e-41	M1_vs_M0	NA	NA	NA	NA	NA	ARHGEF19	YIPF4
ENSG00000291078	NA	1.59342646263755	1.1509957666273699e-20	M1_vs_M0	HSALNG0024083	integenic	Not conserved	hsa-miR-6873-3p	NA	EMC3	ASB12
ENSG00000291080	ZNF252P	-1.08378379081619	2.6410973753165702e-15	M1_vs_M0	NA	NA	NA	NA	NA	ZNF16	HSPA1A
ENSG00000291086	LGALS17A	5.89407624586775	8.28004346531342e-5	M1_vs_M0	HSALNG0126029	integenic	Not conserved	NA	NA	LGALS14	PRKCG
ENSG00000291097	HLA-L	1.94638356197019	0.0113413136320883	M1_vs_M0	HSALNG0049134	integenic	Not conserved	NA	NA	TRIM39	ENSG00000290021
ENSG00000291099	NA	-4.8937882042717	0.0100464951066272	M1_vs_M0	HSALNG0055915	integenic	Not conserved	NA	NA	OCM	CLEC1B
ENSG00000291113	NA	-2.23781758116713	6.2565712789641e-13	M1_vs_M0	HSALNG0046977	integenic	Not conserved	hsa-miR-202-3p,hsa-miR-619-5p,hsa-miR-4727-5p,hsa-miR-6089	Cleft lip; Cleft palate,-	N4BP3	PLXNA1
ENSG00000291114	SIGLEC17P	-2.57721603129112	3.3091189960282297e-16	M1_vs_M0	NA	NA	NA	NA	NA	SIGLEC7	PPCDC
ENSG00000291122	CASTOR3P	-1.83715511826922	5.89913703502915e-14	M1_vs_M0	HSALNG0150011	sense	Not conserved	hsa-miR-125a-3p	NA	GPC2	PTPN2
ENSG00000291129	PPIEL	1.03201232711262	1.03756499691888e-15	M1_vs_M0	HSALNG0002774	anti_sense	Q90	hsa-miR-631,hsa-miR-3135b,hsa-miR-4722-5p,hsa-miR-6089,hsa-miR-8485	Forced expiratory volume; Red blood cell distribution width; Traffic air pollution measurement; Fev/fec ratio; Peak expiratory flow; Peripheral arterial disease,Peripheral arterial disease; Alkaline phosphatase measurement; Traffic air pollution measurement,Testosterone measurement,Diastolic blood pressure,Triglyceride measurement; Mean corpuscular volume,Mean corpuscular volume; Mean corpuscular hemoglobin,Mean corpuscular hemoglobin,High density lipoprotein cholesterol measurement; Waist-hip ratio,Triglyceride measurement; C-reactive protein measurement; Waist-hip ratio,Chronic obstructive pulmonary disease; Resting heart rate,-	PABPC4	DEF6
ENSG00000291132	NA	-2.09198657578958	0.0152866123107738	M1_vs_M0	HSALNG0002304	anti_sense	Q50	hsa-miR-6089	Intelligence,-	TMEM234	PGM5
ENSG00000291133	NA	-5.24512362146407	0.00317567036632917	M1_vs_M0	HSALNG0057196	integenic	Q90	hsa-miR-101-3p	NA	TBX20	TFF2
ENSG00000291135	FCGR1BP	1.26866883958253	5.33647936090918e-5	M1_vs_M0	NA	NA	NA	NA	NA	SRGAP2C	UBA5
ENSG00000291137	GBAP1	-2.05852972930145	1.67682986058794e-8	M1_vs_M0	HSALNG0007483	integenic	Not conserved	NA	NA	THBS3	SGO1
ENSG00000291139	DPY19L2P2	-2.90850471225958	1.52758903171931e-4	M1_vs_M0	HSALNG0060242	integenic	Not conserved	hsa-miR-760,hsa-miR-6720-3p,hsa-miR-6889-3p	NA	NAPEPLD	ENSG00000234286
ENSG00000291143	NA	1.83867140409551	0.00420409251030093	M1_vs_M0	NA	NA	NA	NA	NA	OR2AG2	ZDBF2
ENSG00000291144	NA	2.1902736500596802	1.72407941322848e-39	M1_vs_M0	HSALNG0082349	overlap_sense	Not conserved	NA	Lung carcinoma,Mean corpuscular hemoglobin concentration,Hip bone mineral density; Hip bone size,Diastolic blood pressure,-	OR52K1	SLIT2
ENSG00000291158	LINC00869	1.02631886185569	3.3420300760111604e-9	M1_vs_M0	HSALNG0141914	integenic	Not conserved	NA	NA	PPIAL4C	LINC01341
ENSG00000291176	NA	-2.17271612990787	1.92125519977305e-6	M1_vs_M0	HSALNG0017006	integenic	Q75	NA	NA	CIAO1	HSD17B6
ENSG00000291188	NA	5.17421388037604	0.00355985912473309	M1_vs_M0	HSALNG0110573	integenic	Not conserved	NA	NA	LAT	LRRC1
ENSG00000291233	NA	3.95339136775308	7.15600457464069e-5	M1_vs_M0	NA	NA	NA	NA	NA	NBPF9	ENSG00000290021
ENSG00000291236	NA	4.66017679047325	2.25239972757967e-20	M1_vs_M0	NA	NA	NA	NA	NA	TNS1	C4B
ENSG00000291263	SMG1P7	2.09192879973638	1.82418524533658e-9	M1_vs_M0	NA	NA	NA	NA	NA	EXOSC6	ENSG00000277511
ENSG00000291300	PRSS30P	-1.75272384896318	0.0105851465463696	M1_vs_M0	NA	NA	NA	NA	NA	PRSS22	ENSG00000227704
